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  The Canadian Healthcare System is overburdened and requires fundamental changes for 
its continued sustainability. One possible solution is healthcare professionals working more 
collaboratively and to their maximum scope of practice. Saskatchewan pharmacists have had 
significant expansion in their scope of practice in the last decade and correspondingly, 
expectations of collaboration. This study’s primary objective was to explore the influence of 
pharmacists’ expanded scope of practice (ESoP) on physician collaboration in the community 
pharmacy setting. This thesis proposes a new model, the Community Pharmacists Collaboration 
Model (CPCM), for analysis of community pharmacists’ collaboration derived from the 
Collaborative Working Relationship, Hudson’s, Artimage’s, and Spectrum of Collaboration 
models. It uses this model to examine collaboration in the context of a community pharmacy 
setting, taking into consideration pharmacy partnerships and collaborative practice agreements.  
An online questionnaire was emailed to all 1165 practicing community pharmacists in 
Saskatchewan. The questionnaire acquired data on: participant demographics, ESoP engagement, 
most beneficial activities, influence on physician collaboration, and strategies for fostering 
collaboration. The questionnaire response rate was 15.7%. Pharmacists suggested ESoP 
positively influenced communication and collaboration, pharmacist utilization, clinical 
management, and pharmacist-physician relationships. ESoP may play a role at increasing the 
frequency and quality of exchanges between pharmacists and physicians, however, did not 
appear to improve the opportunity for verbal or written agreements. The most effective strategy 
identified for fostering collaboration was maximizing exchanges with physicians, especially 
verbal exchanges. Lack of physician engagement and restrictions to direct communication 




Pharmacists’ utilization of ESoP activities and its subsequent correspondence may be an 
avenue in which to improve collaboration with physicians. The CPCM model could prove to be a 
useful tool to aide in the understanding of collaborative practice in the community pharmacy 
setting. Further exploration into community pharmacy collaboration, particularly regarding 
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CHAPTER ONE: INTRODUCTION 
Background to the Study 
 The Canadian Pharmacist Association (CPhA) released a report in 2016, Toward an 
optimal future: Priorities for action, indicating that the landscape of community pharmacy has 
experienced extensive changes over recent years, both locally and internationally. “The role of 
the pharmacist has transitioned beyond dispensing medications to include direct patient care 
roles in primary care that complement the skill set of the physician” (Scott, Heck, & Wilson, 
2017, para. 22). Regulatory changes for licencing technicians have resulted in less dispensing 
functions by pharmacists and more technicians assuming the role (CPhA, 2016b). The traditional 
functions of a pharmacist, such as compounding, have largely been replaced by large-scale 
manufacturers (Jorgenson, 2012). “The primary role of the pharmacist is evolving from a focus 
on dispensing medications to taking increased responsibility for and facilitating optimal 
medication use through collaboration” (Kelly et al., 2013, p. 218). The International 
Pharmaceutical Federation (FIP, 2009) found a global trend toward more clinical, patient-
centered care with enhanced responsibilities and accountabilities. In Canada, this trend is 
occurring throughout the health system and the CPhA is addressing this need through the 
creation of pharmacy guidance documents. However, implementing this trend is difficult because 
Canada’s healthcare system is under extreme pressure and faces challenges to its future 
sustainability (CPhA, 2016b). Population health research suggests these stresses will likely 
continue to grow as the population ages, the prevalence of chronic disease increases, and drug 
costs continue to rise (CPhA, 2016b). Furthermore, as reforms push the Canadian healthcare 
system toward greater use of community-based models of care, community pharmacists will 
have increased expectations to work in a more coordinated and collaborative manner” (Dobson 




ways pharmacists can adapt their role to enhance drug therapy outcomes through patient centered 
care. The CPhA report (2016b) indicated that: 
Over the last 30 years, every healthcare profession has examined ways their profession 
can evolve and change how they work with other healthcare providers in order to focus 
on the patient, provide greater efficiencies in the delivery of services and support better 
health outcomes for Canadians. The need for information sharing, patient engagement 
and interprofessional collaboration has never been greater. (p. 10) 
The impact of these changes is now being reflected in community pharmacy practice through 
expansion of pharmacists’ scope of practice.  
Legislative and regulatory changes in Canada support expansion of pharmacists’ scope of 
practice (Donald et al., 2017). Since every province has its own body for registering and 
regulating pharmacy practice, every province has their own response to approving expanded role 
activities like renewing, adjusting, initiating or substituting prescriptions, as well as ordering and 
interpreting laboratory tests (Donald et al., 2017). Saskatchewan increased funding of more 
pharmacist-led clinical activities and passed legislation to expand the scope of practice of 
community pharmacists, such as immunizations, prescribing and ordering and accessing lab 
results (CPhA, 2015). When compared to other provinces and territories, Saskatchewan has some 
of the broadest changes to pharmacists’ scope of practice in Canada (CPhA, 2020). Furthermore, 
many of the amendments made to The Pharmacy Act within the last decade expanding 
pharmacists’ scope of practice are expected to be implemented by working collaboratively with 
doctors and other health professionals (Government of Saskatchewan, 2014). This increased 
opportunity theoretically has the potential to expand the degree and quality of interprofessional 




The benefits of effective teamwork can positively affect patient safety, patient outcomes, 
and is globally recognized as an essential tool for the delivery of effective patient-centered health 
care (Babiker et al., 2014). “The evolution in health care and a global demand for quality patient 
care necessitate a parallel health care professional development with a greater focus on patient 
centred teamwork approach” (Babiker et al., 2014, p. 1).  Healthcare professionals, including 
pharmacists, have been called upon to work more collaboratively in their practice (CPhA, 
2016b). Both physicians and pharmacists agree that collaborative practice can optimize patient 
care and health outcomes and both groups want more collaboration opportunities (Kelly et al., 
2013). One such opportunity is Expanded Scope of Practice (ESoP), which allows pharmacists to 
be more involved in community health care.  
In the broad frameworks and context of allied health practice of the individual 
professions, scope of practice refers to the range of roles, functions, responsibilities, and decision 
making capacity which the professional performs in the context of their practice (Sarrah.org.au, 
n.d.). Pharmacy ESoP refers to the legislative and regulatory changes that broaden the role and 
responsibilities of practicing pharmacists (Tannenbaum & Tsuyuki, 2013). Under authority of 
these new regulations pharmacists can provide additional services such as, initiating drug 
therapy, adjusting prescriptions, and administering a drug by injection (Tannenbaum & Tsuyuki, 
2013). Currently there is variability in the adoption of pharmacists’ ESoP services across 
Canada, since each province or territory is responsible for registering and regulating pharmacy 
practice (Tannenbaum & Tsuyuki, 2013).  
Evaluating community pharmacists’ perspective on how collaboration has changed 
between themselves and physicians because of the advances to pharmacists’ scope of practice, 




Additionally, information could be gathered on pharmacists’ level of engagement in ESoP 
activities and how they compare to traditional activities. Community pharmacists may also offer 
valuable insight into effective ways to enhance collaboration between physicians. Having a 
richer understanding in these areas has the potential to guide changes in pharmacy practice 
guidelines and legislation related to ESoP services. If expanding the pharmacists’ scope of 
practice results in improved interprofessional collaboration with physicians or positively 
influences community pharmacy practice, further support may be garnered, with the ultimate 
benefit of improving the health and wellbeing of members in our community. 
Purpose of the Study 
 The purpose of the study was to determine how changes to Saskatchewan pharmacists’ 
scope of practice have influenced interprofessional collaboration between community 
pharmacists and physicians. The study gathered data on the most influential expanded practice 
activities and access, and perceptions regarding engagement compared to traditional activities. 
Additionally, the study obtained pharmacists’ perspectives on strategies to improve 
collaboration.  
Research Questions 
The overarching research question was: how have changes to pharmacists’ scope of practice 
influenced interprofessional collaboration between community pharmacists and physicians? The 
following research sub-questions provide additional direction for this study:  
1. What level of engagement do community pharmacists have in ESoP activities compared to 
traditional pharmacy activities, and which are most impactful to collaboration? 
2. How have ESoP activities influenced interprofessional collaboration between Saskatchewan 




3.What strategies do community pharmacists find effective for fostering collaboration? 
Significance of the Study 
Multiple studies worldwide have demonstrated that interprofessional collaboration can 
increase functioning in healthcare and facilitate improved health care outcomes (Zwarenstein, 
Goldman, & Reeves, 2009). Working in a multidisciplinary fashion can foster “improved patient 
care through increased opportunities for communication, sharing of knowledge, cross-
fertilisation of ideas and a sense of partnership” (Weiss, Grey, Family, Tsuyuki, & Sutton, 2018, 
p.1). Community pharmacists are often forgotten members of healthcare teams, despite their 
potential to play a significant role in healthcare; therefore establishing collaborative relationships 
with general practice has proven difficult (Weiss et al., 2018). Doucette, Nevins, and 
Mcdonough, (2005) indicted that if pharmacists are going to have a positive impact on patient 
outcomes achieved with drug therapy, they will likely need to work more closely with physicians 
in managing medication therapy more effectively (Doucette et al., 2005). Kelly et al. (2013) 
stated: 
The organized structure of institutional settings facilitates communication and 
collaboration between health care professionals. Hospital pharmacists have demonstrated 
their ability to improve care by decreasing mortality and morbidity, reducing health care 
costs. However, collaborative practice in the community is more challenging (p. 219) 
The expansion to pharmacists’ scope of practice in recent years may create new opportunities for 
enhanced interprofessional collaboration, considering they are expected to be implemented in a 
collaborative manner with doctors and other healthcare professionals (Government of 
Saskatchewan, 2014). However, there appears to be limited information about ESoP influence on 




have explored the collaborative relationship between community pharmacists and physicians; 
therefore future research is warranted to gather the impact of changes to the pharmacist scope of 
practice (Kelly et al., 2013). Community pharmacists may offer valuable insight into how 
expansion of their role has affected collaboration with physicians and offer ideas and strategies 
for more robust collaboration. 
Researcher’s Positionality 
My interest in pharmacy or perhaps healthcare in general, was apparent from a very early 
age. As a child I always aspired to help people. I remember making special healing potions, 
lining up all my stuffed animals, each who had an ailment of some type, and curing them one by 
one. I was the neighbourhood pet and small animal rescuer who tried to nurture any living 
creature back to good health in make-shift cages in my backyard. I likely developed a false sense 
of confidence in my ‘healing abilities’ when my parents reported that the mauled gopher, bird 
with a broken wing, or whatever prairie animal being treated at the time, had miraculously 
sprung back to health while I was sleeping and released into the wild to enjoy their days. This 
solidified the perception of myself as a healthcare provider.  
Growing up and attempting to fit in and be accepted was difficult. I often felt different, 
de-valued, and outcast by people. The experience provided me with a deep sense of compassion 
and an understanding of what it is like to feel alienated, rejected, and unappreciated. The early 
and sustained impact of these experiences were so profound that it impelled me to identify with 
marginalized people or groups through out my life. It also fostered a very strong sense of 
advocacy for people or groups that are treated unfairly or with disregard. This desire for 
inclusion and equality remains a powerful driving force that guides many of my decisions and 




During my career, I worked in a variety of roles within the profession of pharmacy, the 
majority being community pharmacy. I worked in a busy community pharmacy setting and faced 
the difficulty of trying to incorporate patient care activities into workflow. I had the opportunity 
to work with inspiring pharmacists who pushed the boundaries of pharmacist’s scope of practice. 
Many fought tirelessly for new and innovative ways to work collaboratively with other 
professionals and help establish the community pharmacist as a valuable team member. My work 
in a clinical pharmacist role within a community pharmacy provided the opportunity to create 
new programs, form partnerships in the community, and explore creative ways to maximize the 
use of existing provincially funded services. These activities inadvertently challenged me to 
discover ways pharmacists could better collaborate interprofessionally and utilize their 
knowledge and skills; the success of the programs and expansion of services largely depended 
upon it. Working as a clinical pharmacist provided insight into how effective interprofessional 
collaboration could achieve positive patient outcomes, improve efficiencies in the delivery of 
healthcare, and help establish the pharmacist as a valuable member of an interprofessional team. 
Unfortunately, I also experienced the challenges faced by community pharmacists to 
collaborate interprofessionally. Barriers such as lack of time and training, attitudes around 
collaboration, and inadequate funding of pharmacist clinical services, often impeded progress. 
Quite often I witnessed pharmacists be ostracized, stereotyped, and their contributions 
minimized or discounted. There seemed to be a misconception and lack of awareness by some 
healthcare professionals as to the contribution and skill set pharmacists had to offer to patients 
and the health system in general. Furthermore, there appeared to be a reluctance to collaborate 




My position working at the College of Pharmacy and Nutrition at the University of 
Saskatchewan as coordinator of the pharmacy skills and experiential learning programs, provided 
exposure to the high priority placed on expanding the skill set of students in interprofessional 
collaboration. I helped facilitate a variety of different programs and activities aimed at increasing 
pharmacy students’ collaborative opportunities with students from other healthcare disciplines. I 
learned that pharmacy graduates have more training in interprofessional collaboration than ever 
before, along with new opportunities to practice pharmacy with the expansion of the 
pharmacists’ scope of practice.  I witnessed first-hand the talent, enthusiasm, and desire to help 
people from a new generation of pharmacy students. These positive attitudes reminded me of my 
own passion and reignited my drive to improve the opportunities available for new pharmacists 
to work interprofessionally and be accepted as valuable members of the healthcare team.  
In the past ten years the Saskatchewan College of Pharmacy Professionals (SCPP) in 
conjunction with the Saskatchewan government, have dramatically expanded the pharmacists’ 
scope of practice and with it associated training and funding of services (Government of 
Saskatchewan, 2014). Given the recent changes in the pharmacy landscape, I am interested in 
examining the influence pharmacists’ ESoP has on interprofessional collaboration with 
physicians. Additionally, I am curious about pharmacists’ level of engagement, determining 
which ESoP activities have affected collaboration the most, and gaining insight into effective 
strategies for improved collaboration. 
Delimitations 
The study had the following delimitations: 





• Only pharmacists connected to a community pharmacy were included in the study. 
Community pharmacists and pharmacies are the target of the study. 
• Pharmacists included in the study had to be practicing pharmacists as determined by 
SCPP. The study aimed to get perspectives from pharmacists who have real world 
experience with ESoP activities and collaborations with physicians. Data should be 
reflective of current pharmacy practice. 
Limitations 
The study had the following limitations: 
• Pharmacists are busy professionals; they may not participate in the questionnaire or may 
not go in depth with some of the answers because of that context. 
• My past and current relationships in community pharmacy could influence participation 
in the study or result in bias in responses. 
• Participants may provide socially acceptable answers because of their position or 
employment situation, even though they were informed the data is handled confidentially. 
Assumptions 
The study had the following assumptions: 
• Participants will clearly understand questions on the questionnaire.  
• Participants can accurately account for the quantity and appropriately assess the type of 
collaboration in which they have been involved.  
• Participants will be honest with their opinions and experiences. 
Definitions 




Advanced Practice: A practice that is so significantly different from that achieved at initial 
licensure that it warrants recognition of the expertise of the practitioner and the education, 
training and experience from which that capacity was derived (CPhA, 2016b, p.12). 
Collaboration: Collective action toward a common goal. It includes relationships and 
interactions between health professionals regardless of whether or not they perceive themselves 
as part of a team. Collaboration can be viewed as a spectrum, depending on the type of care 
required (Oandasan et al., 2006). 
Collaborative Care: “A joint communicating and decision-making process with the goal of 
satisfying the patient wellness and illness needs while respecting the unique abilities of each 
professional” (Makowsky et al., 2009, p.169). 
Collaborative Practice: “A process which includes communication and decision making, 
enabling a synergistic influence of grouped knowledge and skills. Elements of collaborative 
practice include responsibility, accountability, coordination, communication, cooperation, 
assertiveness, autonomy, and mutual trust and respect” (Bridges, Davidson, Odegard, Maki & 
Tomkowiak, 2011, para. 6). 
Differentiation: The state of segmentation of the organizational systems into subsystems, each 
of which tends to develop particular attributes in relation to the requirements posed by it relevant 
external environment (Lawrence & Lorsch, 1967). 
Exchanges: Physicians and pharmacists exchanging permission, information and responsibility 
for patient care (Randal et al., 2001). 
Integration: "the process of achieving unity of effort amount the various subsystems in the 




Partnership: A shared commitment, where all partners have a right and an obligation to 
participate and will be affected equally by the benefits and disadvantages arising from the 
partnership (Carnell & Carson, 2005). 
Pharmaceutical Care: Involves taking direct responsibility for patients and their disease states, 
medications, and management of each to improve overall patient outcomes (CPhA, 2016b, p.16). 
Pharmacist Collaborative Practice Agreements (CPA): CPA create a formal practice 
relationship between pharmacists and other health care practitioners, whereby the pharmacist 
assumes responsibility for specific patient care functions that are otherwise beyond their typical 
“scope of practice”, but aligned with their education and training. These patient care services can 
include initiation and modification of drug therapy (The American College of Clinical Pharmacy, 
2015). 
Pharmacy Expanded Scope of Practice: Pharmacy ESoP refers to the legislative and 
regulatory changes that broaden the role and responsibilities of practicing pharmacists. Under 
authority of these new regulations pharmacists can provide additional services such as, initiating 
drug therapy, adjusting prescriptions, and administering a drug by injection (Tannenbaum & 
Tsuyuki, 2013). 
Scope of Practice (of an Allied Health Professional): The broad frameworks and context of 
allied health practice of the individual professions including: (1) the range of roles; (2) functions 
and responsibilities; and (3) decision making capacity which the professional performs in the 
context of their practice. (Sarrah.org.au, n.d.) 
These definitions will serve to provide some context to terms used throughout the preceding 




Organization of the Thesis 
The objective of the study is to examine the influence of pharmacists’ ESoP on physician 
collaboration in community pharmacies. Chapter One provides an orientation into the landscape 
of community pharmacy in relation to recent changes to pharmacy practice. Readers are given 
some context with an overview of the current pharmacy environment and background about the 
researcher’s experience and interest in the topic. Goals and objectives of the study are presented, 
as well as its significance in the field. Chapter One closes with fundamental study information 
and definitions used throughout the rest of this document to help frame the upcoming 
information in Chapter Two.  
Chapter Two is arranged to provide readers with a foundation of relevant topics related to 
the research. Readers are guided through some background on community pharmacy practice, 
the changes to pharmacist scope of practice and the significance of those changes. Next, the topic 
of interprofessional practice and collaboration will be discussed and its relation and importance, 
as well as associated challenges. The reader is presented with three different theories or models 
of collaboration. The last stage of Chapter Two ties all elements of pharmacist ESoP and 
physician collaboration by presenting a theoretical model based on the theories presented. The 
model provides insight into the conceptual design and directs the study design discussed in 
Chapter Three. 
Chapter Three provides background about how the researcher chose to design their study 
to achieve their stated objectives. The choice of methodology is discussed, along with the 
theoretical underpinnings guiding the study design. Relevant details about the study are provided 
including information about participants and the study tool utilized. Discussion of data collection 




Three discusses strategies used to enhance the quality of the study by addressing trustworthiness 
of data and ethical considerations. The chapter aptly prepares readers to understand the data 
presented in Chapter Four. This chapter contains a description of the study’s findings and their 
relevance, presented through a series of text, graphs, and tables. Chapter Five examines the data 
in more depth and connects the findings back to the literature, and to the conceptual framework, 


















CHAPTER TWO: LITERATURE REVIEW 
 Background to the Study 
 The Canadian Pharmacist Association (CPhA) (2016b) suggested a stressed and 
overburdened Canadian healthcare system is a main driving force for expansion of scopes of 
practice and progression toward person-focused care. Population health research indicated that 
stress on the healthcare system will continue to grow as the rates of chronic disease increase, the 
population ages, and technological and pharmaceutical innovations drive up costs (CPhA, 
2016b). Rather than pouring more money into the healthcare system, focusing on fundamental 
changes in how healthcare is organized, financed, and delivered will likely lead to improvements 
in access to healthcare and overall health outcomes (CPhA, 2016b). All healthcare professions 
are currently evaluating how their profession can evolve and work with other healthcare 
providers to focus on the patient, provide greater efficiencies in the delivery of services, and 
support better health outcomes for Canadians (CPhA, 2016b). A 2016 Review of Pharmacy 
Services in Canada and the Health and Economic Evidence by the CPhA stated that pharmacists 
play an integral role in mitigating healthcare expenses and improving health outcomes. As a 
result, each province and territory has taken steps to expand the pharmacists’ scope of practice 
(CPhA, 2016a). Additionally, Canadian pharmacy organizations have responded by providing 
reports to guide pharmacy stakeholders on the expectations and roles the pharmacy profession 
should take in helping address patient and healthcare system needs. 
In 2015 the CPhA reviewed the formalized document known as The Blueprint for 
Pharmacy to outline the vision for Pharmacy in Canada and discuss its evolution in relation with 
the changes to pharmacists ESoP. The document stated that pharmacists and technicians are 
essential to emerging healthcare models and therefore should practice to the full scope of their 




therapy in collaboration with patients, caregivers and other healthcare providers; 2) initiate, 
modify and continue drug therapy (e.g. through practice collaborative agreements, delegated or 
prescriptive authority); and 3) conduct practice research and contribute to evidence-based 
healthcare policy and best practices in patient care (CPhA, 2015). 
These recommendations formulated over a decade ago provided direction and created the 
necessary foundation for subsequent practice and legislative changes to pharmacists’ expanded 
scope of practice (ESoP).   
In 2016 the Canadian Pharmacist Association released another report titled, Toward an 
optimal future: Priorities for action. Its purpose was to facilitate the identification and 
communication of goals, actions, and responsibilities to move the profession forward and enable 
optimal scopes and practices for the profession of pharmacy in Canada. It stated, “The global 
trend for pharmacy continues toward a more clinical, patient-focused profession, with enhanced 
responsibilities and accountabilities for pharmaceutical care in clinical environments” (CPhA, 
2016b, p.11). They acknowledged that the profession of pharmacy has undergone significant 
changes in Canada and worldwide. Both pharmacists and technicians are working in advanced 
roles that provide value to other healthcare professionals, patients, and the broader healthcare 
system. Backed by regulatory changes, the pharmacist’s role is evolving away from dispensing 
medications and toward direct patient care (CPhA, 2016b). The report states that even though 
there is progress in this area and much championing for advancing practice, many pharmacists 
are lagging in provision of pharmacy patient care services. The CPhA (2016b) acknowledged, 
“unique barriers exist in different settings and that uptake of advanced practice varied greatly 
between jurisdictions” (p. 3). They argued that the pharmacy profession is an untapped resource 




According to the CPhA (2016b) report, pharmacists are considered the most accessible 
healthcare providers and have a unique body of knowledge and skills, making them well-
positioned to provide solutions to many of Canada’s healthcare system challenges. “The 
pharmacy profession has experienced extensive changes in recent years, but more needs to be 
done to support pharmacy professionals embracing their full scopes of practice in order to 
respond to health system needs in Canada” (CPhA, 2016b, p.11). Both physicians and 
pharmacists agree that collaborative practice can optimize patient care and health outcomes 
(Kelly et al., 2013). Exploration into pharmacists’ ESoP in community practice and collaboration 
with physicians could provide valuable insight into the contribution community pharmacists are 
making to the broader goals of improved health outcomes for Canadians and healthcare system 
efficiencies.  
Expanded Scope of Practice 
The role of the pharmacist is continuing to evolve away from traditional functions like 
dispensing, and toward taking increased responsibility for facilitating optimal medication use 
through collaboration (Kelly et al., 2013). Research from the International Pharmaceutical 
Federation (FIP) (2009) found that there was a global trend toward more clinical, patient-
centered care with enhanced responsibilities and accountabilities. Labrie (2015) indicated that 
much scientific literature shows benefits of expanding the pharmacists’ role to the health care 
system, such as improved access to care, improved quality of care, and numerous economic 
savings. Conscious of the benefits that pharmacist services can bring, some provincial 
governments have delegated certain tasks that were traditionally the responsibility of physicians 
to pharmacists (Labrie, 2015). The range of enhanced authority supporting pharmacist-driven 
clinical services varies widely internationally, but also significantly within Canada (FIP, 2009) 




mainly comprised of 14 single payer systems. Therefore, pharmacists have a range of activities 
and associated funding related to their scope of practice which differs from one province to the 
next. Below is a chart created by the Canadian Pharmacist Association (CPhA) highlighting 
provincial differences in scope of practices as of June 2020. 
Table 2.1 Pharmacists Expanded Scope of Practice Among Canadian Provinces and Territories 
(Canadian Pharmacists Association, 2020) 
  
 
The CPhA chart categorizes pharmacists’ ESoP into four general areas: prescriptive 
authority, injection authority, labs, and technician regulation. This general layout acts as a basis 




of the four general categories are 15 sub-categories with more specific activities listed.  Based on 
the chart the largest pharmacist ESoP is in Alberta with 15/15 activities implemented, followed 
by 12/15 activities implemented for Saskatchewan and New Brunswick. Although the chart 
provides a general glimpse into ESoP nationally, it does not provide detail about the large 
variances within each sub-category from province to province, such as minor ailment 
prescribing. 
Saskatchewan pharmacists have one of the largest scopes of practice compared to other 
provinces (CPhA, 2020) and thus it serves as a prime location to evaluate pharmacist 
collaboration in relation to the newly appointed changes in practice and subsequent clinical 
services. Twelve years have now passed since The Blueprint for Pharmacy was released and the 
profession has had exponential growth in scope of practice, particularly in Saskatchewan (CPhA, 
2015). Rigby (2010) suggested that given the changes in the pharmacists’ role toward more 
patient-centered care, the traditional relationship between physician and pharmacist may no 
longer be appropriate to ensure safety, effectiveness, and adherence to therapy. Now seems like 
an ideal time to investigate the influence this change has had on collaboration with physicians 
and community pharmacy practice. Many pharmacists have experienced what community 
pharmacy practice entailed before ESoP activities were implemented. Therefore, they may offer 
valuable insight into its influence, particularly in relation to physician collaboration. 
Benefits of Expanded Scope of Practice 
 The World Health Organization (as cited by CPhA, 2016b) suggested that the shortage of 
healthcare workers worldwide would increase from a 7.2 million deficit to 12.9 million by 2035. 
In Canada, five million Canadians do not have access to a family physician due to a physician 




such as those in Saskatchewan, where one-third of the population lives in rural areas (Gauvin, 
Lavis, & McCarthy, 2015). Expanding the pharmacists’ role and practicing care that is more 
advanced is one way to address healthcare workers shortages (CPhA, 2016a). “Internationally, 
pharmacists are increasingly integrated into front-line services and collaborate with doctors and 
other health professionals to improve the efficiency of the health care system and access to care” 
(Labrie, 2015, p.2). Liaw and Peterson (2009) surmised that pharmacists can improve prescribing 
practices, reduce medication costs and health-care utilization, along with contributing to clinical 
improvements in chronic diseases like diabetes, cardiovascular disease, and psychiatric 
conditions.   
The demand on the healthcare system and healthcare professionals is expected to increase 
as our population ages (CPhA, 2016b). More complex care needs, increased number of drug 
therapies, patient demand, and deficiencies in the healthcare system are increasing the need for 
more pharmaceutical care (CPhA, 2016b). Many countries have created pharmacist run programs 
designed to manage chronic diseases such as hypertension, asthma, and diabetes (Labrie, 2015). 
Increased pharmaceutical care could improve compliance, decrease medication errors and result 
in better chronic disease management (CPhA, 2016b). In Canada, for example, having 
hypertension managed in community pharmacies could lead to lower blood pressure outcomes 
and save an estimated $70 million dollars as a whole for the public health care system (Labrie, 
2015). Additional areas potentially benefitting from pharmacists’ ESoP are comprehensive 
medication reviews, minor ailment management, immunizations, expanded clinical services to 
improve access and safety, transitions in care, education, behavioural counselling, and 




An example of the beneficial effects of pharmacists’ ESoP is in minor ailment 
management. Pharmacists assessing patients, helping manage minor conditions or prescribing a 
medication for its management could avoid costly physician or emergency room visits. The 
CPhA (2016b) referenced a report by the Health and Welfare Commissioner from 2014 that 
claimed upward of 60% of hospital emergency room visits were attributed to minor conditions 
that could be treated elsewhere, such as a pharmacy, thereby reducing wait times, saving 
healthcare system dollars and potentially increasing access to care. The CPhA (2016b) report 
includes an estimate from the Ontario Pharmacists Association (2009) suggesting maximizing 
pharmacists’ scope in this area could yield an economic saving of 4.7 to 14 million dollars per 
year. Another projection done in 2013 by the British Columbia Pharmacists Association 
estimated a 32 million dollar per year saving by transferring treatment of minor ailments from 
physicians to pharmacists (CPhA, 2016b). Labrie (2015) speculated that programs expanding the 
pharmacists’ role can alleviate the physician workload, thereby saving an estimated 23 million 
Canadian dollars per year. From a system and economic standpoint alone, it may prove 
advantageous to determine optimal implementation strategies, including effective collaboration 
with other healthcare professionals. 
Expanded Scope of Practice in Saskatchewan 
Background 
 There are 1755 practicing pharmacists in Saskatchewan, with approximately 1183 of 
those working in 360 community pharmacies, in over 80 communities in Saskatchewan 
(Saskatchewan College of Pharmacy Professionals, 2020). This figure translates to community 
pharmacists accounting for 67% of all pharmacists positions in Saskatchewan.  Over the last 




legislative changes to The Pharmacy Act expanding their scope of practice, with the majority of 
changes affecting community pharmacy practice (Bareham, 2016). Subsequently, as the 
pharmacist role continues to expand, so too does that of the pharmacy technician (CPhA, 2016b). 
Saskatchewan currently has registered technicians practicing provincially, which potentially free 
up the pharmacist for more clinical related opportunities (CPhA, 2016b).  
In 2011, Saskatchewan pharmacists were given the authority to prescribe medications for 
specific minor ailments, provide emergency supplies of prescribed medications, and extend 
refills on existing prescriptions while working in a collaborative practice environment 
(Government of Saskatchewan, 2014). In 2014 Health Minister Dustin Duncan introduced 
another set of legislative amendments to The Pharmacy Act of 1996 that further expanded the 
scope of practice for Saskatchewan pharmacists (Government of Saskatchewan, 2014). 
Implemented in 2015, these amendments authorized pharmacists to administer vaccines and 
other drugs, as well as, order, access, and use laboratory tests when working in collaboration 
with physicians. 
Expanded Scope of Practice/Advanced Practice Activities and Reimbursement 
 In the last twelve years, Saskatchewan pharmacists have been granted a wide range of 
ESoP and professional practice activities. To best examine the influence of pharmacist ESoP 
activities, it is pertinent to have a clear description of what ESoP services are. The 2016 CPhA 
report Review of pharmacy services in Canada and the health and economic evidence provided a 
brief description of the services. In 2015, the PAS also created a chart of funded professional 
services in Saskatchewan. Based on the above sources, the following chart provides an overview 
of the specific ESoP and advanced practice activities currently in place in Saskatchewan, along 




Table 2.2 Saskatchewan Pharmacists Expanded Scope of Practice Activities 





Continuity of Care 
Pharmacists can renew a prescription without prior 
prescriber consent, to ensure continuity of care. 
Pharmacists can fill up to 3 months of a medication and 




To enhance patient outcomes, pharmacists can provide a 
patient assessment and adapt a prescription to change the 




To best suit the needs of the patient, pharmacists can make 
a therapeutic substitution to another drug, provided the 




Pharmacists can have prescriptive authority for any 
schedule 1 drug, excluding controlled drugs and 
substances, within or under a practice collaborative 
agreement. In the case of an emergency, where there is an 
immediate need but no existing prescription, pharmacists 
may also initiate Schedule 1 prescription drug therapy.  
Emergency 
supplies Only - 
$10  
Prescribe for Minor 
Ailments 
Pharmacists can prescribe Schedule 1 drug therapy for the 
treatment for 26 specific minor ailments outlined in the 
jurisdictional legislation/regulation.  
$18  
Administer a Drug by 
Injection 
Pharmacists can administer a drug or substance by 
injection. This includes most routine injections or 
immunizations (most commonly influenza). Specific 
regulations and restrictions apply.  
Influenza & 
Depo-Provera 




For the purpose of medication monitoring, pharmacists 
have authorization to order, receive, and interpret the 
results of laboratory screening. Implementation is pending 






To increase medication adherence and compliance, avoid 
harmful interactions, and de-prescribe. Pharmacists can 
provide core medication assessment and review via the 







Counselling to assist in reduction and discontinuation use 
of tobacco via the PACT program (Partnership to Assist in 
the Cessation of Tobacco). 
$2/min  
$180 max/year 
Adapted from PAS 2015 Ministry of Health, Drug Plan and Extended Benefits Branch Funded 
Professional Services in Saskatchewan and CPhA 2020 report A Review of Pharmacy Services 
in Canada and the Health and Economic Evidence (note that changes in remuneration were 
announced November 2018 but are not yet publicly available) 
 
For the purposes of this study, these services listed in the chart have been classified as those that 
are outside of the usual scope of pharmacist services and thereby considered ESoP activities.  
Collaborative Practice Agreements (CPA) 
 Another avenue available for pharmacists to practice beyond their traditional scope is via 
a Collaborative Practice Agreement (CPA). The American College of Clinical Pharmacy (ACCP, 
2015) defined Collaborative Practice Agreements (CPA) as a “ formal practice relationship 
between pharmacists and other health care practitioners, whereby the pharmacist assumes 
responsibility for a specific patient care function that are otherwise beyond their typical scope of 
practice but aligned with their education and training” (p.2). This could include initiation and 
modification of drug therapy (ACCP, 2015). The Centre for Disease Control and Prevention 
(CDC) released a 2013 document in which they defined a CPA as “a formal agreement in which 
a licensed provider makes a diagnosis, supervises patient care, and refers the patient to a 
pharmacist under a protocol that allows the pharmacist to perform specific patient care functions 
(p.1). The Saskatchewan College of Pharmacy Professionals (SCPP) allows pharmacists to 
prescribe schedule 1 medications, excluding narcotic and controlled substances, and order and 
interpret lab values via a CPA. They created a document Framework for Developing a Safe and 
Functional Collaborative Practice Agreement on their website (SCPP, 2017 n.d.). The document 




interdisciplinary collaboration. CPAs appear to be a widely accepted concept in pharmacy 
settings, and are often portrayed as the gold standard, yet there seems to be limited literature 
about where CPAs fit within pharmacist collaboration. 
Expectations of Collaboration  
The amendments to The Pharmacy Act recognize the ability of pharmacists to improve 
health care delivery in the province, working collaboratively with doctors and other health 
professionals. Health Minister Dustin Duncan stated at the time that, “All health care providers, 
including pharmacists play an increasingly important role by working to their full scopes of 
practice on a collaborative team (Government of Saskatchewan, 2014, para. 3). Furthermore, the 
regulatory body, Saskatchewan College of Pharmacy Professionals (SCPP) registrar Ray Joubert 
emphasized at the time that they would take steps to work collaboratively with the various 
stakeholders to ensure appropriate standards and training are in place so that services are 
delivered safely and are properly co-ordinated within the health system (Government of 
Saskatchewan, 2014). Many of the new ESoP services have resources built into the process to 
encourage collaboration, such as a form sent to physicians after prescribing a medication for a 
minor ailment. Exploring if and how these services have influenced collaboration with 
physicians in practice, compared to traditional duties is interesting. Health Minister Duncan, 
SCPP and PAS, all claimed that Saskatchewan residents should benefit from pharmacists’ 
expansion in scope of practice by providing greater and more timely access to health services 
(Government of Saskatchewan, 2014). To assess pharmacist and physician collaboration, we 





There is variance in the literature of what it means to practice interprofessionally. Having 
a clear understanding of what it means is vital in the evaluation of collaboration in community 
pharmacy. Confusion about what it means to be part of primary healthcare teams, 
multidisciplinary teams, or interdisciplinary teams could result in a false narrative of community 
pharmacists’ actual degree and nature of collaboration. Some pharmacists may not consider 
themselves as part of a multidisplinary team or a primary health team, even though they may be 
actively involved in collaborative actions that are improving the health and wellbeing of patients; 
possibly this perspective could be because of environmental determinants such as the physical 
separation of the community pharmacy from other healthcare providers. For example, if 
collaboration is viewed as a community pharmacist sitting at a round table with other healthcare 
professionals discussing therapeutic options for a patient then there is the potential to largely 
under represent the various types of collaboration that are taking place, particularly in 
community pharmacy, in which it would be rare for such an activity to occur.  
The organized structure of institutional facilities like hospitals or structures within the 
health regions facilitates communication and collaboration between health care professionals; 
however, collaborative practice in the community is more challenging (Kelly et al., 2013). 
Oandasan et al. (2006) argued that “collaboration is a process that requires relationships and 
interactions between health care professionals regardless of whether or not they perceive 
themselves as part of a team” (p.16). The preferred term used when examining integration of 
services is collaboration (Bradley, Darren & Peter, 2012). Loxley, as cited in Bradley et al. 
(2012), agreed that ‘collaboration’ is an appropriate description in the context of health and 
working together since it acknowledges the interwoven conflict between professionals. For the 




pharmacists’ interactions with healthcare professionals, rather than teams, team work, primary 
health teams, interprofessional or multidisciplinary teams. 
The term collaboration has varying definitions in the literature. Makowsky et al. (2006) 
defined collaboration as a “joint communicating and decision-making process with the goal of 
satisfying the patients’ wellness and illness while respecting the unique abilities of each 
professional” (p. 169). Unlike many of the very descriptive terms defining collaboration, 
Oandasan et al. (2006) portrayed collaboration in a broader sense; they described it as collective 
action toward a goal. They acknowledged that collaboration is a process that requires 
relationships and interactions between healthcare professionals. As a result, ultimately the health 
care professionals themselves determine when collaboration has occurred. Oandasan et al. (2006) 
viewed collaboration as a spectrum, involving a wide range of collaboration, depending on the 
type of care required. This view of collaboration seems less restrictive and more consistent with 
the collaborative practices experienced in community pharmacy. 
If the ultimate goal of interprofessional collaboration is, care that leads to improved 
quality, access, continuity of care, and more appropriate utilization of resources, then it is 
important to broaden the scope of what it means to practice collaboratively (Oandasan et al., 
2006). This understanding is particularly relevant when analysing interprofessional collaboration 
through the lens of community pharmacists. Community pharmacists are often not viewed as a 
core part of primary healthcare teams since they are perceived as a retailer, and reimbursement 
was historically for the sale of a good or physical product rather than services (Rigby, 2010). 
Add to that the geographical isolation and separate premises (Rigby, 2010), it seems unrealistic 
to apply the same standards in evaluating interprofessional collaboration in community 




study evaluating pharmacists’ and physicians’ views on collaborative practice. They stated they 
could not identify a standard definition in the literature for collaboration that was applicable to 
the subject matter. Therefore, they choose to define collaborative practice as “Family doctors and 
community pharmacists sharing information and working together to improve health care 
delivery for a specific patient” (Kelly et al., 2013, p. 219). This definition is more closely aligned 
with collaboration occurring in community pharmacy practice, since the main recipient of 
interprofessional collaboration tends to be family physicians, who are main prescribers of 
medications in community pharmacy settings. 
Benefits of Collaboration 
The Canadian Academy of Health Sciences (CAHS) released a report on optimizing 
scopes of practice (as cited by CPhA, 2016b). The report suggested that a prime way to expand 
and integrate advanced scope and services into practice is through collaborative care models 
(CPhA, 2016b). Interprofessional collaboration has played an important role in improving 
healthcare services and patient outcomes (Reeves et al., 2011). As a result, interprofessional 
collaboration has become a high priority for healthcare and health education decision-makers 
internationally (Reeves et al., 2011). In particular, pharmacist-physician collaboration can help 
improve medication safety and resolve medication therapy problems (Liu & Doucette, 2011). 
Having a better understanding of how to foster such collaboration can assist in the 
implementation of medication therapy management (MTM) services (Liu & Doucette, 2011). 
However, Reeves et al. (2011) noted that despite a growth of research in this area, there remains 
poor conceptualization of these related interprofessional activities.  
Oandasan et al. (2006) acknowledged that collaboration has the potential to improve 




Coster, and McCormick (2010) indicated that both community pharmacists and physicians 
believed improvements in collaboration could result in greater satisfaction and professional 
development, while making the healthcare system easier to use. Additionally, cooperation could 
improve system efficiency, quality of interactions and better address patients’ needs. However, 
“despite a common interest in optimizing the benefits and minimizing the risk of medication to 
patients, community pharmacists and GPs have tended to work in isolation from one another 
with only minimal contact on routine matters” (Bradley et al., 2012, p. 37). Dobson et al. (2006) 
noted that the need for collaboration is widely acknowledged and team-based models are not a 
new concept. They also indicated that despite attempts to encourage these models, pharmacists 
and other health care professionals continue to work alone with limited opportunities to share 
their skills and expertise. Doucette et al. (2005) noted that although such collaboration between 
pharmacists and physicians is desired, there has been limited study with regard to the influences 
on collaboration and to the factors that support the development of such collaborative 
relationships, particularly from the pharmacists’ perspective. 
Canadian health reform is driving the health care system toward greater use of 
community-based models of care and with it, increased expectation of community pharmacists to 
work in a more coordinated manner with other health care disciplines (Fyke, 2001; Romanow, 
2002). Goldman, Meuser, Rogers, Lawrie, and Reeves (2010) stated that this last decade was 
particularly important for health reform in Canada since there were reports documenting the 
challenges of fragmented health care, and the conception of policies and allocation of resources 
for the implementation of interprofessional team-based care. Pharmacy and physician 
organizations are encouraging the pursuit of strategies for more collaborative practice between 
pharmacists and physicians as a means of improving medication management (Doucette et al., 




adopt more collaborative approaches to health care delivery since it is an effective way to 
achieve therapeutic goals and enhance medication management, thereby improving patient care 
(Van, Costa, Abbott, Mitchell & Krass, 2012). Furthermore, Doucette et al. (2005) noted: 
In practice settings where pharmacists have been integrated successfully into drug 
therapy management processes, patient outcomes have improved. Several studies have 
evaluated pharmacist-physician team management of drug therapy and have reported 
improvements in blood pressure, diabetes outcomes, cholesterol levels, and depression. 
(p. 566) 
 There are several studies that have shown that pharmacist-provided medication 
reconciliation can help reduce medical discrepancies and help move care forward. In Ontario the 
introduction of family health teams (FHT) is an approach aimed at bringing different healthcare 
providers together, many of which have funds specifically for pharmacists (Goldman et al., 
2010). Saskatchewan and Alberta follow a similar model in their primary healthcare teams 
(CPhA, 2016b).  
A Cochrane review from Pande, Hiller, Nkansah, and Bero (2013) which analysed the 
effect of outpatient pharmacists on patient outcomes and prescribing patterns showed the 
pharmacists were particularly effective in reducing systolic blood pressure, blood glucose and 
managing asthma. Loffler et al. (2017) also acknowledged that “numerous studies from various 
settings provide evidence for the positive effect of community pharmacists on medication 
management, patient counselling, health education, and improved care resulting in better clinical 
outcomes” (p.2). Burton, Duffus and Williams (1995) acknowledged that community 




models of care; however, relatively little is known about interprofessional collaboration as a 
routine part of pharmacy practice.  
Barriers to Collaboration 
 There are numerous barriers identified in the literature that can impede a pharmacist’s 
ability to collaborate successfully with other healthcare professionals. Belanger and Rodriguez 
(2008) identified several barriers in their exploration of multi-disciplinary healthcare teams: 1) 
unclear role identification; 2) reimbursement structures/mechanisms; 3) regulatory constraints; 4) 
lack of interprofessional training, possibly due to faculties, power differentials, different 
approaches to patient care; 5) lack of communication, trust and respect, and shared goals among 
health professionals; and 6) lack of supportive clinical and administrative systems. 
Kelly et al. (2013) examined pharmacists’ and physicians’ views on collaborative 
practice. They acknowledged pharmacists working in silos might have added challenges. They 
referenced two Canadian studies that have investigated the collaborative relationship specifically 
between community pharmacists and physicians in the provision of patient care. In the Ontario 
study, opinions differed regarding appropriate pharmacists’ roles (Kelly et al., 2013). Both 
community pharmacists and physicians identified the necessity for clarifying professional roles, 
for identifying effective strategies for enhanced communication and determining compensation 
mechanisms to encourage collaboration. A Saskatchewan study investigating opinions of family 
physicians around pharmacists’ collaboration also determined lack of financial reimbursement, 
along with time constraints being barriers to collaboration (Kelly et al., 2013). Van, Mitchell and 
Krass (2011) hypothesised that although there are barriers to collaboration between pharmacists 
and physicians, the most common are difficulty-integrating pharmacists into primary health 




the pharmacist, physicians may accommodate some of the changes; however, they may see the 
expansion of the pharmacist role as a threat to their autonomy and control (Edmunds & Calnan, 
2001). This view has the potential to threaten collaboration between community pharmacists and 
physicians, particularly if pharmacists attribute ultimate authority to physicians (Edmunds & 
Calnan, 2001).  
Attitudes around Collaboration 
D’Amour, Ferrada-Videla, Rodriguez, and Beaulieu (2005) postulated that health care 
professionals are socialized throughout their education to adopt a discipline-based vision of their 
clientele and the services they offer. Healthcare disciplines often develop strong theoretical and 
discipline-based frameworks that can rigidly define their professional role and responsibilities 
(D’Armour et al., 2005). She indicated that the dynamic established between professionals is just 
as important as the context of the collaboration and that it needs to be understood not only as a 
professional endeavor, but a human process. Healthcare professionals understanding the benefits 
of collaboration alone will likely be insufficient since “professionals will not collaborate if the 
effort is only based on the notion it will be good for the clients” (D’Amour et al., 2005, p. 128). 
As a result, interprofessional collaboration is a complex phenomenon influenced by a number of 
variables, including the attitudes around collaboration. 
Multiple literature reviews have suggested, “Most community pharmacists are not 
participating in team-based models of interprofessional practice” (Dobson et al., 2006, p.128) 
and that pharmacists have the potential to contribute significantly to primary health teams. 
Gilbert and Ray (as cited in Dobson et al., 2006) warned that “if community pharmacists are 
unable or unwilling to participate in the emerging team-based models of care their potential is 




care team” (Dobson et al., 2006, p.128). The CHSRF policy on teamwork indicates that 
healthcare professionals have their own understanding of what constitutes teamwork and that no 
one definition exists. Teamwork is a product of collaboration and collaboration is a process of 
interactions and relationships between health professionals, regardless of whether or not they 
perceive themselves as part of a team (CHSRF, 2006). When community pharmacists were 
questioned regarding their attitudes around collaboration, they largely showed support and 
willingness to participate collaboratively; furthermore, they demonstrated an understanding of 
the value of collaboration to improved patient outcomes (Jove et al., 2014). Kelly et al. (2013) 
stated that both pharmacists and physicians want more collaboration opportunities and agree that 
collaborative practice can positively affect patient outcomes. This entire notion seems 
paradoxical in nature and suggests that there could be much to unearth by re-examining 
collaboration in the context of a community pharmacy setting. Since collaboration is defined by 
the relationships and interactions that occur between co-workers, then it is ultimately the health 
professionals themselves who determine whether collaboration occurs (Oandasan et al., 2006, 
p.4); querying practicing community pharmacists may be the best source to glean light on the 
subject matter.  
Factors that community pharmacists have given as barriers to collaboration include 
mainly lack of time and inadequate remuneration (Kelly et al., 2013). Until recently pharmacist 
services reimbursed by public payers were primarily those associated with dispensing 
prescriptions. Pharmacists’ desire to apply their knowledge and skills to enhance patient care is 
hampered in an environment in which remuneration is tied to the dispensing of a product, rather 
than services rendered. “A recent analysis of remuneration models for pharmacy professional 
services indicates that the method of remuneration does appear to influence the provision of 




is a lack of incentive to provide more or higher quality service” (Kelly et al., 2013, p.219). 
Legislative changes expanding the scope of practice of pharmacists by the SCPP and the 
Ministry of Health, have often been coupled with associated funding of these new services 
(Pharmacy Association of Saskatchewan, 2018). If remuneration does influence the provision of 
services, then that sentiment should be reflected in the professional practice of Saskatchewan 
community pharmacists. 
Categorizing Interprofessional Activities 
Reeves et al. (2011) stated that despite the increased awareness that interprofessional 
collaboration can improve the quality of health care, services, and patient outcomes, there is still 
poor conceptualization of what constitutes interprofessional activities. As a result, they attempted 
to gain a better theoretical and empirically tested understanding of interprofessional 
collaboration and education by analysing literature in the field (Reeves et al, 2011). One pivotal 
finding was the necessity to understand what constitutes an interprofessional intervention. 
Reeves et al. (2011) categorized the various interprofessional interventions into three groups: 1) 
interprofessional education (IPE) interventions, which occur when two or more professions learn 
interactively to improve collaboration and the quality of care; 2) interprofessional practice (IPP) 
interventions, which are activities or procedures incorporated into regular practice to improve 
collaboration and the quality of care; and 3) interprofessional organizational (IPO) interventions, 
which are changes at the organizational level (e.g. space, staffing, policy) to enhance 
collaboration and the quality of care (p. 169). Reeves et al. (2011) indicated that differentiating 
amongst types of interventions could help with better understanding their processes and effects. 
Categorization could help us move beyond the terminological quagmire, by helping to 
differentiate between the types of interventions, and delineating distinctions among intervention 




In the context of community pharmacy, there is a range of interactions considered 
collaborative. Interactions may range from simple clarifications, sharing of information for 
seamless care, to discussions of the best therapy options or the formation of partnerships in the 
delivery of clinical services. Loffler et al. (2017) noted that interprofessional collaboration did 
not develop with community pharmacists to the same extent as with other health professionals 
and that overall general practitioner to pharmacist interactions are of low frequency. With the 
onset of the ESoP, it would be interesting to assess if these collaborative interactions have 
increased in frequency or changed in their nature. However, to assess collaboration, we need to 
have a deeper understanding of what collaboration is. Axelsson and Axelson (2006) postulated 
that there have been several conceptual models developed to assist in the understanding of 
characteristics and stages of collaboration. However, Bradley et al. (2012) noted that little 
consideration has been given to how they relate to collaboration between community pharmacists 
and physicians. 
Theoretical Models of Collaboration 
There is a growing trend for healthcare professionals from all disciplines to work together 
in a collaborative fashion to provide patient services (Rathbone, Mansoor, Krass, Hamrosi, and 
Aslani, 2016). Consequently, there are various conceptual models developed for examining 
interprofessional collaboration. The following section examines several models that are either 
directly or indirectly related to understanding collaboration between pharmacists and physicians 
in the community pharmacy setting.  
Armitage’s taxonomy of collaboration 
Bradley et al. (2012) stated the push for integrative systems and collaboration across 




conceptualize collaborative behaviour; however, they indicated there are limited models 
available that reflect that of the dynamics of community pharmacists and physicians. One such 
model created is known as Artimage’s taxonomy of collaboration as seen below (as cited in 
Bradley et al., 2012).  
  
Figure 2.1 Armitage's Taxonomy of Collaboration (as cited in Bradley et al., 2012) 
 
Artimage, as cited in Bradley et al. (2012), formulated a five-stage taxonomy of 
collaboration in primary care. The first, isolation, refers to members who do not meet, talk or 
write each other. Next is encounter, in which members correspond but the nature of the 
interaction is not meaningful. The third stage in Artimage’s taxonomy is communication which 
denotes encounters, correspondence and the transfer of information. Next is collaboration 
between two agents which refers to “members who act on the information sympathetically: 
participate in patterns of joint working: subscribe to the same general objective as others on a 
one-to-one basis in the same organization” (Bradley et al., 2012, p. 38). The last stage is 
collaboration throughout the organization in which the work of all members is fully integrated. 
Breaking down interprofessional collaboration into more specific levels of interaction may be a 
more effective way of understanding the type of collaboration, particularly in the context of a 
community pharmacy setting.  
 
 







Hudson’s Model  
Hudson’s model has been a suggested model for attempting to understand 
interprofessional collaboration, particularly in the context of interprofessional relationships. 
Hudson, Hardy, Henwood, and Wistow (1997) created a four-step model of characteristics of 
collaboration known as the primary health care-social care collaborative continuum.  
Table 2.3 Characteristics of Collaboration (Hudson et al., 1997) 
Hudson’s Characteristics of Collaboration 
Isolation/Encounter Absence of joint activity with no communication at all between agencies. 
Some ad hoc inter-agency contact, but lowly connected networks, divergent organizational 
goals and perceived rivalry and stereotyping. 
Communication Joint working, but work completed is marginal to the main organizational 
goals. Frequent interactions and sharing of information as it applies to users whose needs cross 
boundaries, some joint training, a nominated person is responsible for liaison, expectation of 
reciprocation. 
Collaboration Joint working is central to mainstream activities. Trust and respect in partners 
means that they are willing to participate in formal, structured joint working including joint 
assessments, planning, service delivery and commissioning. There is a highly connected 
network and low expectation of reciprocation. 
Integration No longer see their separate identity as significant. May be willing to consider 





The four steps include isolation/encounter, communication, collaboration, and 
integration. The last step focuses on integration rather than collaboration. Bradley et al. (2012) 
acknowledged that integration is a term often used by policy makers and that the concept has its 
roots in organizational theory. Lawrence and Lorsch’s (1967) work concentrated on the 
differences between integration and differentiation in organizational systems. They defined an 
organization as: 
a system of interrelated behaviors of people who are performing a task that has been 
differentiated into several distinct subsystems, each subsystem performing a section of 
the task, and the efforts of each being integrated to achieve effective performance of the 
system (Lawrence & Lorsch, 1967, para. 3).  
If we view community pharmacy practice as an organization, then we may be able to understand 
its components with greater clarity. Lawrence and Losch (1967) described two important 
definitions in our understanding of organizational systems. The first is differentiation, which they 
define as "the state of segmentation of the organizational systems into subsystems, each of which 
tends to develop particular attributes in relation to the requirements posed by its relevant external 
environment" (Lawrence & Losch, 1967, para. 4). Integration is defined as "the process of 
achieving unity of effort among the various subsystems in the accomplishment of the 
organization's task" (Lawrence & Losch, 1967, para. 5). Understanding these definitions can help 
assist in categorizing pharmacist collaboration by applying these concepts to the types of 
exchanges occurring in the community pharmacy environment.  
Lawrence and Lorsch’s (1967) contingency theory explained that organizations often 
become separated into sub-units to best deal with their external environment. They established 




became specialized with specific tasks geared toward meeting the specific needs of the 
environment, the more differentiation there was, and the less integrated they became. Lawrence 
and Lorsch (1967) ultimately concluded that highly differentiated systems had more difficulty 
with integration. This separation could be problematic in achieving overall organizational goals 
or over arching objectives, since success tended to favour organizations that were highly 
differentiated and highly integrated. 
If we apply this theory to the constructs of the pharmacy and physician relationship, some 
important parallels can be drawn. Liaw and Peterson (2009) noted that the relationship between 
the pharmacist and physician dates back to the apothecary, in which physicians and pharmacists 
had a more integrated working relationship. However, in 19th century England, dispensing and 
prescribing became separated. This separation of duties has since continued to divide, resulting 
in two specialized professions, with a high-level of differentiation (Liaw & Peterson, 2009). 
Each has become more specialized due to factors such as introduction of regulatory frameworks, 
introduction of a universal health care system, and emphasis on cost and safety to name a few 
(Liaw & Peterson, 2009). Liaw and Peterson (2009) acknowledged the importance of improved 
safety, effectiveness and improved patient outcomes and highlighted that ongoing training and 
professional development, within and across professional boundaries is essential to support 
harmonious and cost-effective interprofessional practice. Separation does not assure system 
efficiencies nor effective utilizations of medicine (Liaw & Peterson, 2009). Lawrence and Lorsch 
(1967) contended that differentiation played a role in each profession meeting their requirements 
with a certain degree of proficiency. However, unfortunately it has also decreased the level of 
integration between the two and unfortunately created a somewhat adversarial relationship (Liaw 




The most effective organizations are ones that have both high levels of differentiation and 
integration; therefore, it is incumbent that we examine strategies to assess and improve the levels 
of integration (Lawrence & Lorsch, 1967). Liaw and Peterson (2009) discussed the importance 
of an integrated interprofessional and patient centered approach. He surmised that the “approach 
must be ‘apothecarial’ complementary roles and responsibilities for the prescriber and dispenser 
within the patient-clinician therapeutic relationship, and not adversarial” (Liaw & Peterson, 
2009, p.276). They suggested that close collaboration and communication is particularly 
important in areas of pharmacists’ expanded practice, such as pharmacist prescribing. The recent 
changes to the profession of pharmacy with expanded scope of practice and advanced practice 
activities may provide a segue to and a tremendous opportunity for improved integration and 
collaboration. These changes could create a return to more similarities in the activities of each 
profession, thereby making them less differentiated. However, there is still confusion about what 
constitutes interprofessional practice and ways to enhance communication and collaboration 
between pharmacists and physicians (Liaw & Peterson, 2009). 
Spectrum of Collaboration 
 Oandasan et al. (2006) created a model that depicts collaboration as a spectrum. The 
report claims that collaboration between healthcare professionals is dynamic and can encompass 
a wide range of collaborations depending on the type of care required. As seen in the figure 
below, the model starts with independent parallel practice in which autonomous health 
professionals are working side by side. It then progresses to more consultation and referrals in 
which professionals exchange information. Lastly the spectrum proceeds to interdependent co-










Figure 2.2 Spectrum of Collaboration (Oandasan et al., 2006)  
As the model progresses from left to right, there is an increasing level of interdependence 
required. “Health professionals who practice using a process of interprofessional communication 
and decision-making that promotes collaboration based on shared knowledge and a range of 
professional skills to influence patient care are engaged in collaborative practice” (Oandasan et 
al., 2006, p.5). The report also stated that interprofessional collaboration varies depending on the 
complexity of healthcare needs. 
Collaborative Working Relationship (CWR) Model 
 Doucette et al., (2005) created a conceptual model to describe pharmacist physician 
collaboration which was synthesized from models of business relationships, interpersonal 
relationships and collaborative care, known as Collaborative Working Relationships (CWR) 
model. This model suggested that professional relationships between pharmacists can progress 
through several stages: stage 0 connotes professional awareness, stage 1 includes professional 
recognition, stage 2 involves exploration and trial, stage 3 is associated with professional 
relationship expansion, and finally stage 4 is commitment to collaborative working relationship 
(McDonough, & Doucette, 2001, p. 683). There is literally no interaction between the physician 
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pharmacist. As the relationship develops, the level of interdependence increases, and 
communication becomes bilateral in nature. Stage 4 marks the point where mutual trust and 
respect have been established, with both parties working to maintain the relationship.  
Stage 0 – Professional awareness  
Stage 1 – Professional recognition  
Stage 2 – Exploration and trial  
Stage 3 – Professional relationship expansion  
Stage 4 – Commitment to the collaborative working relationship  
Figure 2.3 The Collaborative Working Relationship (CWR) model (as cited by Bradley et al., 
2012, p.39) 
 
McDonough and Doucette (2001) specified that interactions between physicians and pharmacists 
are viewed as exchanges. At stage 0, exchange is minimal and considered discrete. An example 
would include making a refill request. Interactions are short in duration, with limited effort spent 
in developing the relationship or improving the patient care process. At stage 1, efforts to forge 
the relationship are primarily unilateral and initiated by the pharmacist. The pharmacist is 
cognizant of the value of fostering the relationship for the benefits of supporting their practice 
and clinical services provided. At this point the physician may not see the value of the service or 
the value in establishing a relationship with the physician. Progression toward stage 4 indicates 
increasing collaboration among the pharmacist and physician and greater motivation to maintain 
the relationship. McDonough and Doucette (2001) identified three main variables that influence 
the progression of the pharmacist and physician collaborative relationship among the stages; 








Individual characteristics refer to characteristics of the participants such as demographics, 
age, and degree of education. McDonough and Doucette (2001) hypothesised that younger 
pharmacists whose pharmacy training included more interprofessional training may be more 
receptive to collaboration with a physician. Additionally, knowledge as to the benefits of 
collaboration, attitudes around collaboration and confidence level could influence the level of 
engagement in pharmacist-physician collaboration. Previous history of collaboration, 
professional skills, and abilities may also be valuable characteristics supporting increased 
relations (McDonough & Doucette, 2001).   
Context Characteristics 
 Context characteristics are an additional variable that can influence the growth of 
pharmacist-physician collaboration. Context characteristics refer to the settings and practices in 
which the pharmacists and physicians interact (McDonough & Doucette, 2001). This category 
refers to professional practices including patient care activities, resources present, patient mix 
and organizational structure. Practitioners consider these factors relevant when determining the 
costs and benefits of forming a CWR (McDonough & Doucette, 2001). Practice features include 
patient mix and practice type. McDonough and Doucette (2001) suggested that if pharmacists 
and physicians share the same patient pool and work in single provider practices, such as in a 
rural setting, there may be more shared incentive to collaborate and the collaboration may be less 
formal, structured and open, verses that of an urban group practice setting with a varied patient 
population.  
Additional context characteristics include proximity, volume of interaction and system 




pharmacist and physician practices, the more opportunity exists for collaboration. The volume of 
the interaction between pharmacist and physician is also significant, since increased interaction 
could improve professional relationships and with it, enhanced collaboration. Lastly, being part 
of the same healthcare system or administrative system will likely result in more integration and 
collaboration (McDonough & Doucette, 2001). 
Exchange Characteristics 
 The last set of characteristics that influences the development of the CWR is exchange 
characteristics. This category refers to physicians and pharmacists exchanging permission, 
information and responsibility for patient care (McDonough & Doucette, 2001). Interactions can 
range from discrete to relational. Discrete interactions are impersonal in nature and characterised 
as separate, unrelated interactions with little effort afforded for relationship development. In 
contrast, relational exchanges focus on the relationship in which both participants perceive the 
relationship as beneficial long term rather than on a transaction-by-transaction basis. “Exchange 
characteristics include attraction, communication, power and justice, norm development, 
expectation assessment, performance assessment and conflict resolution” (McDonough & 
Doucette, 2001, p. 685). Through my experience, exchanges at the community pharmacy level, 
may occur through a variety of mediums, including in-person, phone, fax, digital messages, or 
written communication. 
Conceptual Model of Collaboration  
Examining collaboration in the context of community pharmacy rather than making 
direct comparisons with collaboration that occurs in primary healthcare teams may provide 
additional information and another perspective on which to investigate the topic. Community 




sector, with a different set of demands, reimbursement structure, and often in a physical location 
away from the physician or healthcare team. Therefore it is possible that traditional models of 
collaboration derived from literature on teamwork including those with pharmacists on primary 
healthcare teams or in a hospital setting, may not be the best lens from which to examine 
collaboration in the community pharmacy setting. Creating a model that applies the theories and 
concepts related to collaboration and adapts it to the context of the community pharmacy setting 
may add to our understanding in this area. 
Community Pharmacists’ Collaboration Model (CPCM) 
The theoretical model of pharmacist collaboration that I developed to help frame my 
research is called the Community Pharmacists’ Collaboration Model (CPCM). It contains 
elements derived from Artimage’s theory of collaboration (as cited in Bradley et al., 2012), 
Hudson’s model (1997), Oandasan et al. (2006) Spectrum of Collaboration, and the CWR model 
(McDonough & Doucette, 2001). I took principles of each and applied to my own knowledge 
base in community pharmacy practice and of organizational systems from education 
administration to form a model on collaboration to apply to my research in community 






                        Figure 2.4 Community Pharmacist Collaboration Model (CPCM) 
 
 





















This perspective on collaboration in community pharmacy is that collaboration is not one 
single entity or stage that is reached, but rather a spectrum that varies depending on the 
exchanges and agreements made, some being more differentiated in nature and some more 
integrative. Collaboration in its most simplistic form begins at the point of contact. Contact starts 
with collaboration that involves a mutual awareness by both pharmacist and physician of each of 
their roles and professional duties and responsibilities. Exchanges carried out are more 
differentiated based on the traditional pharmacist and physician roles and expectations. If 
pharmacist initiated unilateral exchanges, there is an expansion in collaboration toward 
integration. If exchanges are physician initiated or bilateral in nature, there is again enhanced 
collaboration that is less differentiated and more integrated. If exchanges are more developed or 
formalized, a partnership or Collaborative Practice Agreement (CPA) may occur. The increase in 
exchanges toward integration could provide sharing of mutually beneficial goals, information, 
coordination of services, and shared decision making between physician and pharmacist. 
Furthermore, it implies there is a clear understanding of the roles and capabilities of each 
professional and mutual trust and respect indicative of good interprofessional collaborative 
practices. The model depicts that exchanges progressing toward integration require an increasing 
level of interdependence between pharmacists and physicians. 
Community Pharmacist Model of Collaboration Components 
 Collaborative interactions can have several different forms that range along a spectrum, 
from simple contacts to detailed and more formalized agreements. The following section 






 Artimage and Hudson categorized the first stages of collaboration as Isolation/Encounter. 
Hudson et al. (1997) described this stage as the absence of joint activity with no communication 
at all between agencies. I choose not to use the term ‘Isolation/Encounter’ but rather to use 
‘Contact’ as the first step in the CPCM. My rationale is that I do not feel the term 
‘Isolation/Encounter’ clearly applies to the community pharmacy setting. In my experience there 
is no complete lack of joint activity and communication between pharmacists and physicians 
once a prescription is received or ‘Contact’ is made. Pharmacists and physicians are working on 
the same goal of having the positive treatment outcomes for their patient through the safe and 
effective use of medication. Communication of this is done via a prescription for the product 
along with any special instructions or notations. This can occur with a direct verbal order from 
the physician or indirectly with a written or digital order. Contact is the starting point for all 
collaboration and implies that the physician has an awareness of the role of the pharmacist, their 
skills set, and certain expectations about what service the pharmacist will provide. Contact relies 
on adherence to and understanding of each of the typical roles and responsibilities of the 
physician and pharmacist. Pharmacists and physicians have already began the process of 
collaborating at the point of Contact; however, roles are highly differentiated with the physician 
being responsible for assessing, diagnosing, and prescribing for the patient’s condition and the 
pharmacist accurately interpreting these orders and ensuring the safe acquisition of the 
medication to the patient. Expectations of each party are based on the typical and traditional roles 
of both professionals, rather than the individualization or close alignment of specific needs, 





Pharmacist Initiated Unilateral Exchange 
Pharmacist initiated unilateral exchange refers to a transference of information from the 
pharmacist to the physician. This exchange may involve the pharmacist sharing information 
about a patient, which will prevent harm, improve adherence, improve patient outcomes, or 
provide detail about a patient’s health and medication that will add to the physician’s knowledge 
of the patient health and medication status. Collaboration in this area may involve a larger 
utilization of pharmacist’s knowledge and skills. Information shared with the physician could 
provide the potential to influence decisions made in managing the patient’s health and wellness. 
Patients may directly or indirectly benefit from the pharmacists’ initiated unilateral exchange. 
Exchanges are more singular in nature, pertaining to one patient or case and there is minimal 
interaction from the physician and, therefore, a limited understanding of physicians’ concerns 
regarding the patient’s health and medication concerns. 
Physician Initiated/Bilateral Exchange  
Physician initiated bilateral exchanges refers to the physician instigating an exchange 
such as, requesting information, asking questions, or for completion of a specific task or service.  
Exchanges themselves are more bilateral in nature or have patterns of joint working in which 
information is shared back and forth between the physician and the pharmacist. Information is 
acted on sympathetically by both physician and pharmacist. Exchanges of this nature may imply 
an expanded level of trust and awareness of the pharmacist’s knowledge and skill set. 
Additionally, they may have enhanced opportunity for shared decision making and a greater 
degree of receptiveness by the physician to implement a pharmacist’s recommendations. The 
physician engaged in this type of exchange could provide the pharmacist with a greater 




exchange provides less differentiation of professional roles and lends itself to improved 
integration between pharmacists and physicians.   
Partnership 
Partnership in the Community Pharmacists Collaborative Model (CPCM) refers to a 
verbal or informal agreement between the pharmacist or pharmacy and the physician or 
physician group for a specific task or service. The service would be related to more than one 
patient and occur in an on-going fashion. This type of collaboration has both pharmacist and 
physician working together on a mutually beneficial and shared goal. Agreeing to work together 
on a shared goal, in a coordinated fashion provides a collaborative relationship that is more 
integrated in nature. 
Collaborative Practice Agreement (CPA) 
In a collaborative practice agreement (CPA) or other written agreement the collaborative 
relationship is formalized in writing. As such, there is likely specific information about the role 
of the pharmacist and physician, including expectations and possibly outcomes. The written 
agreement assures a level of commitment on both sides and potentially ensures legal 
accountability. A written agreement assumes shared responsibility and mutually beneficial goals 
that are incorporated into the structure and processes of the organization, in this case the 
physicians’ and pharmacists’ community practice. In these ways, a CPA or other written 
agreement is the ultimate in integration between pharmacists and physicians. 
Comparative Theories of Collaboration   
 Hudson’s model of collaboration and the CWR model portrays collaboration in a step 




or achieve true collaboration, with the ultimate goal being integration or collaboration within the 
organization. The CWR model goes as far as presenting a guide of determinants that help lead to 
more advanced stages of collaboration. Although it may be possible for collaboration to start 
from contact and progress from pharmacist initiated and physician-initiated exchanges, to 
partnership and ultimately integration, it may not be a requirement. A pharmacist and physician 
can collaborate at any of the five listed types of collaboration independently depending on the 
situation. For example, a pharmacist may approach a physician with an idea of partnering in an 
initiative to provide influenza immunizations to high risk patients in the upcoming flu season. 
The collaboration started at a partnership level and did not have preceding traditional exchanges 
or physician-initiated exchanges. The CPCM reflects this independence of the types of 
collaboration by not having arrows connecting the types of collaboration or identifying them in 
the term of stages. 
Artimage’s taxonomy of collaboration and Hudson’s model presents collaboration as a 
process starting with isolation and encounter, communication and progressing to collaboration 
within the organization. When applied to community pharmacy, I identify with collaboration 
starting with an encounter; however, I do not see communication and collaboration as separate 
steps in the process. Communication and collaboration in community pharmacy occurs at every 
level. At the early stages of an encounter information is communicated via a prescription and 
through the patient. There is an expectation of what the pharmacist will do to fulfill the work the 
physician is requiring, that being to accurately interpret the medication and dose in relation to the 
condition being treated, screen for drug interactions or allergies, clearly communicate 
information about the medication and condition and instructions to the patient and assist in 
insurance coverage. If there is an error, allergy, interaction or other issue the physician expects to 




assessing, diagnosing, and prescribing for the patient and the pharmacist’s role includes 
completing the safe delivery and utilization of that medication. Communication and 
collaboration occur at the very first contact or encounter, and throughout the process. Therefore, 
when describing interactions between pharmacists and physicians in the community pharmacy 
setting, rather than using the terms communication and collaboration, terminology borrowed 
from the CWR model as exchanges seems more suitable. 
McDonough and Doucette (2001) identified variables that influence the progression of 
the pharmacist and physician collaborative relationship among the stages; individual 
characteristics, context characteristics and exchange characteristics. Progression toward stage 4 
indicates increasing collaboration among the pharmacist and physician and greater motivation to 
maintain the relationship. The variable that I choose to highlight in the progression of the 
pharmacist and physician collaborative relationship in the CPCM was exchange characteristics. 
As mentioned earlier, exchange characteristics refer to physicians and pharmacists exchanging 
permission, information and responsibility for patient care (McDonough & Doucette, 2001). I 
choose to use the term ‘exchanges’ in the development of the CPCM because I felt it provided a 
more comprehensive and representative description of the types of interactions occurring 
between community pharmacists and physicians in community pharmacy practice. Furthermore, 
focusing on exchanges, rather than on all three variables, simplified the process and made it 
more applicable for the measurement of collaboration in community pharmacy settings. To 
provide more specificity within the CPCM, exchanges were separated into pharmacist-initiated, 
physician initiated, and bilateral.  
Doucette et al. (2005) applied the CWR model to better understand factors affecting care 




collaboration between the two groups. They noted that at low levels of collaboration, the 
pharmacist initiated most or all communication with physicians. Communication that was more 
bidirectional was more supportive of collaboration and of effective multidisciplinary teams. 
Doucette et al., (2005) further suggested that practitioners could become more dependent on each 
other to manage the medication therapy, and thereby interact in more diverse ways and in greater 
frequency (Doucette et al., 2005). As a result, the CPCM depicts this type of collaboration closer 
to integration and further from differentiation. 
Differentiation and Integration 
The arrow on the CPCM model provides a reflection on where collaboration occurs in 
relation to exchanges that are differentiated versus those more integrated. Hudson et al. (1997) 
acknowledged integration as part of the process of later stages of collaboration. Lawrence and 
Lorsch (1967) discussed differentiation and integration from an organizational theory standpoint, 
surmising that organizations with high levels of both differentiation and integration are more 
effective. Considering that both pharmacists and physicians started off as highly integrated and 
over the centuries have largely become differentiated, the trend back toward the inclusion of 
collaborative practices integrative in nature would theoretically result in more effective 
organizations.  
Patient outcomes have improved in practice settings where pharmacists were effectively 
integrated into the medication management process (McDonough & Doucette, 2001). Zillich et 
al., (2004) noted that “A greater level of professional interaction relates to discussions of drug-
related problems, exchanges of patient information, planning of a pharmacist’s role, and making 
referrals. Communications about these topics suggest that the physician and pharmacist have 




suggested that for organizations to deal with their external environment, there is a need to 
become segmented into units. However, to accomplish overall goals, these units need to be 
linked, leading to integration. Collaborative Practice Agreements are one way pharmacists are 
integrating their services with those of physicians (McDonough & Doucette, 2001). CPAs are 
important to the successful integration of pharmacists’ and physicians’ practices Collaboration 
that is more integrated may provide more opportunity for shared goals, activities and improved 
efficiencies in the delivery of health care with the potential for improved health outcomes for 
patients and communities. It will be interesting to see if the recent changes to the profession of 
pharmacy with expansion of pharmacists’ scope of practice provide more opportunity for 
exchanges that have a higher level of integration. 
Summary  
 The CPCM model provides an opportunity to build upon existing theories of 
collaboration developed in healthcare. Collaboration models such as Armitage, Hudson’s, 
CSHRF Spectrum of Collaboration, and the CWR model, all address certain aspects of 
collaboration applicable to community pharmacy. Taking the ideology from these pre-existing 
models and further developing them to the context of the community pharmacy setting, might 
assist in exploring pharmacists’ collaboration with physicians. Furthermore, understanding how 
expansion of pharmacists’ scope of practice in Saskatchewan over the last ten to twelve years has 
influenced collaboration, could provide relevant information to be used in conversations 
surrounding pharmacy practice change and legislation. Improving collaborative practices 
between health care professionals, like pharmacists, may contribute to the larger systemic and 
widespread goal of improving access, efficiency in the healthcare system and ultimately 
improved healthcare outcomes. Chapter Three provides relevant details of how the researcher 




on the methodological approach, study design, participant selection and tools, data analysis and 




















CHAPTER THREE: RESEARCH DESIGN AND METHODOLOGY 
Research Design 
The purpose of this study was to explore community pharmacists’ perspectives to 
determine if recent changes to pharmacists’ scope of practice have influenced interprofessional 
collaboration with physicians, to evaluate Expanded Scope of Practice (ESoP) activities, and 
gain insight into the most effective forms of collaboration. A quantitative research design was 
chosen because quantitative research is an approach for testing theories by examining the 
relationship among variables (Creswell, 2014). This chapter describes the methodological 
approach, research design, instruments and data collection and analysis. 
The worldview or paradigm chosen to guide this study was postpositivism. 
Postpositivism is the viewpoint that causes most likely determine outcomes; therefore, problems 
studied need to identify and assess the causes that influence outcomes (Creswell, 2014). “The 
knowledge that develops through a postpositivist lens is based on careful observation and 
measurement of the objective reality that exists” (Creswell, 2014. p.7).  Research involves 
collecting information on instruments based on measures completed by participants (Creswell, 
2014). Evidence, data and rational consideration help shape knowledge and data are collected to 
address a research question based on what best suits that question (Creswell, 2014). Further, it is 
also reductionistic by reducing ideas into a small, discrete set to test hypothesis and research 
questions (Creswell, 2014). Jackson (1997) compared positivism to Carlo Lastrucci’s (1967) 
definition of science as “an objective, logical, and systematic method of analysis of phenomena, 
devised to permit the accumulation of reliable knowledge” (p.6). They stated that this objective 
approach helps minimize bias and grounds its assumptions in fact rather than opinion. Its logical 
and systematic approach allows for data to be subjected to statistical analysis so that reliable 




The objective of this study was to obtain perspectives from a range of practicing 
pharmacists in a variety of community pharmacy settings to gain insight as to the general level of 
engagement in ESoP and its particular influence on collaboration with physicians. Since there 
appears to be less literature in this particular area, particularly from Saskatchewan pharmacists, I 
felt it would be more advantageous to acquire a larger quantity of data from as many practicing 
pharmacists as possible rather than to concentrate on more detailed opinions and experiences 
from a few. A quantitative study design more readily provides the opportunity to acquire a large 
amount of data and subject it to statistical analysis and categorization so that stronger 
conclusions can be drawn. Applying a quantitative approach to the research provides a broader 
scope of the context of the research compared to that of a qualitative approach (Creswell & Plano 
Clark, 2011).  Although a qualitative approach would have likely provided deeper richer data 
that uncovered more details and explored the complexity of the question to a greater degree, 
given the scale of the project and resources available, the participant sample size would have 
been significantly smaller (Creswell & Plano Clark, 2011). Consequently, analysis would be 
based on only a few and would be difficult to extrapolate or draw conclusions to the group as a 
whole. Because Saskatchewan community pharmacy is diverse and spans the province, it is 
possible there could be large differences in pharmacists’ experiences, depending on if they 
worked in rural or isolated communities versus if they practiced in larger urban settings. The 
experiences of a few risk misrepresenting the actual influence of ESoP on physician 
collaboration. 
Creswell (2014) stated that quantitative assessment was as a particularly helpful research 
design at addressing and measuring how one variable influences the other. The primary objective 
of the study is to evaluate the influence ESoP has had on physician collaboration. Since the study 




quantitative approach provided the opportunity to assess and objectively measure that change. 
Maintaining objectivity was particularly important considering I am a practicing community 
pharmacist and have experiences and opinions about the subject matter that could result in bias 
in the interpretation of the results. A qualitative study by nature requires more interpretation of 
results by the researcher and therefore is potentially less objective than a quantitative approach. 
To further increase objectivity, the Community Pharmacy Collaboration Model (CPCM), which 
was derived from four theoretical models of collaboration, was used to measure collaboration. 
This model was created to help guide the type of questions asked as well as provide a stronger 
foundation from which to measure and analyze pharmacists’ responses and draw conclusions. 
Participant Solicitation and Criteria 
Selection of participants for this quantitative study occurred through distribution of an 
electronic survey to the whole population of practicing community pharmacists in Saskatchewan. 
The population was determined using specific criteria. In the context of this study, all 
pharmacists who are registered as practicing community pharmacists with the Saskatchewan 
College of Pharmacy Professionals (SCPP) were invited to participate in the study. Targeting all 
members of the population provided an opportunity for a large sample size and increased 
generalizability, thereby strengthening results (Teddlie & Tashakkori, 2009). A questionnaire 
was developed using Survey Monkey, the official University of Saskatchewan survey tool. After 
approval from the University of Saskatchewan Research Ethics Board, permission and 
subsequent support was sought from the Saskatchewan College of Pharmacy Professionals 
(SCPP). The SCPP reviewed the study, the questionnaire, and the ethics approval and agreed to 
support the study by distributing the survey electronically to its members. Having SCPP 
distribute the study invitation and the reminder emails electronically may have increased 




organization to participants. Additionally, SCPP’s involvement created a separation of the study 
participants from the researcher to reduce any perceived biases. SCPP clearly informed all 
potential pharmacist participants in each email that SCPP would not have access to participant 
responses which gave assurances of confidentiality and anonymity. An invitation was sent to 
pharmacists to participate in the study and they were provided a link to the questionnaire. 
Participants who clicked on the link and completed the questionnaire were providing consent to 
their participation in the study (as outlined in the email invitation; see Appendix B). All 
participants’ names, practice sites, and any other identifying information were excluded from the 
questionnaire to protect privacy and reduce bias. At the end of the questionnaire participants 
were offered entry to a prize draw for two $100.00 Tim Hortons or Starbucks gift cards. Those 
who were interested were redirected to a separate questionnaire that was not linked to their 
results, in which they could enter their contact information. They were also asked if they would 
like to be sent a summary of the research findings once they were available. Once data collection 
ended, responses were analysed, and themes formed.  
Study Instrument 
Questionnaire 
A questionnaire was used as the instrument for data collection in the study. The purpose 
of the questionnaire was to provide the opportunity to develop a larger picture of pharmacists’ 
community practices across the province and collect a variety of perspectives to better 
understand the influence ESoP had on physician collaboration. Fink (2013) suggested that when 
deciding on a survey’s contents it is important to define the attitude, belief, value, or idea being 
measured. There are many definitions of collaboration in the literature. Every pharmacist, 




ESoP activities. To help provide continuity of response and increase its validity, a theoretical 
model of collaboration, CPCM, was used to help guide some of the questions for the 
questionnaire. This model was created by examining existing strategies for measuring 
collaboration in the literature and applying concepts applicable to a community pharmacy 
setting. Having a framework to guide some of the questions helped improve objectivity and 
assisted in the analysis of the results. Further, definitions of terms such as quality, exchanges, 
and collaboration were included to ensure consistency and clarity in understanding.  
The choice of question style consisted of both closed-ended and open-ended questions. 
Closed-ended questions included multiple choice, ranking, checklist, and 5-point Likert style. 
The primary style of question utilized throughout the questionnaire was multiple choice. 
Multiple choice questions have proven themselves to be more reliable and efficient (Fink, 2013). 
They are easy to use, score, and provide uniform data (Fink, 2013). I chose to include open-
ended questions in addition to closed-ended questions. Closed-ended questions require 
respondents to interpret them the same way, whereas open-ended can provide the opportunity for 
participants to share their opinions in their own words (Fink, 2013). Including open-ended 
questions allowed pharmacists to state their thoughts, opinions and experiences on collaboration 
in their own words, using their own terminology. This approach might reduce participants from 
being steered to answer questions in a certain way and reduces the misinterpretation of answers. 
Furthermore, it serves as the necessary building blocks for the formation of new ideas and 
theories which could be further explored in future research. Farrell (2016) stated that “open-
ended questions prompt people to answer with sentences, lists, and stories and giving deeper and 
new insights” (para.1). Given the size of the potential participant pool, the number of open-ended 




The questionnaire was divided into two parts: community pharmacy and pharmacist 
demographic information; and questions pertaining to ESoP and collaboration with physicians. 
The first section of the questionnaire consisted of Likert type questions. The goal was to try and 
obtain the most information in a reasonable amount of time considering the questionnaire was 
sent to pharmacists who work in a busy community pharmacy setting. The first section’s purpose 
was to obtain demographic information, such as years of practice, type of pharmacy setting, 
volume of prescriptions and other demographic data. This data helped the researcher gain 
information about the community pharmacists’ practice setting and pharmacy experience to help 
provide some context to their responses and paint a general picture of the pharmacy landscape in 
Saskatchewan. The second section of the questionnaire focused on gaining insight into 
pharmacists’ ESoP and collaboration with physicians. The section queried the level of 
engagement in the various types of ESoP activities and which were considered most beneficial to 
collaboration. Additionally, it helped provide more information regarding collaboration with 
physicians. The section consisted of multiple choice, Likert scale, ranking, and more open-ended 
questions pertaining to collaboration with physicians.  
Once the questionnaire was crafted, a pilot test link was given to committee members and 
a local expert in survey design and assessment for their review and feedback. Fink (2013) stated 
that pilot testing can help make the survey more usable by revealing whether people understand 
the directions you have provided and determine if they can answer the survey questions. Further, 
it can improve the response rate by eliminating severe potential sources of difficulty, such as 
poorly worded questions. Experts given the pilot test had a range of different backgrounds and 
expertise to provide a comprehensive and multifaceted perspective on the questionnaire. Their 





A postal letter was sent via the Saskatchewan College of Pharmacy Professions (SCPP) 
to all 1165 licensed practicing community pharmacists in Saskatchewan. The letter contained 
relevant study details and invited pharmacists to participate in the study via an upcoming email 
containing the link to the study’s online questionnaire. The postal letters and emails were sent to 
the personal email addresses provided by pharmacists to the Saskatchewan College of Pharmacy 
Professionals (SCPP) as part of their licensure process. Having SCPP distribute the study 
invitation and link to the online questionnaire provided separation from the researcher and the 
employer to decrease conflict of interest. Further, it may have improved the legitimacy of the 
study and thereby encouraged more people to participate. Procuring the information in the form 
of a questionnaire reduced unnecessary time querying all pharmacists in depth, especially those 
who indicate that ESoP has limited impact on their practice. Additionally, it reduced the volume 
of data collected to allow for a manageable workload for the researcher and better fit within the 
expectations of a master’s thesis. 
The questionnaire was anonymous; no names, addresses or personal identifiers, such as 
birth date, were elicited. All participants were fully informed on pertinent details of the study and 
were asked to provide consent to use of their information as part of the study. Their consent was 
implied when they clicked on the link. 
Questionnaire Development  
The decision of what content to use to guide the types of questions asked and the data 
acquired from the questionnaire was made by reviewing relevant literature in the area, guided by 
theoretical models of collaboration like the Community Pharmacists Collaboration Model 
(CPCM), and by applying my own knowledge and experience working as a community 




Part One – Demographic Information 
The questionnaire’s first section gathered demographic data about pharmacists and their 
practice sites. The demographic data served to paint a picture about the landscape of community 
pharmacy in Saskatchewan and provide the appropriate context to best understand the 
participants’ responses and allow for comparisons between groups and variables related to ESoP 
or collaboration. Four of the six demographic questions pertained to size of pharmacy location, 
proximity to physicians’ clinic, and average daily prescription volume and staffing. The other 
two demographic questions were related to pharmacists’ characteristics such as years of 
experience practicing community pharmacy and position in the pharmacy.  
The first question asked pharmacists to classify their pharmacy based on the location size. 
Classification was based on Statistics Canada (2017) definitions of large (>100,000 people), 
medium (30,000-99,999 people), small (5000-29,999 people), and rural (<5000 people) 
population sizes. This context is important because “internationally, there have often been 
suggestions of differences in community pharmacy practice between rural and urban locations” 
(Howarth, Peterson, & Jackson, 2020, p. 3). Further, Howarth et al. (2020) suggested that rural 
pharmacists may have a better working relationship with prescribers. Saskatchewan is a very 
geographically diverse province with community pharmacies spread through out various regions. 
Therefore, pharmacy practice could differ based on the practice location of the pharmacist. 
The next question asked was the pharmacy’s location in relationship to proximity to 
physicians’ clinics. A report released in April 2019 by the Canadian Pharmacist Association 
titled Innovation in Primary Care, Integration of Pharmacists into Interprofessional Teams 
demonstrated that co-located pharmacists or “in-house” pharmacists resulted in improved 




experiences with collaboration may be different based on the physical location or proximity to 
the clinic. To account for this variable, community pharmacists were asked to classify the 
proximity of their community pharmacy practice site to the physician clinic. 
Subsequent questions obtained information pertaining to pharmacist workload and 
staffing at the pharmacy. Community pharmacists were asked to estimate the approximate daily 
prescription volume and composition of the staff working at their community pharmacy practice 
site. Acquiring this information is relative since evidence suggests that a high workload can 
negatively influence the provision of services and act as a barrier to practice change (Lea, 
Corlett, & Rodgers, 2012).  Workload can be defined as the amount of work completed in a 
specified period of time, such as the amount of prescriptions in a specified period of time (Lea, et 
al., 2012). Further, information on pharmacy staffing is relative to the analysis of ESoP and 
collaboration since pharmacists perceive delegation of tasks to non-pharmacists staff as being 
important for management of workload and to take on new professional roles (Lea et al., 2012). 
This may be particularly useful information to obtain in Saskatchewan since incorporation of 
registered technicians into pharmacies is relatively new. 
The two demographic questions related to individual pharmacists’ characteristics were 
the number of years of experience pharmacists had working in community pharmacy and if their 
position in the pharmacy was as a staff pharmacist, owner, manager, clinical pharmacist, or a 
floater/relief pharmacist. Pharmacists’ ESoP has increased significantly in the last decade. 
Pharmacists who have practiced for one year may have a different perspective on the influence 
ESoP has had on physician collaboration than pharmacists who have worked over ten years, for 
example. With regard to the pharmacist position, Gregory, Teixeira, and Austin (2017) identified 




pharmacy practice with Extended Scope of Practice (ESoP) activities. In their discussion, they 
recognized that pharmacy managers’, owners’, and staff pharmacists’ level of engagement, 
direction provided, and positive reinforcement of practice changes could have an effect on 
implementation of these changes. My own experience working in community pharmacy has 
reinforced that the staffing position held at the pharmacy can have an influence on the level of 
engagement in ESoP activities. Having pharmacists’ years of experience and position included in 
the data allows for comparisons and correlations to be made between responses.  
Part Two – Expanded Scope of Practice and Collaboration Information 
Part two of the questionnaire contained 11 questions related to ESoP and physician 
collaboration. The first two questions were to gauge pharmacists’ level of involvement in ESoP 
activities compared to traditional activities and determine which specific ESoP activities they 
were most involved in. The responses to these questions were used to directly answer the study’s 
research questions. In addition, the information helped in comparative analysis of the responses 
in the data analysis portion of the study. Comparing responses based on level of involvement can 
help identify differences in responses between pharmacists with low and high levels of 
pharmacist engagement and gain further insight on the influence of ESoP on physician 
collaboration. Pharmacists who spend a large percentage of their workload on ESoP activities 
may offer a different perspective to its influence on physician collaboration than pharmacists 
who have limited involvement. Furthermore, the information acquired could identify differences 
in ESoP engagement or notable correlations between groups. For example, does ESoP 
engagement differ based on pharmacy location, workload, or years of pharmacist experience etc. 
Two questions pertained to the medium pharmacists used for exchanges. Community 




which was the most effective for collaboration. Medium options were phone, fax, in-person, text 
or digital messages, emails, or round-table discussions. Pharmacists were asked to select which 
type of medium they most commonly used for exchanges with physicians and which were the 
most effective for collaboration. I intentionally did not provide pharmacists a rigid definition for 
what was considered ‘effective’. Oandasan et al. (2006) portrayed collaboration in a broader 
sense; these authors described collaboration as the collective action toward a goal. They 
acknowledged that collaboration is a process that requires relationships and interactions between 
healthcare professionals. As a result, it is ultimately the health care professionals themselves who 
determine when collaboration has occurred. Oandasan et al. (2006) viewed collaboration as a 
spectrum involving a wide range of interactions, depending on the type of care required. This 
view of collaboration seems less restrictive and more consistent with the collaborative practices 
experienced in community pharmacy. Allowing the pharmacists to determine what they 
considered effective seemed appropriate, especially considering the limited knowledge available 
exploring collaboration practices in a community pharmacy setting.  
Communication is a key element identified in various theoretical models of collaboration 
such as Artimage’s and Hudson’s model. Identifying how communication is done in community 
pharmacy is relevant if we are to have a complete picture of collaboration in the community 
pharmacy setting. One of the biggest challenges to collaboration unique to community pharmacy 
is the fact that most pharmacies have physical separation away from physicians that can limit the 
opportunity for in-person interactions or more formalized discussions. The organized structure of 
institutional facilities like hospitals or structures within the health regions facilitates 
communication and collaboration between health care professionals; however, collaborative 
practice in the community is more challenging (Kelly et al., 2013). Having a better 




should help provide a more comprehensive perspective of how the medium used supports or 
hinders collaboration. Further the CPCM model used to guide the study places emphasis on 
evaluating collaboration in terms of exchanges; thus the mode in which it is occurring is relative.  
There were several ways that the questionnaire was used to evaluate the influence of 
ESoP on physician collaboration. The most direct was to simply ask pharmacists directly via an 
open-ended questions. This allowed for pharmacists to state in their own words its influence. The 
next strategy was to use the CPCM as a guide. Unlike other models of collaboration, the CPCM 
adapts previous theoretical models of collaboration to put emphasis on exchanges. It places 
exchanges in the context of those that are differentiated compared to those more integrated. 
Several questions included in the questionnaire were designed to get data on the frequency of 
these exchanges. Pharmacists were asked to quantify the frequency of exchanges of traditional 
pharmacy activities compared to ESoP activities. Further they were asked to agree, strongly 
agree, neither agree or disagree, disagree, or strongly disagree with statements on ESoP ability to 
increase contact, pharmacist-initiated exchanges, bilateral exchanges, physician-initiated 
exchanges, partnerships or verbal agreements, written agreements, and CPAs. The data obtained 
would help assess ESoP influence on physician collaboration through the lens of the CPCM. 
Along with evaluating the frequency of exchanges were questions assessing the quality of 
the exchanges. The term ‘quality’ in the context of this study was defined as sharing information, 
making recommendations, and decision making that have the potential to improve patient care 
outcomes or health system outcomes. This definition was derived from Oandasan et al.’s (2006) 
view of teamwork and collaboration in healthcare. Based on this definition pharmacists were 
asked to rate the quality of the exchanges made with ESoP versus those from traditional 




with physicians. Oandasan et al. (2006) also viewed teamwork as a product of collaboration and 
collaboration as a process of interactions and relationships between health professionals. 
Subsequently, a question was included addressing ESoP ability at improving relationships with 
physicians. The last question added to address the quality of the exchange was ESoP effect on 
role awareness. The CWR model has two of its five stages devoted to role recognition and 
awareness and is considered an important element particularly in the formation of collaborative 
relationships.  
The remaining two questions asked on the questionnaire were related to collaboration in 
general. Pharmacists were asked to state via an open-ended question, in their own words, 
strategies for fostering collaboration with physicians. This question directly answers one of the 
study’s research questions. Lastly, pharmacists were asked to categorize the current state of the 
collaborative relationship with the physician or physician groups with whom they work and 
which strategies they considered effective for fostering collaboration with physicians. Rather 
than having pharmacists simply state whether they have or do not have a collaborative 
relationship, I wanted to increase the specificity and determine more specifically what type of 
collaborative relationship was present by providing seven options of possible collaborations. 
Because I could not find data in the literature specifically listing pharmacist and physician 
relationship classifications or ranking, I constructed the seven selections based on how 
pharmacist and physician relationships were often described in individual pieces of literature on 
the subject matter and coupled them with the knowledge I acquired on collaborative relationships 
through my experience working in a community pharmacy practice. The following collaborative 




• A CPA (Collaborative Practice Agreement) formalized through SCPP to perform 
activities or services.  
• A written agreement to perform activities or services.  
• A verbal agreement to perform activities or services.  
• No written or verbal agreement; however, a cooperative relationship in which they work 
well together regarding individual patients or tasks consistently.  
• Limited collaboration. Communication is one-sided and limited to technical matters 
related to filling prescriptions.  
• No collaboration. As professionals they work independently almost exclusively.  
• Hostility, conflict, or opposition when dealing with physicians or physician groups 
The questionnaire was thoughtfully designed to provide much data to be collected and used for 
analysis. 
Data Collection 
Neuman and Robson (2009) stated that quantitative design has a variety of data collection 
methods such as content analysis, existing statistics, surveys, and experiments. The data 
collection method chosen for this study was survey research. Survey research involves 
systematically asking many people the same questions and then recording and analyzing their 
responses (Neuman & Robson, 2009). In this study, a questionnaire was sent to all 1165 licensed 
practicing community pharmacists, with the intention of obtaining an overview of pharmacists’ 
thoughts and providing further insight into this relatively unexplored area.  
A mixed-mode data collection was used in survey design (Dillman, Smyth, & Christian, 
2014). Initially a letter was mailed to all practicing licensed community pharmacists. The letter 




online link to the questionnaire, and offered a mailed paper copy of the questionnaire, if desired. 
Ten days later pharmacists received an email invitation, through SCPP, to participate in the 
online survey via a link provided. Traditionally, having a second mode offered an alternative 
means for people to participate, in case one mode was more appealing than another (Dillman et 
al., 2014). However, in today’s environment, multiple modes of communication can be a 
powerful way to encourage response to single mode of survey delivery and improve the survey’s 
response and the quality of those responses (Dillman et al., 2014). Millar and Dillman (2011) 
noted that response rate improves when following a postal request with an email containing a 
link to an online survey. Mixed-mode survey design can use these multiple contact points to have 
the various modes work synergistically to convince participants to respond (Dillman, et al., 
2014).  My questionnaire’s response rate was 15.6%. Unfortunately, the timing of the survey was 
not ideal because the questionnaire was not distributed during the summer months; that left very 
little time for a three week window before the start of influenza season, a busy time in the 
pharmacy. Further SCPP did not send the last email reminder invitation, due to some complaints 
from members that the multiple email invitations were a nuisance, particularly when they already 
completed the survey. The mixed-mode method may have contributed to my relatively favorable 
response rate of 15.6%, even though there were other factors that may have negatively impacted 
response rates. 
The questionnaire was designed into two parts, part one had six questions on 
demographics and part two had 11 questions on ESoP and collaboration. The responses in part 
one were mandatory meaning that participants were not allowed to select “Next” and continue to 
part two of the questionnaire unless all fields had a response entered in. Part two contained 11 
questions however responses were not mandatory for all fields. At the end of the questions was a 




responses and were ready to submit them. Only questionnaires that were submitted by the 
pharmacists selecting “Done” were included in the analysis and the study’s response rate.  
 215 or 18.5% out of 1165 community pharmacists sample size completed part one of the 
study questionnaire via the link provided in the email invitation. However only 183 of out of the 
215 or 15.7% of the 1165 study sample size questionnaire responses were submitted by the 
pharmacist. Submission of their answers was completed by pharmacists selecting the “Done” 
button after answering questions in part two of the questionnaire. In the remaining 32 of the 215 
responses, pharmacists did not click the “Done” button needed to submit their responses and 
therefore any answers they may have entered were not recorded or included in the study. Almost 
all 183 pharmacists completed the 9 closed-ended questions in part two, however only three-
quarters answered the two open-ended questions in part two of the questionnaire. Responses 
produced from the questionnaire were analyzed, and open-ended responses coded. This data was 
used to start to formulate results and draw conclusions. Data collected will be secured for a five 
year time frame on the researcher’s password protected One Cloud account and then destroyed to 
maintain confidentiality. 
Data Analysis 
Data analysis in this study was completed in two distinct phases, phase one used 
descriptive statistics on all the closed-ended questions, followed by coding of the responses for 
the two open-ended questions. A data summary was presented in the form of bar graphs, 
histograms, and pie charts. Data analysis was primarily computed in the form of percentages and 
averages depending on the questions being asked. Data acquired were also divided between 
groups for comparison. For example, when further analyzing pharmacists’ response on the 




spending more than 40% of their workload on ESoP compared to those who reported spending 
less than 20% of their workload. Another comparison made was reviewing pharmacists’ 
responses based on urban or rural location size, to determine any major deviations between 
groups.  
Pharmacists’ responses to open-ended questions were reviewed, analysed, and 
reoccurring themes identified. The goal of data analysis is to make sense of the data by 
consolidating, reducing, and interpreting responses and what the researcher has read (Merriam, 
2009). Data analysis involves a systematic strategy for analysing a data set (Merriam, 2009). 
Common themes obtained from the research data were recorded and subcategories created. Fink 
(2013) suggested that it is more advantageous to have a larger number of subcategories, since it 
is easier to combine them later rather than break categories apart. After all the subcategories 
were created they were grouped into core categories. The core categories functioned as the main 
conceptual element by which all other categories and properties were connected (Merriam, 
2009).  Results were recorded based on the frequency of times the theme was identified in the 
responses. For example, if a pharmacist mentioned in their open-ended response that ESoP 
improved communication, then it was given a score of one. If it was mentioned several times in 
one pharmacist’s comments, it only received a maximum score of one per person. The overall 
score was calculated for each subcategory and core category and displayed in a chart form. Bar 
graphs and pie charts were also used to illustrate and compare responses. Further steps were 
taken with the data to help improve trustworthiness, as described in the following section. 
Trustworthiness of Data 
Neuman and Robson (2012) stated that researchers want their measurements reliable and 




refers to dependability or consistency of findings (Neuman & Robson, 2012). “It suggests that 
the same thing is repeated or recurs under the identical or very similar conditions” (Neuman & 
Robson, 2012, p.109). Validity refers to the degree of truthfulness or how well the construct fits 
with reality (Neuman & Robson, 2012). Fink (2013) purported that reliable and valid surveys 
produce consistent and accurate information. The following steps were taken in the study to 
increase reliability, validity, and reduce researcher bias. 
Reliability 
 Bolarnwa (2016) refers to reliability as the degree a test or measurement such as a 
questionnaire can produce the same results. There were several steps taken to increase this 
study’s reliability. The questionnaires used for data collection had clear definitions defining 
terms used throughout the questionnaire for improved clarity. Furthermore, the questions were 
developed based on theoretical models of collaboration derived from the literature. Neuman and 
Robson (2012) stated that reliability is increased with clearly conceptualized, unambiguous 
constructs to reduce distractions. Fink (2013) supported this notion by suggesting that reliable 
and valid surveys have definitions and models used to select questions that are grounded in 
theory and experience. The theory used to guide questions was the Community Pharmacists 
Collaboration Model (CPCM). This theory was formed examining existing models of 
collaboration in the literature and creating a new model more applicable to a community 
pharmacy setting. The second method used to increase reliability was to increase the level of 
measurement. When indicators are higher or more precise the levels of measurement increase 
and more detailed information is obtained, thereby enhancing its reliability (Neuman & Robson, 
2012). In this study the levels of measurement were increased by including questions that had 




no style questions. Answer options included strongly disagree, disagree, neither, agree, and 
strongly agree. Another method used to increase reliability was to provide a pilot of the 
questionnaire. Pilot tests help determine ahead of time if the survey is well-constructed, 
comprehensible and user friendly (Fink, 2013). The pilot questionnaire was given to three 
professionals. Feedback was provided and used to make minor modifications to improve clarity 
and ease of use. 
 The last method used to increase reliability of the questionnaire was to use principles 
derived from alternate-form reliability. Bolarinwa (2016) described alternate form as the amount 
of agreement between two or more research instruments. Often this involves using a differently 
worded questionnaire to measure the same attribute or construct (Bolarinwa, 2016). While it was 
not practical in this study to re-administer another questionnaire with re-worded questions, I did 
ask multiple questions regarding the same construct through-out the questionnaire such as 
questions pertaining to the frequency of exchanges, relationships with physicians, and the 
influence of ESoP on collaboration. Having alternate strategies in place to help determine if 
answers to the differing questions reproduced the same responses, played a role at increasing the 
reliability of the results and conclusions made. 
Validity 
 Cohen, Manion, and Morrison (2011) identified validity as being a vital aspect in creating 
effective research. They stated that in quantitative research data validity may be enhanced 
through careful sampling, suitable instrumentation and appropriate statistical treatments of the 
data (Cohen, Manion, & Morrison, 2011). A variety of decisions were made to ensure that 
careful sampling was implemented in this study’s design to increase its validity. The sample was 




Saskatchewan can work in a variety of roles, such as hospital, community, academia, industry, 
corrections, government etc. Although hospital pharmacists also have experience with physician 
collaboration, expansion of the pharmacist’s role is the most applicable to community 
pharmacists. Community pharmacists comprise the majority of pharmacist positions in the 
province and are, therefore, the most representative of the group. In addition, only practicing 
pharmacists were invited to participate, since expansion of the pharmacists’ role has occurred 
most heavily recently. Therefore, data acquired represents the largest group of pharmacists and 
targets those most affected by ESoP.  
Another strategy incorporated within the study to increase validity was the use of 
appropriate instruments. Cohen et al. (2011) expressed that devising appropriate instruments that 
are accurate, representative, relevant, comprehensive, and reflect the complexity of issues, can 
increase validity. Further they suggested proper readability level, unambiguous instructions, 
terms, and questions. The questionnaire used in the study was designed to include relevant and 
comprehensive data that represented the current state of ESoP in the province. Including 
demographic data such as years of work experience, position, prescription, workload, staffing, 
medium of collaboration, and engagement in ESoP activities helped provide the required context 
to best interpret and analyze responses. Additionally, it helped control other variables that may 
be contributing factors to responses provided.  
Researcher Bias 
My experience working in community pharmacy, with ESoP activities, and in 
collaborative practice has the potential to add to researcher bias in the design and interpretation 
of the data acquired from the study. Consequently, many steps were taken to assist in minimizing 




exploration, identify relevant experiences, and share it in my positionality portion of my 
research. Creswell (2014) stated that to strengthen a study it is important for the researcher to 
self-reflect and to clarify the bias that a researcher brings through an open and honest narrative. 
Through this process I was able to identify specific life experiences and expose underlying 
personal characteristics that had the potential to influence my study design and interpretation. 
Being cognizant of this helped me identify and proactively make decisions to minimize potential 
interference of my biases in acquiring objective study data and results.  
  The next step was to choose a study design which was less likely to cause bias. Neuman 
and Robson (2012) stated that a quantitative study design is more likely to use explicit and 
standardized procedures with an emphasis on objectivity. An additional method used was to find 
a theoretical conceptual model on collaboration to use to help shape my study design (Neuman & 
Robson, 2012). Modeling my study on foundational pieces on collaboration and utilizing clear 
definitions from the literature helped ensure the design was based in scientific evidence rather 
than via my own experiences. Further, the study questionnaire included open-ended questions on 
the most essential research questions so that pharmacists had the opportunity to state in their own 
words their opinions rather than just through the predetermined options offered by the researcher 
in the Likert-scale questions. In addition, open-ended responses were coded by the researcher 
and then forwarded to a non-pharmacist professional to ensure there was no obvious bias 
influencing the coding of the responses. Neuman and Robson (2012) recommended that a single 
researcher find another person to cross-check their codes to increase reliability of the study. 
Another step was for the questionnaire tool to be pilot tested by three different professionals to 
have an alternative perspective on it. All of these steps were incorporated into the study to help 
assist in acquiring more objective findings and minimizing researcher bias.  Querying 




in the design to help obtain accurate data. Having converging sources of perspectives from 
participants can help build themes, thereby adding to the validity of the study (Neuman & 
Robson, 2012). 
Ethical Considerations 
This study was submitted to the University of Saskatchewan Research Ethics Board and 
given approval. Risk to participants in this study was taken into consideration and appropriate 
steps taken to minimize the risk. Risks included participating pharmacists being identified and 
their opinions and activities made known to others. Sharing of pharmacy information could be 
prohibited by some pharmacy chain employers and has the potential of a pharmacist having to 
contend with consequences of doing so. Additionally, a pharmacist’s reputation could be 
negatively affected if their opinions were identified. Since the pharmacy community is small and 
often tight knit, differing opinions could limit future pharmacist opportunities and collaborations. 
To minimize risk, the questionnaire was distributed to participants by the Saskatchewan 
College of Pharmacy Professionals via personal emails listed in their registration, thereby, 
providing distance from their employer and the researcher’s opinions and affiliations in the 
community. SCPP also provided confirmation in every email sent to participants that SCPP has 
no access to participant responses as an added assurance of respondents’ anonymity. The 
questionnaire was confidential and did not have detailed specificity, to reduce the likelihood of 
associations being made and participants inadvertently identified. All participants were fully 
informed on pertinent details of the study and asked to provide consent.  They could choose to 
close their browser at any time and exit the survey; incomplete surveys were not included in data 
analysis. Data collected will be secured for the allotted time frame on the researcher’s password 





 A 17-question questionnaire (Appendix A) was used as the instrument to obtain data 
about practicing community pharmacists’ demographics, experience with ESoP, and physician 
collaboration. The intention was to acquire data directly from many practicing community 
pharmacists from varied practice locations. Attempts to improve trustworthiness of data acquired 
were incorporated into the study design to enhance the reliability, validity and reduce researcher 
bias. Data were collected, coded and analyzed, and used to try and gain some insight into this 
area of study, with the hope of providing more information about expanded scope of practice and 
physician collaboration. The data collected from the study were compiled and organized in the 
following chapter. Chapter Four includes a complete presentation of findings and summarizes 













CHAPTER FOUR: FINDINGS 
 The objective of this study was to obtain perspectives from practicing community 
pharmacists about how expansion of the pharmacists’ role has influenced collaboration with  
physicians. Additionally, the study queried how engaged pharmacists were in expanded scope of 
practice (ESoP) activities versus traditional activities and asked pharmacists to share effective 
strategies for physician collaboration. A quantitative study design was chosen to gather a large 
amount of information and opinions on the subject matter. Data were collected by emailing a link 
to a 17-question online questionnaire to all licenced practicing community pharmacists in 
Saskatchewan. The Saskatchewan College of Pharmacy Professionals (SCPP) distributed the link 
to 1165 pharmacists. Of the 1165 pharmacists, 215 pharmacists responded to the questionnaire; 
however only 183 of those submitted their responses at the end of the questionnaire. Only the 
183 responses that were submitted at the end of the questionnaire were used in the study.or 
approximately 16% of practicing community pharmacists. The results are as follows. 
Demographic Data 
 The questionnaire’s first section gathered demographic data about pharmacists and their 
practice sites. The first question asked pharmacists to classify their community size based on 
where the pharmacy was located. Classification was based on Statistics Canada (2017) 
definitions of large (>100,000 people), medium (30,000-99,999 people), small (5000-29,999 
people), and rural (<5000 people) population sizes. According to the Saskatchewan College of 
Pharmacy Professionals (SCPP, 2020), the SCPP registry of practicing community pharmacists 
indicated that 50% practice in large urban centres, 10% in medium centres, 14% in small centres, 
and 26% in rural centres. The questionnaire yielded similar results of 44% (n =95) of practicing 
community pharmacists from large urban centres, 11% (n=23) from medium centres, 22% 




percentage of the respondents who are practicing in large, medium, small centre settings and how 
many are rural or remote settings.  
 
 
Figure 4.1 Community pharmacy location (in %) of practicing community pharmacist 
respondents 
 
Figure 4.2 reflects what percentage of pharmacists categorised their pharmacy as within, 
beside, within 2 blocks, in the same, or in a different town or city as the physician groups with 



















Figure 4.2 Community pharmacy’s proximity to physician clinic (in %) of practicing community 
pharmacist respondents 
Figure 4.3 represents the average number of prescriptions performed in a typical day at 
the community pharmacy at which they worked. Results are displayed as the percentage of 
pharmacists who estimated their daily prescription workload within the following ranges.  
 



























Community pharmacists were asked to estimate the approximate composition of the staff 
working at their community pharmacy practice site. Figure 4.4 represents what the average 
number of pharmacists, registered and non-registered technicians, as well as assistants working a 
typical 8-hour shift in the pharmacy. Results are displayed as the percentage of pharmacists who 
estimated each number of the different type of pharmacy staff working during a typical 8-hour 
shift. 
 
Figure 4.4 Average number of pharmacy staff working a typical 8-hour shift in community 
pharmacy practice site 
 
Figure 4.5 depicts what positions pharmacists hold at their pharmacy location. Results 
are posted as percentage of total pharmacist respondents who hold the following position of: 
owner, staff pharmacist, clinical pharmacist, floater/relief pharmacist or pharmacy manager.   










Figure 4.5 Community pharmacy’s position (in %) of practicing community pharmacist 
respondents 
 Figure 4.6 provides a breakdown of how long respondents have been practicing in 
community pharmacy. 
 





















<6 months (n=6) 6 months-2 years
(n=19)




The results show that most of the pharmacists who participated in the questionnaire had a wide 
array of experience in community pharmacy, ranging from less than six months to over 20 years. 
The majority of pharmacists had over ten years of experience working as a community 
pharmacist. In fact, over a third of all responses were from pharmacists who had over twenty 
years of experiences.  
Summary of Demographic Data  
Demographic data acquired from the questionnaire indicate that practicing community 
pharmacists were from a wide range of community pharmacies across Saskatchewan, work in 
different capacities within the pharmacy, and have a large range of experience. The following 
information provides data comparing ESoP activities to traditional pharmacy activities. 
Expanded Scope of Practice Activities versus Traditional Pharmacy Activities 
 On average, pharmacists estimated that they spend roughly 30% percent of their 
workload or approximately 2 hours and 24 minutes of an 8 typical hour shift, providing ESoP 
activities compared to traditional pharmacy activities. There were a wide range of responses in 
pharmacists’ estimated time spent in ESoP activities. Figure 4.7 provides a visual depicting the 
array of involvement in ESoP. Data are presented as the percent of a community pharmacist’s 






Figure 4.7 Pharmacists’ estimation of their approximate workload spent on providing ESoP 
activities compared to traditional pharmacy activities 
 
ESoP activities include a wide range of possible activities that differ from the traditional 
activities that pharmacists customarily practice. The questionnaire asked pharmacists to share 
which types of ESoP activities they most frequently provided to their patients. Pharmacists were 
asked to rank the various ESoP activities on a scale of one to ten with ten being their most 
frequent activity. The figure below illustrates pharmacists’ level of engagement in the various 



















Figure 4.8 Ranking of community pharmacist engagement in ESoP activities 
 
The ESoP activities pharmacists performed the most were: renewing prescriptions, prescribing 
for minor ailments, and administering a drug by injection. With the exception of influenza 
injections, all of these ESoP activities require communication by the pharmacist to the patient’s 
physician.  
Frequency of Exchanges 
 The term exchanges used in this study refers to the exchange of permission, information, 
and responsibility for patient care (McDonough & Doucette, 2001). This exchange may include 
any interaction with a physician including phone call, fax communication, email, electronic 
message, text message, email, or face-to-face interaction. Community pharmacists were asked to 
quantify the frequency of exchanges with physicians when engaged in traditional pharmacy 
services versus ESoP activities. The results from the questionnaire suggested that overall, 
traditional pharmacy services were more likely to occur daily compared to ESoP. However, the 
Ordering/interpreting lab tests






Administering a drug by injection





more heavily pharmacists engaged in ESoP, the more they reported these physician exchanges 
occurred daily. An additional method used in the questionnaire to gauge the frequency of 
exchanges was to ask pharmacists if they strongly disagree, disagree, neither agree or disagree, 
agree, or strongly agree with statements that ESoP activities increased pharmacist-initiated, 
physician-initiated, and bilateral exchanges. The figure below compares the percentage of 
pharmacists who disagreed verses those who agreed with the statements. 
  
Figure 4.9 Comparison of the number of pharmacists who agreed verses disagreed with ESoP 
influence on exchanges with physicians 
This data suggests that ESoP activities increased the frequency of exchanges initiated by the 
pharmacist and between pharmacists and physicians. However, most pharmacists felt it did not 
dramatically increase the likelihood of physicians initiating exchanges with pharmacists. For 
further analysis of the impact of ESoP on exchanges, the data was broken down into two groups: 
community pharmacists with low and high ESoP engagement. The average ESoP engagement 
pharmacists reported was 30% with the majority of respondents falling between the 20-40% 























ESoP engagement and >40% considered high ESoP engagementLow engagement is defined as 
pharmacists who were spending 20% or less of their workload on ESoP activities. High 
engagement is defined as pharmacists who were spending 40% or more of their workload on 
ESoP activities. The results for both groups are illustrated in the following figure. 
  
Figure 4.10 Number of pharmacists who disagree versus agree with the following statements on 
the influence of ESoP activities, based on low and high levels of pharmacist ESoP engagement 
 
The results indicate that the more highly engaged pharmacists were in providing ESoP services, 
the more they considered ESoP beneficial in increasing exchanges between pharmacists and 
physicians.  
Quality of Exchanges 
 The following sections of data focus on how the quality of the exchange with physicians 
differ when community pharmacists are performing traditional pharmacy services compared to 
ESoP services. The term ‘quality’ in the context of this study connotes actions such as sharing 
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patient care outcomes or health system outcomes. Pharmacists rated exchanges with ESoP as 
being 20% higher in quality and 30% less likely to have a low-quality exchange, compared to 
traditional pharmacy services. A visual of how community pharmacists rated the quality of 
exchanges of traditional versus ESoP activities is depicted in Figure 4.11 below. The figure 
presents the data when grouped together regardless of the pharmacists’ level of engagement in 
each activity.  
  
Figure 4.11 Comparison of how many pharmacists ranked quality of the exchanges with 
physicians regarding traditional versus ESoP activities 
 
As demonstrated in Figure 4.12 however, when the quality of the exchanges was based 
on pharmacists’ engagement in ESoP activities, pharmacists highly engaged in ESoP activities 
reported a 56% increase in the quality of exchanges compared to traditional activities. Figure 
4.12 compares the quality of exchanges produced with traditional and ESoP activities, based on 
the pharmacists’ level of engagement in ESoP. Data were broken down into two groups, 





















Figure 4.12 Number of pharmacists who rated the quality of exchanges with physicians produced 
from traditional and ESoP activities, based on low and high levels of pharmacist ESoP 
engagement 
The information presented in Figure 4.12 suggests when pharmacists are more involved in 
providing ESoP services to patients, the quality of exchange with physicians is enhanced when 
compared to providing traditional pharmacy services.  
Expanded Scope of Practice Influence on Physician Collaboration 
The primary objective of the study was to determine the influence of pharmacists’ ESoP 
on collaboration with physicians. The first way this was assessed in the questionnaire was 
participants stating whether they strongly agreed, agreed, were neutral, disagreed, or strongly 
disagreed with eight statements about the possible influence of ESoP on physician collaboration. 
These statements were derived from the Community Pharmacists Collaboration Model (CPCM) 
presented in Chapter Two. Figure 4.13 compares the percentage of pharmacists who disagreed or 






























Figure 4.13 Comparison of the number of pharmacists who disagreed versus those who agreed 
with ESoP’s influence 
 
The level of engagement in ESoP activities varied greatly among community 
pharmacists. Figure 4.14 and Figure 4.15 compare the percentage of pharmacists who disagreed 
versus those who agreed with each of the following statements on ESoP’s influence on 
collaboration. The figures separate responses into two groups: pharmacists who have low 



























































Figure 4.14 Comparison of the number of pharmacists who disagreed versus those who agreed 
with ESoP’s influence from pharmacists with LOW ESoP engagement  
 
Figure 4.15 Comparison of the number of pharmacists who disagreed versus those who agreed 
with ESoP’s influence from pharmacists with HIGH ESoP engagement  
 
The data was further analyzed to determine if a community pharmacist’s level of engagement in 

















































































































with high levels of engagement in ESoP activities agree more and disagree less with all eight 
statements on the influence of ESoP compared to pharmacists with low levels of engagement in 
ESoP activities. There is a positive correlation between ESoP engagement and the perceived 
value of ESoP to collaboration with physicians. 
 An additional method the study used to meet its objectives of determining what influence 
pharmacists’ ESoP had on collaboration with physicians was by asking community pharmacists 
this question directly via an open-ended prompt. 137 pharmacists responded to the open-ended 
question and these responses were then coded and recorded based on the frequency of times the 
theme was identified in the responses. Every time a theme was brought up in a pharmacist’s 
response it received one point. For example, if five pharmacists mentioned in their open-ended 
response that ESoP improved communication, then it was given a total score of five. However, if 
the same theme was brought up numerous times in a single pharmacists’ response it was still 
only given a maximum of one point. The overall score was calculated for each subcategory and 











Table 4.1 Influence of Expanded Scope of Practice on Physician Collaboration in Community 
Pharmacy  





Communication Increased communication 21 35 
Increased sharing of information 14 
 
Collaboration Positively affected/Increased 33 33 
Pharmacist utilization 
 




Increased physician/clinic pharmacist 
referrals 
5 
Increased partnership opportunities (CPA) 
 
4 
Clinical effects Enhanced shared decision making 19 27 
Improved patient outcomes 
 
8 
Pharmacist – Physician 
relationship 
Increased appreciation and respect 10 23 
Improved relationship with physician 8 
Enhanced trust 5 
 
Minimal effect Little improvement in collaboration with 
physicians 
21 21 
Adverse effect on 
collaboration 
Negatively affected collaboration with 
physicians 
16 19 
Increased territorial issues with physicians 
 
3 
Role recognition Enhanced recognition of pharmacist 
physician roles 
 18 
Lack of physician 
engagement 
Pharmacist attempts to collaborate with 
no response from physician 
16 16 
Varied response from 
physicians 
Response to collaboration depends on the 





Decreased physician workloads 13 13 
No influence Has not resulted in any changes to 
collaboration with physicians 
10 10 
Unsure Not aware of how collaboration has been 
influenced 
2 2 





The results from the study indicated the largest influence of pharmacists’ ESoP has been 
enhanced communication and collaboration with physicians. In this question, ESoP activities are 
grouped into one category. However, they encompass a wide variety of services, some which 
may be more beneficial than others at fostering collaboration with physicians. 
Most Influential ESoP Activities at Fostering Collaboration with Physicians 
 ESoP activities encompass a large range of pharmacist services. To gauge which 
activities were more valuable at fostering collaboration, community pharmacists were asked to 
rank the various ESoP activities as to their overall influence. Figure 4.16 provides a break down 
from most to least beneficial activities at fostering collaboration with physicians, as indicated by 
the pharmacist questionnaire participants.  
 
Figure 4.16 Comparison of ESoP activities considered most influential at fostering collaboration 
with physicians by practicing community pharmacists 
Medication assessment was considered the most influential ESoP activity at fostering 
collaboration, followed by prescribing for minor ailments, and renewing prescriptions.  
None
Smoking cessation
Administering a drug by injection
Ordering/interpreting lab tests










Strategies for Fostering Collaboration with Physicians 
In the questionnaire, pharmacists were asked an open-ended question as to which 
strategies have had the greatest impact at fostering collaboration with physicians. 136 
pharmacists responded to the open-ended question and these responses were then coded into core 
categories and sub-categories based on common themes presented in the data. Table 4.2 
represents the frequency in the occurrence of the following themes that emerged from the 
responses. 
Table 4.2 Most effective strategies for fostering collaboration with physicians according to 
practicing community pharmacists 






Increasing exchanges  In-person face to face interaction or meeting 27 84 
Phone call/speaking with physician directly 25 
Written communication/ fax communication 22 
Written communication via fax followed up 
with a phone call 
5 
Physician will only accept written 
communication via fax 
5 
Expanded Scope of 
Practice Activities  
Collaboration built off of expanded scope of 
practice activities. Particularly medication 
assessments 
21 21 
Knowledge and skills Providing physician with strong clear and 
concise recommendations baked with strong 
evidence-based medicine and clinical 
decision making 
16 16 
Communication Providing effective clear and open 
communication 
 15 
Physician Relationship Getting to know the physician 6 12 
Building trust 4 




Patient-centered care Collaboration is built by focusing on patient 
care or patient involvement 
8 8 
Not sure Pharmacist not aware of effective strategies 




Increasing awareness of pharmacist and 
physician roles 
6 6 
Proximity to clinic Closer proximity to physician or physician 
clinic improves collaboration 
6 6 
*arranged in order from most frequently mentioned categories to least frequently mentioned 
 
The most mentioned theme identified in the questionnaire’s responses for effective strategies for 
fostering collaboration with physicians was increasing exchanges used for collaboration. Many 
pharmacists felt that the choice of medium used for communication with physicians played a 
significant role in the process. Most pharmacists reported that exchanges which were done in 
which the medium used was verbal, either via the phone or in-person, were most effective at 
fostering collaboration with physicians. 
Medium of Collaboration 
The predominant theme pharmacists identified for fostering collaboration with physicians 
was by increasing their exchanges with physicians. Most responses included the medium the 
pharmacists utilized for collaboration. Community pharmacists were asked which medium they 






Figure 4.17 Main medium being used for collaboration with physicians (%) currently by 
practicing community pharmacists 
  
Figure 4.18 Most effective medium for collaboration with physicians (%) as determined by 









Round table discussions 
(n=7), 4%
Phone (n=73), 40%
Text or digital messages 
(n=2), 1%
In-person (n=14), 8%
Email (n=4) Fax (n=79) Round table discussions (n=7)





According to the survey, 90% of pharmacists stated that the main medium they used was 
fax, followed by seven percent using the phone, and three percent in-person. However, when 
they were asked which medium was most effective for collaboration, only 43% indicated fax, 
followed by 40% suggesting phone, 12% stated in person or via round table discussions, and 2% 
said fax was the most effective means of collaboration.  
State of Community Pharmacists’ and Physicians’ Collaborative Relationship 
The last question that was asked on the questionnaire was to categorize the current state 
of the collaborative relationship with the physician or physician groups with whom they work. 
Rather than having pharmacists simply state whether they have or do not have a collaborative 
relationship, I wanted to increase the specificity and determine more specifically what type of 
collaborative relationship was present by providing seven options of possible collaborative 
relationships between pharmacists and physicians: 
• A CPA (Collaborative Practice Agreement) formalized through SCPP to perform 
activities or services.  
• A written agreement to perform activities or services.  
• A verbal agreement to perform activities or services.  
• No written or verbal agreement; however, a cooperative relationship in which they work 
well together on individual patients or tasks consistently.  
• Limited collaboration. Communication is one-sided and limited to technical matters 
related to filling prescriptions.  
• No collaboration. As professionals they work independently almost exclusively.  




Figure 4.19 provides the breakdown with how pharmacists view their collaborative 
relationship with physicians. Then Figure 4.20 compares the collaborative relationship 
classification based on the pharmacists’ level of engagement in ESoP. Data is broken down into 
two groups: community pharmacists with low and high ESoP engagement. 
 




Figure 4.20 Breakdown of how many pharmacists classified their collaborative relationship with 




































Hostility/conflict No collaboration Limited/one sided Collaborative Verbal/written
agreement





Overall, most pharmacists reported a positive collaborative relationship with physicians. There 
was often no written or verbal agreement; however, the relationship was cooperative with both 
parties working well together. Very few pharmacists classified their relationship as hostile or 
void of collaboration altogether. Further, when responses were compared to community 
pharmacists’ level of engagement in ESoP activities, those more highly involved in ESoP viewed 
their relationship with physicians as more collaborative and containing more verbal partnerships 
and written agreements 
Summary of Demographic Data and Comparisons Amongst Groups 
Demographic data was acquired to help paint a picture and give some context to the 
responses. Given the time and resources available along with taking in consideration the 
appropriate scope of a Master’s thesis, additional variables pertaining to collaboration such as 
affect of workload, staffing, proximity to physicians clinics. Further inquiry could prove 
advantageous and assist in acquiring a greater and more in-depth understanding of the study’s 
findings.  
Summary Data based on Community Pharmacy Location  
 The data obtained from the online questionnaire provided a sample of opinions from 
community pharmacies and practicing pharmacists across the province, including urban and rural 
settings. The particular category choices for the location of the pharmacy were based on the size 
of the community and included: large (>100,000 people), medium (30,000-99,999 people), small 
(5000-29,999 people), and rural (<5000 people) population sizes. Some differences and 
similarities amoung groups based on pharmacy location are discussed in terms of pharmacist 





Over half of all pharmacists had worked at least 11 years. There were no large variations 
between groups in average years of pharmacy experience. Most pharmacists claimed they were 
staff pharmacists, with the exception of rural pharmacists who indicated they were mostly 
managers or pharmacy owners. Medium urban area pharmacies reported being most likely to be 
in or directly beside a physician clinic and rural pharmacies were the least likely. 
Workload and Staffing 
 Medium urban sized pharmacies have the largest daily prescription volume and rural 
pharmacies have the least. Both large and medium urban sized pharmacies have the most support 
staff of technicians and assistants. The majority of their technicians are non-registered 
technicians compared to registered technicians. However, small urban centres report the most 
registered technicians; additionally, rural centres have the least overall number of registered 
technicians.  
ESoP Activities 
The percentage of time of pharmacist workload performing ESoP activities is similar 
among the groups, ranging between 26- 31%. All locations reported that the most frequently 
used ESoP were renewing prescriptions, treating minor ailments, and injections. Rural 
pharmacies report performing more medication assessments, whereas other locations indicate 
more emergency supplies.  
Physician Collaboration 
 There were some differences in how pharmacists from the various locations classified 




relationship as more collaborative and with the least negativity compared to large and medium 
sized urban centres. The smaller the centre, the more positive comments that were made 
regarding the influence of ESoP on physician collaboration. Conversely, the larger the centre, the 
less positive comments and more negative comments expressed regarding ESoP influence.  
All pharmacy locations claimed an improvement in the relationship with physicians 
because of ESoP; however small urban and rural centres agreed most to its influence. 
Additionally, small urban and rural pharmacies were more likely to state that ESoP increased 
partnership opportunities with physicians, unlike medium urban pharmacies who claimed it 
largely did not. Small urban pharmacies had the most written and verbal partnerships with 
physicians at 35%. Medium sized urban pharmacies reported no written or verbal partnerships 
and classified their relationship as primarily collaborative; however pharmacists in these medium 
sized urban pharmacies reported more of the collaborative activities as being limited in nature. 
This location was also the only one where medication assessments was not listed as one of the 
most effective ESoP activities for collaboration with physicians and the only location to rank 
ESoP as producing less quality interactions compared to traditional pharmacy services.  
All pharmacy locations tended to agree more than they disagreed with the statement that 
ESoP increased pharmacist-lead exchanges, sharing of information, more bilateral exchanges, 
and greater insight into physicians’ goals and objectives. All locations also tended to disagree 
more than they agreed with the statement that ESoP increased physician-initiated exchanges. The 
medium used for collaboration was similar between groups, with fax being the primary 
mechanism. Additionally, all locations considered fax and phone as equally an effective means 
of collaboration with physicians. To gain more perspective, Table 4.3 summarizes the 




small urban settings and rural settings. Pharmacies in remote and “other” locations were 
excluded from the summary due to a low response rate.   








Same building 18% 
n=17/95 
Directly beside 16% 
n=15/95 
Within 2 blocks 42% 
n=40/95 
Same city/town 24% 
n=23/95 
Different town  n=0 
Same building 35% 
n=8/23 
Directly beside 13% 
n=3/23 
Within 2 blocks 34% 
n=11/32  
Same city/town 47% 
n=15/32 
Different town 3% 
n=1/32 
Same building 9% 
n=4/46 
Directly beside 20% 
n=9/20 
Within 2 blocks 34% 
n=11/32 
Same city/town 47% 
n=15/32 
Different town 3% 
n=1/32 
Same building 2.0% 
n=1/49 
Directly beside 4% 
n=2/49 
Within 2 blocks 34% 
n=11/32 
Same city/town 47% 
n=15/32 
Different town 3% 
n=1/32 
 
Average # of daily 
Rxs 
 
<100 14% n=13/95 
100-300 56% n=53/95 
>300 31% n=29/95 
 
<100 4% n=1/23 
100-300 61% n=14/23 
>300 35% n=8/23 
 
<100 9% n=4/46 
100-300 67% n=31/46 
>300 24% n=11/46 
 
<100 29% n=14/49 
100-300 67% n=33/49 





1-2 58% >3 39% 
R.tech 1-2 44% >3 1% 
Tech 1-2 49% >3 15% 
Assis 1-2 45% >3 41% 
 
Pharmacists  
1-2 57% >3 43% 
R.tech 1-2 47% >3 0% 
Tech 1-2 45% >3 20% 
Assis 1-2 47% >3 47% 
 
Pharmacists  
1-2 70% >3 30% 
R.tech 1-2 57% >3 0% 
Tech 1-2 31%% >11% 
Assis 1-2 51% >3 36% 
 
Pharmacists  
1-2 73% >3 27% 
R.tech 1-2 19% >3 0% 
Tech 1-2 42% >3 3% 






< 2y 11% n=10/95 
3-10y 35% n=33/95 
>11 55% n=52/95 
 
< 2y 13% n=3/23 
3-10y 26% n=6/23 
>11 61% n=14/23 
 
< 2y 11% n=5/46 
3-10y 30% n=14/46 
>11 59% n=27/46 
 
< 2y – 12% n=6/49 
3-10y – 31% n=15/49 




Staff 69% n=66/95 
Clinical 8% n=8/95 
Manager 21% n=20/95 
Owner 8% n=8/95 
Relief 4% n=4/95 
 
Staff 57% n=13/23 
Clinical 0% 
Manager 35% n=8/23 
Owner 9% n=2/23 
Relief 9% n=2/23 
 
Staff 52% n=24/46 
Clinical 7% n=3/46 
Manager 33% n=15/46 
Owner 11% n=5/46 
Relief 13% n=6/46 
 
Staff 49% n=24/49 
Clinical 2% n=1/49 
Manager 35% n=17/49 
Owner 24% n=12/49 
Relief 6% n=3/49 
 
Most used 
expanded scope of 
practice activities 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
3 Emergency supply 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Med Assessments 
 
% of workload in 











Most used medium 
for collaboration 
 
Fax 94% n=80/85 
Phone 5% n=4/85 
Other 1% 1/85 
 
Fax 85% n=17/20 
Phone 10% n=2/20 
Other 5% n=1/20 
 
Fax 86% n=31/36 
Phone 8% n=3/36 
Other 6% n=2/36 
 
Fax 85% n=34/40 
Phone 8% n=3/40 






Fax 44% n=37/85 
Phone 45% n=38/85 




Fax 40% n=8/20 
Phone 50% n=10/20 




Fax 36% n=13/36 
Phone 36% n=13/36 




Fax 53% n=21/40 
Phone 30% n=12/40 







Expanded Scope of 
Practice 
Statements 
D = Disagree 
A = Agree 
 
Info sharing  
D 7% n=6/85 vs A 75% 
N=64/85  
More pharm exch 
D 8% n=7/85 vs A 78% 
n=66/85 
More bilateral exch 
D 20% n=17/85 vs A 
44% n=37/85 
More Dr exchange 
D 46% n=39/85 vs A 
20% n=17/85 
Improved relations 
D 18% n=15/85 vs A 
28% n=24/85 
More partnership 
D 36% n=31/85 vs A 
20% n=17/85 
More written agreem 
D 38% n=33/85 vs A 
21% n=18/85 
More Dr info of goals 
D 22% n=19/85 vs A 
44% n=37/85 
 
Info sharing  
D 10% n=2/20 vs A 65% 
n=13/20 
More pharm exch 
D 10% n=2/20 vs 65% 
n=13/20 
More bilateral exch 
D 15% n=3/20 vs A 40% 
8/20 
More Dr exchange 
D 40% n=8/20 vs A 15% 
n=3/20 
Improved relations 
D 20% n=4/20 vs A 35% 
n=7/20 
More partnership 
D 40% n=8/20 vs A 25% 
n=5/20 
More written agreem 
D 40% n=4/20 vs A 20% 
n=4/20 
More Dr info of goals 
D 10% n=2/20 vs A 55% 
n=11/20 
 
Info sharing  
D 14% n=5/36 vs A 
78% n=28/36 
More pharm exch 
D 8% n=3/36 vs 69% 
n=25/36 
More bilateral exch 
D 39% n=14/36 vs A 
47% n=17/36 
More Dr exchange 
D 50% n=18/36 vs A 
31% n=11/36 
Improved relations 
D 17% n=6/36 vs A 
44% n=16/36 
More partnership 
D 28% n=10/36 vs A 
33% 12/36 
More written agreem 
D 33% n=12/36 vs A 
36% n=13/36 
More Dr info of goals 
D 17% n=6/36 vs A 
56% n=20/36 
 
Info sharing  
D 18% n=7/40 vs A 
68% n=27/40 
More pharm exch 
D 10% n=4/40  vs 
73% n=29/40 
More bilateral exch 
D 25% n=10/40 vs A 
58% n=23/40 
More Dr exchange 
D 43% n=17/40 vs A 
33% n=13/40 
Improved relations 
D 15% n=6/40 vs A 
43% n=17/40 
More partnership 
D 33% n=13/40 vs A 
35% n=14/40 
More written agreem 
D 45% n=18/40 vs A 
25% n=10/40 
More Dr info of goals 





T = Traditional 
E = Expanded 
Scope 
L = Low H= High 
 
T L 11% n=9/85 vs H 
38% n=32/85 
E L 6% n=5/85 vs H 
45% n=38/85 
 
T L 10% n=2/20 vs H 
45% n=9/20 
E L 10% n=2/20 vs H 
35% n=7/20 
 
T L n=10/35 28% vs H 
22% n=8/36 
E L 8% n=3/35 vs H 
46% n=16/35 
 
T L 13% n=5/39 vs H 
41% n=16/39 








1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend Rxs 
4 – Emergency fills 
 
1 – Renew/extend Rxs  
2 – Minor ailment 
3 – Therapeutic subs 
4 – Changing dose 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend Rxs 
4 – Therapeutic subs 
 
1 – Med assessments 
2 – Minor ailment 
3 – Therapeutic subs 










Clinical Effects 11/27 
Relationship 11/23 
Minimal effect 6/21 
Adverse effect 11/19 
Role recognition 6/18 
Lack of engagement 
11/16 
Varied response 12/14  
Health system 
outcomes 4/13 






Clinical Effects 1/27 
Relationship 2/23 
Minimal effect 5/21 
Adverse effect 1/19 
Role recognition 2/18 
Lack of engagement 
1/16 
Varied response 0/14 
Health system outcomes 
1/13 






Clinical Effects 5/27 
Relationship 3/23 
Minimal effect 6/21 
Adverse effect 2/19 
Role recognition 5/18 
Lack of engagement 
2/16 
Varied response 1/14 
Health system 
outcomes 6/13 






Clinical Effects 8/27 
Relationship 5/23 
Minimal effect 4/21 
Adverse effect 2/19 
Role recognition 5/18 
Lack of engagement 
2/16 
Varied response 1/14 
Health system 
outcomes 2/13 





Community pharmacists who participated in the questionnaire were practicing pharmacy 
in locations all across Saskatchewan, including large, medium, small urban and rural 
communities. The proportion of pharmacists from each location is representative of the current 
distribution of all practicing community pharmacists in Saskatchewan, based on data obtained 
from SCPP. Results between groups were quite similar with no major outliers; however there 
were some notable differences in some areas. Pharmacists practicing in small urban and rural 
centres generally had less prescription volume, were comprised of more owners, and had less 
physical proximity to physician clinics. Small urban centres also had the most registered 
technicians. Overall pharmacists from small urban and rural pharmacy locations reported having 
the most favorable opinions about the influence on ESoP on physician collaboration when 
compared to medium and larger urban centres. Furthermore, pharmacists practicing in small 
urban and rural centres classified their relationship with physicians as more positive, 
collaborative, and containing more partnerships and written agreements. The study did not 
explore or identify the reasons behind the differences in responses between smaller and larger 
centres but did identify some correlations between the groups that could be researched further. 












CPA/written 9% n=8/85 
Partnership 8% n=7/85 
Collaborative 60% 
n=51/85 
Limited 34% n=29/85 
None 6% n=5/85 





Limited 50% n=10/20 
None 10% n=2/10 
Negative 5% n=1/20 
CPA/written 29% 
n=10/36 
Partnership 6% n=2/36 
Collaborative 58% 
n=21/36 
Limited 28% n=10/36 
None 8% n=3/36 







Limited 15% n=6/40 





Summary Data based on Community Pharmacy Proximity to Physician Clinic 
 Part one of the questionnaire included a question asking pharmacists to state the location 
of the pharmacy they work in based on its proximity to the physician clinic. Pharmacists were 
given 5 options to choose from: within the same building as the physician’s clinic; Directly 
beside the physicians clinic, within two blocks of the physicians clinic; In the same town or city 
as the physicians clinic; or in a different town or city as the physicians clinic. Since only one 
pharmacist indicated they worked in a different town or city, their results were excluded from 
analysis. Table 4.4 provides a comparison of the results based on community pharmacy 
proximity to physician clinic.   





Question Within the same 
building (n=31) 
Directly beside  (n=29) Within 2 blocks 
(n=71) 







< 2y 16% n=5/31 
3-10y 23% n=7/31 
>11 61% n=19/31 
 
< 2y 14% n=4/29 
3-10y 38% n=11/29 
>11 48% n=14/29 
 
< 2y 10% n=7/71  
3-10y 38% n=27/71 
>11 52% n=37/71 
 
< 2y 11% n=9/83 
3-10y 28% n=23/83 
>11 61% n=51/83 
 
Average # of daily 
Rxs 
 
<100 13% n=4/31 
100-300 65% n=20/31 
>300 26% n=8/31 
 
<100 7% n=2/29 
100-300 31% n=9/29 
>300 62% n=18/29 
 
<100 15% n=11/71 
100-300 63% n=45/71 
>300 15% n=15/71 
 
<100 18% n=15/83 
100-300 69% n=57/83 





Large Urban 55% 
n=17/31 
Medium Urban 26% 
n=8/31 
Small Urban 13% 
n=4/31 
Rural 3% n=1/31 
 
Large Urban 52% 
n=15/29 
Medium Urban 10% 
n=3/29 
Small Urban 31% 
n=9/29 
Rural 7% n=2/29 
 
Large Urban 56% 
n=40/71 
Medium Urban 13% 
n=9/71 
Small Urban 10% 
n=7/71 
Rural 21% n=15/71 
 
Large Urban 28% 
n=23/83 
Medium Urban 4% 
n=3/83 
Small Urban 31% 
n=26/83 




Staff 65% n=20/31 
Clinical 10% n=3/31 
Manager 26% n=8/31 
Owner 16% n=5/31 
Relief 3% n=1/31 
 
Staff 59% n=17/29 
Clinical 7% n=2/29 
Manager 28% n=8/29 
Owner 17% n=5/29 
Relief 7% n=2/29 
 
Staff 65% n=46/71 
Clinical 10% n=7/71 
Manager 28% n=20/71 
Owner 7% n=5/71 
Relief 4% n=3/71 
 
Staff 54% n=45/83 
Clinical 1% n=1/83 
Manager 29% n=24/83 
Owner 13% n=11/83 
Relief 11% n=9/83 
 
Most used 
expanded scope of 
practice activities 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Emergency supply 
4 Therapeutic sub 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Emergency supply 
4 Injections 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
3 Med Assessments 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
% of workload in 











Most used medium 
for collaboration 
 
Fax 82% n=23/28 
Phone 7% n=2/28 
Other 11% n=3/28 
 
Fax 68% n=15/22 
Phone 18% n=4/22 
Other 12% n=3/22 
 
Fax 95% n=59/62 
Phone 2% n=1/62 
Other 3% n=2/62 
 
Fax 91% n=64/70 
Phone 7% n=5/70 






Fax 50% n=14/28 
Phone 21% n=6/28 




Fax 23% n=5/22 
Phone 50% n=11/22 




Fax 44% n=27/62 
Phone 44% n=27/62 




Fax 46% n=32/70 
Phone 41% n=29/70 




Expanded Scope of 
Practice 
Statements 
D = Disagree 
A = Agree 
 
Info sharing  
D 14% n=4/28 vs A 
79% n=22/28 
More pharm exch 
D 4% n=1/28 vs 86% 
n=24/28 
More bilateral exch 
 
Info sharing  
D n=0 vs A 91% 
n=20/22 
More pharm exch 
D 9% n=2/22 vs A 82% 
n=18/22 
More bilateral exch 
 
Info sharing  
D 18% n=11/62 vs A 
63% n=39/62 
More pharm exch 
D 13% n=8/62 vs A 
65% n=40/62 
More bilateral exch 
 
Info sharing  
D 10% n=7/70 vs A 
73% n=51/70 
More pharm exch 
D 7% n=5/70 vs A 
76% n=53/70 




D 29% n=8/28 vs A 
39% n=11/28 
More Dr exchange 
D 57% n=16/28 vs A 
11% n=3/28 
Improved relations 
D 18% n=5/28 vs A 
36% n=10/28 
More partnership 
D 36% n=10/28 vs A 
25% n=7/28 
More written agreem 
D n36% =10/28 vs A 
18% n=5/28 
More Dr info of goals 
D 21% n=6/28 vs A 
43% n=12/28 
D 23% n=5/22 vs A 64% 
n=14/22 
More Dr exchange 
D 41% n=9/22 vs A 32% 
n=7/22 
Improved relations 
D 9% n=2/22 vs A 41% 
n=9/22 
More partnership 
D 23% n=5/22 vs A 36% 
n=8/22 
More written agreem 
23% D n=5/22 vs A 50% 
n=11/22 
More Dr info of goals 
D 9% n=2/22 vs A 77% 
n=17/22 
D 21% n=13/62 vs A 
40% n=25/62 
More Dr exchange 
D 47% n=29/62 vs A 
16% n=10/62 
Improved relations 
D 23% n=14/62 vs A 
29% n=18/62 
More partnership 
D 44% n=27/62 vs A 
16% n=10/62 
More written agreem 
D 45% n=28/62 vs A 
15% n=9/62 
More Dr info of goals 
D 27% n=17/62 vs A 
48% n=30/62 
D 26% n=18/70 vs A 
51% n=36/70 
More Dr exchange 
D 40% n=28/70 vs A 
33% n=23/70 
Improved relations 
D 10% n=10/70 vs A 
40% n=28/70 
More partnership 
D 29% n=20/70 vs A 
34% n=24/70 
More written agreem 
D 40% n=28/70 vs A 
30% n=21/70 
More Dr info of goals 





T = Traditional 
E = Expanded 
Scope 
L = Low H= High 
 
T L 14% n=4/28 vs H 
39% n=11/28 
E L 11% n=3/27 vs H 
48% n=13/27 
 
T L 36% n=8/22 vs H 
36% n=8/22 
E L 5% n=1/22 vs H 
41% n=9/22 
 
T L 10% n=6/62 vs H 
42% n=26/62 
E L 13% n=8/62 vs H 
48% n=30/62 
 
T L 12% n=8/69 vs H 
30% n=21/69 








1 – Renew/extend 
2 – Minor ailment 
3 – Med assessments 
4 – Emergency supply 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend 
4 – Therapeutic sub 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend Rxs 
4 – Therapeutic sub 
 
1 – Med assessments 
2 – Minor ailment 
3 –  Renew/extend 
Rxs  










Clinical Effects 3/27 
Relationship 3/23 
Minimal effect 1/21 
Adverse effect 2/19 
Role recognition 1/18 
Lack of engagement 
1/16 
Varied response 0/14 
Health system  
outcomes 1/13  








Clinical Effects 2/27 
Relationship 6/23 
Minimal effect 0/21 
Adverse effect 4/19 
Role recognition 3/18 
Lack of engagement 
2/16 
Varied response 5/14 
Health system outcomes 
3/13 








Clinical Effects 9/27 
Relationship 7/23 
Minimal effect 10/21 
Adverse effect 7/19 
Role recognition 6/18 
Lack of engagement 
10/16 
Varied response 9/14 
Health system 
outcomes 4/13 








Clinical Effects 11/27 
Relationship 5/23 
Minimal effect 9/21 
Adverse effect 4/19 
Role recognition 8/18 
Lack of engagement 
3/16 
Varied response 0/19 
Health system 
outcomes 5/13 







Partnership 7% n=2/28 





















Comparing the data obtained from the questionnaire based on how close the pharmacy 
was in in relation to the physician clinic revealed some interesting details. Although fax was the 
main medium used when collaborating with physicians by all groups, pharmacies that were in 
the same building or directly beside physicians groups were 4 to 5 times more likely to utilize 
verbal communication channels such as in-person communication or communication over the 
phone. Further they ranked in-person communication higher as an effective medium for 
collaboration. Pharmacies that were within or directly beside physician’s clinics were two-three 
times more likely to report collaborative relationships with physicians and less and twice as 
likely to report having a verbal or written partnership. They were also half as likely to report 
collaboration being limited and reduced to technical matters. 
Summary Data based on Community Pharmacy Average Prescription Volume 
 
Table 4.5 Comparison of Questionnaire Results Based on Daily Average Prescription Volume 
Limited 14% n=4/28 
None 4% n=1/28 
Negative 4% n=1/28 
Limited 18% n=4/22 
None n=0 
Negative 9% n=2/22 
Limited 40% n=25/62 
None 10% n=6/62 
Negative 10% n=6/62 
Limited 30% n=21/70 
None 6% n=4/70 




Question <100 Rx/day (n=32) 100-300 Rx/day  
(n=131) 





Same building 9% 
n=3/32 
Directly beside 6% 
n=2/32 
Within 2 blocks 34% 
n=11/32 
Same city/town 47% 
n=15/32 
Different town 3% 
n=1/32 
Same building 15% 
n=20/131 
Directly beside 7% 
n=9/131 
Within 2 blocks 34% 
n=45/131 
Same city/town 44% 
n=57/131 
Different town n=0 
Same building 11% 
n=4/35 
Directly beside 29% 
n=10/35 
Within 2 blocks 40% 
n=14/35 
Same city/town 20% 
n=7/35 
Different town n=0/35 
Same building 24% 
n=4/17 
Directly beside 47% 
n=8/17 
Within 2 blocks 6% 
n=1/17 
Same city/town 24% 
n=4/17 






< 2y 9% n=3/32 
3-10y 34% n=11/32 
>11 25% n=18/32 
 
< 2y 11% n=14/131 
3-10y 29% n=38/131 
>11 60% n=79/131 
 
< 2y 14% n=5/35  
3-10y 43% n=15/35 
>11 43% n=15/35 
 
< 2y 18% n=3/17 
3-10y 24% n=4/17 





Large Urban 41% 
n=13/32 
Medium Urban 3% 
n=1/32 
Small Urban 13% 
n=4/32 
Rural 44% n=14/32 
 
Large Urban 41% 
n=53/131 
Medium Urban 11% 
n=14/131 
Small Urban 24% 
n=31/131 
Rural 25% n=33/131 
 
Large Urban 49% 
n=17/35 
Medium Urban 20% 
n=7/35 
Small Urban 20% 
n=7/35 
Rural 6% n=2/35 
 
Large Urban 71% 
n=12/17 
Medium Urban 6% 
n=1/17 






Staff 50% n=16/32 
Clinical 3% n=1/32 
Manager 34% n=11/32 
Owner 25% n=8/32 
Relief 6% n=2/32 
 
Staff 56% n=73/131 
Clinical 4% n=5/131 
Manager 31% n=40/131 
Owner 11% n=15/131 
Relief 9% n=12/131 
 
Staff 80% n=28/35 
Clinical 9% n=3/35 
Manager 11% n=4/35 
Owner 6% n=2/35 
Relief 3% n=1/35 
 
Staff 71% n=12/17 
Clinical 24% n=4/17 
Manager 29% n=5/17 




expanded scope of 
practice activities 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Emergency supply 
4 Injections 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Med Assessments 
3 Injections 
 
1 Renew/extend rxs 
2 Minor ailments 
3  Emergency supply 
4 Therapeutic sub 
 
% of workload in 











Most used medium 
for collaboration 
 
Fax 89% n=25/28 
Phone 4% n=1/28 
Other 7% n=2/28 
 
Fax 93% n=102/110 
Phone 5% n=6/110 
Other 2% n=2/110 
 
Fax 74% n=23/31 
Phone 13% n=4/31 
Other 13% n=4/31 
 
Fax 86% n=12/14 
Phone 7% n=1/14 






Fax 50% n=14/28 
Phone 29% n=8/28 




Fax 44% n=48/110 
Phone 42% n=46/110 




Fax 32% n=10/31 
Phone 48% n=15/31 




Fax 50% n=7/14 
Phone 29% n=4/14 




Info sharing  
 
Info sharing  
 
Info sharing  
 




Expanded Scope of 
Practice 
Statements 
D = Disagree 
A = Agree 
D 18% n=5/28 vs A 
71% n=20/28 
More pharm exch 
D 11% n=3/28 vs 61% 
n=17/28 
More bilateral exch 
D 18% n=5/28 vs A 
50% n=14/28 
More Dr exchange 
D 39% n=11/28 vs A 
32% n=9/28 
Improved relations 
D 14% n=4/28 vs A 
39% n=11/28 
More partnership 
D 32% n=9/28 vs A 
29% n=8/28 
More written agreem 
D 43% n=12/28 vs A 
29% n=8/28 
More Dr info of goals 
D 25% n=7/28 vs A 
46% n=13/28 
D 9% n=10/110 vs A 
74% n=81/110 
More pharm exch 
D 5% n=6/110 vs 76% 
n=84/110 
More bilateral exch 
D 22% n=24/110 vs A 
50% n=55/110 
More Dr exchange 
D 42% n=46/110 vs A 
25% n=28/110 
Improved relations 
D 16% n=18/110 vs A 
35% n=39/110 
More partnership 
D 30% n=33/110 vs A 
26% n=29/110 
More written agreem 
D 36% n=40/110 vs A 
25% n=28/110 
More Dr info of goals 
D 17% n=19/110 vs A 
50% n=55/110 
D n=4/31 vs A n=21/31 
More pharm exch 
D 16% n=5/31 vs 74% 
n=23/31 
More bilateral exch 
D 35% n=11/31 vs A 
39% n=12/31 
More Dr exchange 
D 52% n=16/31 vs A 
16% n=5/31 
Improved relations 
D 23% n=7/31 vs A 
29% n=9/31 
More partnership 
D 55% n=17/31 vs A 
23% n=7/31 
More written agreem 
D 58% n=18/31 vs A 
19% n=6/31 
More Dr info of goals 
D 29% n=9/31 vs A 
55% n=17/31 
D 14% n=2/14 vs A 
79% n=11/14 
More pharm exch 
D 14% n=2/14 vs 79% 
n=11/14 
More bilateral exch 
D 36% n=5/14 vs A 
36% n=5/14 
More Dr exchange 
D 71% n=10/14 vs A 
21% n=3/14 
Improved relations 
D 14% n=2/14 vs A 
43% n=6/14 
More partnership 
D 21% n=3/14 vs A 
36% n=5/14 
More written agreem 
D 14% n=2/14 vs A 
29% n=4/14 
More Dr info of goals 





T = Traditional 
E = Expanded 
Scope 
L = Low H= High 
 
T L 11% n=3/27 vs H 
11% n=3/27 
E L 25% n=7/28 vs H 
25% n=7/28 
 
T L 15% n=16/110 vs H 
37% n=41/110 
E L 7% n=8/109 vs H 
51% n=56/109 
 
T L 10% n=3/31 vs H 
52% n=16/31 
E L 65% n=2/31 vs H 
39% n=12/31 
 
T L 29% n=4/14 vs H 
43% n=6/14 








1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend Rxs 
4 – Emergency fills 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend 
4 – Therapeutic sub 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend Rxs 
4 –Initiating Rx 
 
1 – Med assessments 
2 – Therapeutic sub 
3 –  Minor ailments 











Clinical Effects 5/27 
Relationship 4/23 
Minimal effect 5/21 
Adverse effect 2/19 
Role recognition 3/18 
Lack of engagement 
3/16 
Varied response 1/14 
Health system 
outcomes 0/13 







Clinical Effects 18/27 
Relationship 12/23 
Minimal effect 10/21 
Adverse effect 9/19 
Role recognition 8/18 
Lack of engagement 
9/16 
Varied response 8/14 
Health system outcomes 
11/13 







Clinical Effects 1/17 
Relationship 3/23 
Minimal effect 5/21 
Adverse effect 3/19 
Role recognition 5/18 
Lack of engagement 
4/16 
Varied response 3/14 
Health system 
outcomes 1/13 







Clinical Effects 1/17 
Relationship 2/23 
Minimal effect 1/21 
Adverse effect 3/19 
Role recognition 2/19 
Lack of engagement 
0/16 
Varied response 2/14 
Health system 
outcomes 1/13 






Prescription workload did not seem to significantly effect pharmacists estimated 
engagement in ESoP with one exception. Pharmacies doing under 100 prescriptions a day 
reported approximately 50% less engagement in ESoP activities than larger volume pharmacies. 
There appeared to be no major differences in the medium used for collaboration or there 
opinions on exchanges and the frequency or quality of the exchanges. Prescription volume did 
not seem to affect the number or written or verbal agreement or how pharmacists viewed their 
collaborative relationship with physicians. 
Summary Data based on Pharmacist Experience 
Included in the demographic section of part one of the questionnaire was a question 
asking pharmacists to state their years of experience practicing in community pharmacy. The 
following chart breaks down the questionnaire responses based on years of experience: two years 
or less, three to five years, six to ten years, and over 11 years of experience. Table 4.6 provides a 
portrayal of the results based the range of pharmacists experience practicing in community 
pharmacy.  
Table 4.6 Comparison of Questionnaire Results Based on Pharmacist Years of Experience 
Practicing Community Pharmacy  
 





Partnership 4% n=1/28 
Collaborative 54% 
n=15/28 
Limited 21% n=6/28 
None 11% n=3/28 
Negative 7% n=2/28 
CPA/written 9% 
n=10/110 
Partnership 7% n=8/110 
Collaborative 65% 
n=72/110 
Limited 32% n=35/110 
None 6% n=7/110 
Negative 7% n=8/110 
CPA/written 16% 
n=5/31 
Partnership 6% n=2/31 
Collaborative 52% 
n=16/31 
Limited 32% n=10/31 
None 0 







Limited 29% n=4/14 
None 7% n=1/14 




Question < 2 years experience 
(n=25) 
3-5 years experience 
(n=36) 
6-10 years experience 
(n=32) 





Same building 20% 
n=5/25 
Directly beside 16% 
n=4/25 
Within 2 blocks 28% 
n=7/25 
Same city/town 36% 
n=9/25 
Different town n=0 
Same building 11% 
n=4/36 
Directly beside 25% 
n=9/36 
Within 2 blocks 36% 
n=13/36 
Same city/town 28% 
n=10/36 
Different town n=0 
Same building 9% 
n=3/32 
Directly beside 6% 
n=2/32 
Within 2 blocks 44% 
n=14/32 
Same city/town 41% 
n=13/32 
Different town n=0 
Same building 16% 
n=19/122 
Directly beside 11% 
n=14/122 
Within 2 blocks 30% 
n=37/122 
Same city/town 42% 
n=51/122 
Different town 1% 
n=1/122 
 
Average # of daily 
Rxs 
 
<100 12% n=3/25 
100-300 56% n=14/25 
>300 32% n=8/25 
 
<100 19% n=7/36 
100-300 56% n=20/36 
>300 25% n=9/36 
 
<100 13% n=4/32 
100-300 56% n=18/32 
>300 31% n=10/32 
 
<100 15% n=18/122 
100-300 65% 
n=79/122 





Large Urban 40% 
n=10/25 
Medium Urban 12% 
n=3/25 
Small Urban 20% 
n=5/25 
Rural 24% n=6/25 
 
Large Urban 53% 
n=19/36 
Medium Urban 8% 
n=3/36 
Small Urban 22% 
n=8/36 
Rural 17% n=6/36 
 
Large Urban 44% 
n=14/32 
Medium Urban 9% 
n=3/32 
Small Urban 19% 
n=6/32 
Rural 28% n=9/32 
 
Large Urban 43% 
n=52/122 
Medium Urban 11% 
n=14/122 
Small Urban 22% 
n=27/122 




Staff 80% n=20/25 
Clinical 8% n=2/25 
Manager 8% n=2 
Owner n=0 
Relief 16% n=4/25 
 
Staff 69% n=25/36 
Clinical 8% n=3/36 
Manager 31% n=11/36 
Owner 3% n=1/36 
Relief 3% n=1/36 
 
Staff 72% n=23/32 
Clinical 9% n=3/32 
Manager 19% n=6/32 
Owner 6% n=2/32 
Relief 6% n=2/32 
 
Staff 50% n=61/122 
Clinical 4% n=5/122 
Manager 34% 
n=41/122 
Owner 20% n=24/122 
Relief 7% n=8/122 
 
Most used 
expanded scope of 
practice activities 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Emergency supply 
4 Injections 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
3 Med Assessments 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
% of workload in 











Most used medium 
for collaboration 
 
Fax 79% n=15/19 
Phone 10.5% n=2/19 
Other 10.5% n=2/19 
 
Fax 94% n=29/31 
Phone 3% n=1/31 
Other 3% n=1/31 
 
Fax 85% n=22/26 
Phone 12% n=3/26 
Other 3% n=1/26 
 
Fax 90% n=96/107 
Phone 6% n=6/107 






Fax 32% n=6/19 
Phone 53% n=10/19 




Fax 19% n=6/31 
Phone 61% n=19/31 




Fax 35% n=9/26 
Phone 46% n=12/26 




Fax 54% n=58/107 
Phone 30% n=32/107 








Expanded Scope of 
Practice 
Statements 
D = Disagree 
A = Agree 
 
Info sharing  
D 11% n=2/19 vs A 
74% n=14/19 
More pharm exch 
D16%  n=3/19 vs 79% 
n=15/19 
More bilateral exch 
D 32% n=6/19 vs A 
37% n=7/19 
More Dr exchange 
D 58% n=11/19 vs A 
26% n=5/19 
Improved relations 
D 16% n=3/19 vs A 
26% n=5/19 
More partnership 
D 21% n=4/19 vs A 
37% n=7/19 
More written agreem 
D 42% n=8/19 vs A 
32% n=6/19 
More Dr info of goals 
D 16% n=3/19 vs A 
58% n=11/19 
 
Info sharing  
D n=2/31 vs A n=26/31 
More pharm exch 
D 3% n=1/31 vs A 84% 
n=26/31 
More bilateral exch 
D 32% n=10/31 vs A 
45% n=14/31 
More Dr exchange 
D 42% n=13/31 vs A 
23% n=7/31 
Improved relations 
D 13% n=4/31 vs A 29% 
n=9/31 
More partnership 
D 29% n=9/31 vs A 19% 
n=6/31 
More written agreem 
D 35% n=11/31 vs A 
39% n=12/31 
More Dr info of goals 
D 26% n=8/31 vs A 52% 
n=16/31 
 
Info sharing  
D 12% n=3/26 vs A 
81% n=21/26 
More pharm exch 
D 4%  n=1/26 vs a 81% 
n=21/26 
More bilateral exch 
D 19% n=5/26 vs A 
62% n=16/26 
More Dr exchange 
D 50% n=13/26 vs A 
42% n=11/26 
Improved relations 
D 12% n=3/26 vs A 
54% n=14/26 
More partnership 
D 42% n=11/26 vs A 
38% n=10/26 
More written agreem 
D 38% n=10/26 vs A 
27% n=7/26 
More Dr info of goals 
D 23% n=6/26 vs A 
46% n=12/26 
 
Info sharing  
D 13%n=14/107 vs A 
67% n=72/107 
More pharm exch 
D 10% n=11/107 vs 
68% n=73/107 
More bilateral exch 
D 22% n=24/107 vs A 
46% n=49/107 
More Dr exchange 
D 43% n=46/107 vs A 
21% n=22/107 
Improved relations 
D 20% n=21/107 vs A 
35% n=37/107 
More partnership 
D 36% n=38/107 vs A 
24% n=26/107 
More written agreem 
D 40% n=43/107 vs A 
20% n=21/107 
More Dr info of goals 





T = Traditional 
E = Expanded 
Scope 
L = Low H= High 
 
T L 16% n=3/19 vs H 
21% n=4/19 
E L 11% n=2/19 vs H 
21% n=4/19 
 
T L 16% n=5/31 vs H 
32% n=10/31 
E L 10% n=3/31 vs H 
35% n=11/31 
 
T L 19% n=5/26 vs H 
46% n=12/26 
E L 4% n=1/26 vs H 
54% n=14/26 
 
T L 11% n=13/106 vs 
H 38% n=40/106 
E L 11% n=12/106 vs 
H 49% n=52/106 
 
Most influential 




1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend Rxs 
4 – Emergency fills 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend 
4 – Initiating Rx 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend Rxs 
4 – Emergency fills 
 
1 – Med assessments 
2 – Minor ailment 
3 –  Renew/extend 
Rxs  





The majority of the data obtained after separating pharmacists based on practice 
experience in the community was similar including their degree of engagement in ESoP 
activities. However there were a few notable differences in pharmacists’ responses for those who 
had more than 11 years of experience. Based on the data 57% of all responses to part one of the 
questionnaire were completed by pharmacists who had 11 years or more of experience practicing 
as a community pharmacist. Approximately a third of these were from pharmacists who had 11-
20 years of experience and two-thirds had over 20 years of experience. Out of the 60 pharmacists 
who selected they were in a manager position, 42 or 68% of them had over 11 years of 
experience. Furthermore pharmacists in this group were the only group who indicated that fax 










Clinical Effects 2/27 
Relationship 2/23 
Minimal effect 1/21 
Adverse effect 3/19 
Role recognition 0/18 
Lack of engagement 
5/16 
Varied response 4/14 
Health system 
outcomes 1/13 







Clinical Effects 4/27 
Relationship 6/23 
Minimal effect 4/21 
Adverse effect 5/19 
Role recognition 2/18 
Lack of engagement 
5/16 
Varied response 3/14  
Health system outcomes 
2/13 








Clinical Effects 5/27 
Relationship 1/23 
Minimal effect 6/21 
Adverse effect 0/19 
Role recognition 6/18 
Lack of engagement 
1/16 
Varied response 1/14 
Health system 
outcomes 1/13 









Clinical Effects 14/27 
Relationship 12/23 
Minimal effect 10/21 
Adverse effect 9/19 
Role recognition 10/18 
Lack of engagement 
5/16 
Varied response 6/14 
Health system 
outcomes 9/13 
No influence 8/10 




CPA/written 5% n=1/19 
Partnership 11% n=2/19 
Collaborative  74% 
n=14/19 
Limited 47% n=9/19 
None 0 
Negative 11% n=2/19 
CPA/written 19% 
n=6/31  
Partnership 13% n=4/31 
Collaborative 48% 
n=15/31 
Limited 42% n=13/31 
None 3% n=1/31 







Limited 15% n=4/26 
None 0 









None 9% n=10/107 




the 25 pharmacists who stated they had a written or collaborative practice agreement, 17 or 68% 
of those had over 11 years of pharmacy practice experience. 10 out of 11 of the pharmacists who 
stated that there was no collaboration between pharmacists and physicians were also pharmacists 
who practiced more than 11 years. 
Summary Data based on Pharmacist Position 
In part one of the questionnaire obtaining demographic information, pharmacists were 
asked to state their position working at the pharmacy. Pharmacists were given 5 options to 
choose from: floater/relief pharmacist, a staff pharmacist, a clinical pharmacist, a pharmacy 
manager, and a pharmacy owner. Table 4.7 provides a comparison of the results based on 
community pharmacists’ position working in the pharmacy. The table combines results for 
pharmacists who indicated they were managers and owners. 
















Same building 7% 
n=1/15 
Directly beside 13% 
n=2/15 
Within 2 blocks 20% 
n=3/15 
Same city/town 60% 
n=9/15 
Different town n=0 
Same building 16% 
n=20/129 
Directly beside 13% 
n=17/129 
Within 2 blocks 36% 
n=46/129 
Same city/town 35% 
n=45/129 
Different town 1% 
n=1/129 
Same building 23% 
n=3/13 
Directly beside 15% 
n=2/13 
Within 2 blocks 54% 
n=7/13 
Same city/town 8% 
n=1/13 
Different town n=0 
Same building 15% 
n=12/78 
14% Directly beside 
n=11/78 
Within 2 blocks 28% 
n=22/78 
Same city/town 41% 
n=32/78 
Different town 1% 
n=1/78 
 
Average # of daily 
Rxs 
 
<100 13% n=2/15 
100-300 80% n=12/15 
>300 7% n=1/15 
 
<100 12% n=16/129 
100-300 57% n=73/129 
>300 31% n=40/129 
 
<100 8% n=1/13 
100-300 38% n=5/13 
>300 54%n=7/13 
 
<100 21% n=16/78 
100-300 64% n=50/78 





Large Urban 26% 
n=4/15 
Medium Urban 13% 
n=2/15 
Small Urban 40% 
n=6/15 
Rural 20% n=3/15 
 
Large Urban 51% 
n=66/129 
Medium Urban 10% 
n=13/129 
Small Urban 19% 
n=24/129 
Rural 19% n=24/129 
 
Large Urban 67% 
n=8/12 
Medium Urban n=0 
Small Urban 25% 
n=3/12 
Rural 8% n=1/12 
Other 8% n=1/12 
 
Large Urban 32% 
n=25/78 
Medium Urban 13% 
n=10/78 
Small Urban 23% 
n=18/78 






< 2y 27% n=4/15 
3-10y 20% n=3/15 
>11 53% n=8/15 
 
< 2y 16% n=20/129 
3-10y 37% n=48/129 
>11 47% n=61/129 
 
< 2y 15% n=2/13  
3-10y 46% n=6/13 
>11 38% n=5/13 
 
< 2y3%  n=2/78 
3-10y 23% n=18/78 
>11 74% n=58/78 
 
Most used 
expanded scope of 
practice activities 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
1 Renew/extend rxs 
2 Minor ailments 




1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Med assessments 
 
% of workload in 











Most used medium 
for collaboration 
 
Fax 91% n=10/11 
Phone 9% n=1/11 
Other 0% n=0 
 
Fax 87% n=97/112 
Phone 8% n=9/112 
Other 5% n=6/112 
 
Fax 83% n=10/12 
Phone 8% n=1/12 
Other 8% n=1/12 
 
Fax 93% n=62/67 
Phone 3% n=2/67 






Fax 55% n=6/11 
Phone 18% n=2/11 




Fax 55% n=6/112 
Phone 18% n=2/112 




Fax 42% n=5/12 
Phone 33% n=4/12 




Fax 48% n=32/67 
Phone 33% n=22/67 




Info sharing  
 
Info sharing  
 
Info sharing  
 




Expanded Scope of 
Practice 
Statements 
D = Disagree 
A = Agree 
D n=0 vs A 82% 
n=9/11 
More pharm exch 
D n=0/11 vs A 55% 
n=6/11 
More bilateral exch 
D 9% n=1/11 vs A 45% 
n=5/11 
More Dr exchange 
D 36% n=4/11 vs A 
18% n=2/11 
Improved relations 
D 9% n=1/11 vs A 45% 
n=5/11 
More partnership 
D 18% n=2/11 vs A 
18% n=2/11 
More written agreem 
D 27% n=3/11 vs A 
18% n=2/11 
More Dr info of goals 
D 9% n=1/11 vs A 91% 
n=10/11 
D 13% n=15/112 vs A 
71% n=80/112 
More pharm exch 
D 13% n=15/112 vs 71% 
n=80/112 
More bilateral exch 
D 29% n=32/112 vs A 
42% n=47/112 
More Dr exchange 
D 50% n=56/112 vs A 
23% n=26/112 
Improved relations 
D 21% n=24/112 vs A 
31% n=35/112 
More partnership 
D 36% n=40/112 vs A 
29% n=32/112 
More written agreem 
D 42% n=47/112 vs A 
29% n=33/112 
More Dr info of goals 
D 21% n=24/112 vs A 
53% n=59/112 
D 8% n=1/12 vs A 83% 
n=10/12 
More pharm exch 
D n=0 vs 92% n=11/12 
More bilateral exch 
D 25% n=3/12 vs A 
58% n=7/12 
More Dr exchange 
D 58% n=7/12 vs A 
33% n=4/12 
Improved relations 
D 17% n=2/12 vs A 
50% n=6/12 
More partnership 
D 50% n=6/12 vs A 
33% n=4/12 
More written agreem 
D 33% n=4/12 vs A 
33% n=4/12 
More Dr info of goals 
D 25% n=3/12 vs A 
58% n=7/12 
D 11% n=8/74 vs A 
66% n=49/74 
More pharm exch 
D 3% n=2/74 vs 72% 
n=53/74 
More bilateral exch 
D 20% n=15/74 vs A 
49% n=36/74 
More Dr exchange 
D 36% n=27/74 vs A 
24% n=18/74 
Improved relations 
D 9% n=7/74 vs A 
36% n=27/74 
More partnership 
D 32% n=24/74 vs A 
20% n=15/74 
More written agreem 
D 35% n=26/74 vs A 
19% n=14/74 
More Dr info of goals 





T = Traditional 
E = Expanded 
Scope 
L = Low H= High 
 
T L 9% n=1/11 vs H 
18% n=2/11 
E L n=0 vs 45% H 
n=5/11 
 
T L 14% n=15/111 vs H 
39% n=43/111 
E L 7% n=8/112 vs H 
43% n=48/112 
 
T L 25% n=3/12 vs H 
33% n=4/12 
E L 17% n=2/12 vs H 
67% n=8/12 
 
T L 20% n=15/74 vs H 
27% n=20/74 








1 – Med assessments 
2 – Minor ailment 
3 – Smoking cessation 
4 – Ordering labs 
 
1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend 
4 – Initiating Rx 
 
1 – Med assessments 
2 – Renewing/extend 
rxs 
3 – Emergency supply 
4 – Minor ailments 
 
1 – Med assessments 
2 – Minor ailment 
3 –  Renew/extend 
Rxs  










Clinical Effects 0/27 
Relationship 3/23 
Minimal effect 1/21 
Adverse effect 1/19 
Role recognition 0/18 
Lack of engagement 
2/16 
Varied response 1/14  
Health system 
outcomes 1/13 







Clinical Effects 15/27 
Relationship 12/23 
Minimal effect 14/21 
Adverse effect 13/19 
Role recognition 11/18 
Lack of engagement 
9/16 
Varied response 12/14  
Health system outcomes 
8/13 







Clinical Effects 3/27 
Relationship 2/23 
Minimal effect 1/21 
Adverse effect 2/19 
Role recognition 3/18 
Lack of engagement 
0/16 
Varied response 1/14  
Health system 
outcomes 2/13 







Clinical Effects 11/27 
Relationship 8/23 
Minimal effect 9/21 
Adverse effect 5/19 
Role recognition 6/18 
Lack of engagement 
5/16 
Varied response 2/14  
Health system 
outcomes 5/13 






When the questionnaire data was separated based on what position pharmacists held in 
the pharmacy, the following results were noted. Engagement in ESoP activities was almost 50% 
higher for pharmacists who were classified clinical pharmacists. Further, clinical pharmacists 
were twice as likely to report having a verbal or written agreement with physicians. Conversely, 
pharmacists who stated their position was a floater or relief pharmacists reported no verbal or 
written agreements with physicians. There were no significant differences in the medium clinical 
pharmacists used or those considered most effective for communication with other groups. There 
were also no major differences in their exchanges with physicians or the quality of those 
exchanges. 
Further inquiry into understanding the type of pharmacies study participants were from 
included a question on general pharmacy staffing during a typical shift. Pharmacists were asked 
to estimate their average staffing of pharmacists, registered technicians, non-registered 
technicians and other support staff in a typical workday. The following tables compares the data 
obtained separated by registered technician status and pharmacist quantity. 
Table 4.8 Comparison of Questionnaire Results Based on Number of Registered Technician Per 
Shift 







Limited 36% n=5/14 
None n=0 
Negative 7% n=1/14 
CPA/written 11% 
n=16/150  
Partnership 5% n=7/150 
Collaborative 47% 
n=70/150 
Limited 25% n=38/150 
None 5% n=7/150 







Limited 14% n=3/21 
None 5% n=1/21 







Limited 20% n=16/79 
None 6% n=5/79 




Question 0 Registered Technicians 
(n=79) 





Same building 16% n=14/90 
Directly beside 14% n=13/90 
Within 2 blocks 33% n=30/90 
Same city/town 36% n=32/90 
Different town 1% n=1 
Same building 11% n=6/54 
Directly beside 20% n=11/54 
Within 2 blocks 39% n=21/54 
Same city/town 30% n=16/54 
Different town 0% n=0 
Same building 19% n=3/16 
Directly beside 13% n=2/16 
Within 2 blocks 25% n=4/16 
Same city/town 44% n=7/16 
Different town 0% n=0 
 
Average # of daily 
Rxs 
 
<100 21% n=19 
100-300 62% n=56 
>300 17% n=15 
 
<100 0% n=0 
100-300 56% n=30/54 
>300 44% n=24/54  
 
<100 n=0 
100-300 44% n=7/16 





Large Urban 48% n=43/90 
Medium Urban 10% n=9/90 
Small Urban n=18% 
Rural 23% n=21/90 
 
Large Urban 46% n=25/54 
Medium Urban 15% n=8/54 
Small Urban 33% n=18/54 
Rural 6% n=3/54 
 
Large Urban 63% n=10/16 
Medium Urban 0 n=0% 
Small Urban 19% n=3/16 






< 2y 16% n=14 
3-10y 26% n=23 
>11 59% n=53 
 
< 2y 11% n=6/54  
3-10y 41% n=22/54 
>11 48% n=24/54 
 
< 2y n=0 
3-10y 44% n=7/16 




Staff 32% n=25/79 
Clinical 4% n=3/79 
Manager 14% n=11/79 
Owner 1% n=1/79 
Relief 1% n=1/79 
 
Staff 67% n=36/54 
Clinical 11% n=6/54 
Manager 20% n=11/54 
Owner 4% n=2/54 
Relief 9% n=5/54 
 
Staff 56% n=9/16 
Clinical 13% n=2/16 
Manager 19% n=3/16 
Owner 19% n=3/16 
Relief 13% n=2/16 
 
Most used 
expanded scope of 
practice activities 
 
1 Renew/extend rxs 
2 Minor ailments 
3  Emergency supply  
4  Injections 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections  
4 Med Assessments   
 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
% of workload in 













Fax 89% n=70/79 
Phone  5% n=4/79 
Other 6% n=5/79 
 
Fax 87% n=40/46 
Phone 9% n=4/60 
Other 4% n=2/46 
 
Fax 87% n=13/15 
Phone 7% n=1/15 






Fax 43% n=32/79 
Phone 41% n=32/79 
DM, email 3% n=2/79  
In-person/RT 10% n=3/79 
 
Fax 43% n=20/46 
Phone 39% n=18/46 
DM, email 2% n=1/46 
In-person/RT 7% n=3/46 
 
Fax 47% n=7/15 
Phone 40% n=6/15 
DM, email 13% n=2/15 





D = Disagree 
A = Agree 
 
Info sharing  
D 14% n=11/79 vs A 67% 
n=53/79 
More pharm exch 
 
Info sharing  
D 11% n=5/46 vs A 78% n=36/46 
More pharm exch 
D 7% n=3/46 vs A 76% n=35/46 
More bilateral exch 
 
Info sharing  
D n=0 vs A 100% n=15/15 
More pharm exch 
D n=0 vs n=100% 




D 11% n=11/79 vs A 67% 
n=53/79 
More bilateral exch 
D 22% n=17/79 vs A 48% 
n=38/79 
More Dr exchange 
D 46% n=36/79 vs A 18% 
n=14/79 
Improved relations 
D 16% n=13/79 vs A 29% 
n=23/79 
More partnership 
D 33% n=26/79 vs A 25% 
n=20/79 
More written agreem 
D 42% n=33/79 vs A 24% 
n=19/79 
More Dr info of goals 
D 14% n=11/79 vs A 58% 
n=46/79 
D 28% n=13/46 vs A 43% n=20/46 
More Dr exchange 
D 43% n=20/46 vs A 33% n=15/46 
Improved relations 
D 20% n=9/46 vs A 30% n=14/46 
More partnership 
D 30% n=14/46 vs A 31% n=14/46 
More written agreem 
D 30% n=14/46 vs A 24% n=11/46 
More Dr info of goals 
D 24% n=11/46 vs A 46% n=21/46 
D 20% n=3/15 vs A 60% 
n=9/15 
More Dr exchange 
D 40% n=6/15 vs A 33% 
n=5/15 
Improved relations 
D 7% n=1/15 vs A 60% n=9/15 
More partnership 
D 33% n=5/15 vs A 27% 
n=4/15 
More written agreem 
D 33% n=5/15 vs A 20% 
n=3/15 
More Dr info of goals 




T = Traditional 
E = Expanded 
Scope 
L = Low H= High 
 
T L 10% n=8/79 vs  
   H 35% n=28/79 
E L 10%  n=8/79 vs H 40% 
n=31/79 
 
T L 22% n=10/46 vs H 30% 
n=14/46 
E L 7% n=3/45 vs H 41% n=18/45 
 
T L 13% n=2/15 vs H 60% 
n=9/15 
E L n=0 vs H 67% n=10/15 
 
Most influential 




1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend 
4 – Changing dosage  
 
1 – Med assessments 
2 – Minor ailments 
3 – Therapeutic sub 
4 – Renew/extend rxs 
 
1 – Med assessments 
2 – Minor ailment 
3 –  Renew/extend Rxs  








Pharmacist Utilization 12/32 
Clinical Effects 13/27 
Relationship 9/23 
Minimal effect 8/21 
Adverse effect 10/19 
Role recognition 7/18 
Lack of engagement 7/16 
Varied response 7/14 
Health system outcomes 4/13 





Pharmacist Utilization 4/32 
Clinical Effects 4/27 
Relationship 3/23 
Minimal effect 7/21 
Adverse effect 3/19 
Role recognition 5/18 
Lack of engagement 4/16 
Varied response 4/14 
Health system outcomes 7/13 






Pharmacist Utilization 3/32 
Clinical Effects 1/27 
Relationship 1/23 
Minimal effect 1/21 
Adverse effect 0/19 
Role recognition 3/18 
Lack of engagement 0/16 
Varied response 0/14 
Health system outcomes 1/13 





CPA/written 10% n=8/79  
Partnership 5% n=4/79 
Collaborative 62% n=49/79 
Limited 32% n=25/79 
None 6% n=5/79 
Negative 8% n=6/79 
CPA/written 13% n=6/46 
Partnership 11% n=5/46 
Collaborative 57% n=26/46 
Limited 30% n=14/46 
None 9% n=4/46 
Negative 15% n=7/46 
CPA/written 33% n=5/15 
Partnership 7% n=1/15 
Collaborative 47% n=7/15 






The following observations were noted from the questionnaire once responses were 
separated based on pharmacies that had no registered technicians compared to pharmacies who 
had one registered technician and more than one registered technician working. First, most 
registered technicians were employed in pharmacies in large urban centres. There was a positive 
correlation in the number of registered technicians and the average daily prescription volume. 
The more prescriptions the pharmacy completed, the more registered technicians there weree. 
Further, there appeared to be a positive correlation in pharmacists’ engagement in ESoP 
activities and the number of registered technicians. Pharmacies who reported having one 
registered technician on a shift had a 10% increase in their estimated percentage of their 
workload spent on ESoP activities and a 20% increase when two or more registered technicians 
were on a shift. Another observation included the positive correlation between registered 
technicians on staff and the reported number of written and verbal agreements. Pharmacies that 
had more registered technicians reported more written and verbal agreements with physicians. 
Further analysis was done to see if there were any obvious differences in the data based on the 
number of pharmacists working. Table 4.9 compares the data based on if there were one, two, or 
three or more pharmacists working per shift.  








Same building 19% n=12/62 
Directly beside 13% n=8/62 
Within 2 blocks 27% n=17/62 
Same city/town 39% n=24/62 
Different town 2% n=1/62 
Same building 10% n=8/77 
Directly beside 14% n=11/77 
Within 2 blocks 30% n=23/77 
Same city/town 45% n=35/77 
Different town % n=0 
Same building 14% n=11/76 
Directly beside 13% n=10/76 
Within 2 blocks 41% n=31/76 
Same city/town 32% n=24/76 
Different town 0% n=0 
 
Average # of daily 
Rxs 
 
<100 34% n=21/62 
100-300  60% n=32/62 
>300 7% n=4/62 
 
<100 13% n=10/77 
100-300 70% n=54/77 
>300 17% n=13/77  
 
<100 1% n=1/76 
100-300 53% % n=40/76 





Large Urban 40% n=25/62 
Medium Urban 5% n=3/62 
Small Urban 26% n=16/62 
Rural 29% n=18/62 
 
Large Urban 43% n=33/77 
Medium Urban 13% n=10/77 
Small Urban 21% n=16/77 
Rural 23% n=18/77 
 
Large Urban 49% n=37/76 
Medium Urban 13% n=10/76 
Small Urban 18% n=14/76 






< 2y 11% n=7/62 
3-10y 35% n=22/62 
>11 53% n=33/62 
 
< 2y 14% n=11/77  
3-10y 25% n=19/77 
>11 61% n=47/77 
 
< 2y 9% n=7/76 
3-10y 36% n=27/76 




Staff 50% n=31/62 
Clinical 3% n=2/62 
Manager 39% n=24/62 
Owner 18% n=11/62 
Relief 10% n=6/62 
 
Staff 65% n=50/77 
Clinical 6% n=5/77 
Manager 19% n=15/77 
Owner 12% n=9/77 
Relief 8% n=6/77 
 
Staff 63% n=48/76 
Clinical 8% n=6/76 
Manager 28% n=21/76 
Owner 9% n=7/76 
Relief 4% n=3/76 
 
Most used 
expanded scope of 
practice activities 
 
1 Renew/extend rxs 
2 Minor ailments 
3  Emergency supply  
4  Injections 
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections  
4 Med Assessments   
 
1 Renew/extend rxs 
2 Minor ailments 
3 Injections 
4 Emergency supply 
 
% of workload in 













Fax 96% n=50/52 
Phone 0 % n=0 
Other 4% n=2/52 
 
Fax 86% n=54/63 
Phone 11% n=7/63 
Other 3% n=2/63 
 
Fax 87% n=13/15 
Phone 7% n=1/15 






Fax 46% n=24/52 
Phone 35% n=18/52 
DM, email 2% n=1/52  
In-person/RT 12% n=6/52 
 
Fax 44% n=28/63 
Phone 43% n=27/63 
DM, email 2% n=1/63 
In-person/RT 10% n=6/63 
 
Fax 47% n=7/15 
Phone 40% n=6/15 
DM, email 13% n=2/15 





D = Disagree 
A = Agree 
 
Info sharing  
D 12% n=6/52 vs A 79% 
n=41/52 
More pharm exch 
D 12% n=6/52 vs A 63% 
n=33/52 
More bilateral exch 
 
Info sharing  
D 10% n=6/63 vs A 68% n=43/63 
More pharm exch 
D 8% n=5/63 vs A 75% n=47/63 
More bilateral exch 
D 17% n=11/63 vs A 49% n=31/63 
More Dr exchange 
 
Info sharing  
D n=0 vs A 100% n=15/15 
More pharm exch 
D n=0 vs n=100% 
More bilateral exch 






D % n=12/52 vs A 50 % 
n=26/52 
More Dr exchange 
D 38% n=20/52 vs A 25% 
n=13/52 
Improved relations 
D 17% n=9/52 vs A 40% 
n=21/52 
More partnership 
D 35% n=18/52 vs A 23% 
n=12/52 
More written agreem 
D 37% n=19/52 vs A 50% 
n=16/52 
More Dr info of goals 
D 19% n=10/52 vs A 52% 
n=27/52 
D 48% n=30/63 vs A 24% n=15/63 
Improved relations 
D 19% n=12/63 vs A 35% n=22/63 
More partnership 
D 29% n=18/63 vs A 30% n=19/63 
More written agreem 
D 38% n=24/63 vs A 29% n=18/63 
More Dr info of goals 
D 22% n=14/63 vs A 48% n=30/63 
More Dr exchange 
D 49% n=33/68 vs A 25% 
n=17/68 
Improved relations 
D 15% n=10/68 vs A 32% 
n=22/68 
More partnership 
D 38% n=26/68 vs A 26% 
n=18/68 
More written agreem 
D 43% n=29/68 vs A 18% 
n=12/68 
More Dr info of goals 





T = Traditional 
E = Expanded 
Scope 
L = Low H= High 
 
T L 17% n=9/52 vs  
   H 21% n=11/52 
E L 12% n=6/51 vs H 43% 
n=22/51 
 
T L 15% n=9/62 vs H 37% 
n=23/62 
E L 14% n=9/63 vs H 41% 
n=26/63 
 
T L 12% n=8/68 = vs H 47% 
n=32/68 








1 – Med assessments 
2 – Minor ailment 
3 – Renew/extend 
4 – Changing dosage  
 
1 – Med assessments 
2 – Minor ailments 
3 – Therapeutic sub 
4 – Renew/extend rxs 
 
1 – Med assessments 
2 – Minor ailment 
3 –  Renew/extend Rxs  








Pharmacist Utilization 6/32 
Clinical Effects 10/27 
Relationship 5/23 
Minimal effect 7/21 
Adverse effect 2/19 
Role recognition 6/18 
Lack of engagement 4/16 
Varied response 3/14 
Health system outcomes 1/13 






Pharmacist Utilization 8/32 
Clinical Effects 5/27 
Relationship 8/23 
Minimal effect 8/21 
Adverse effect 6/19 
Role recognition 5/18 
Lack of engagement 8/16 
Varied response 4/14 
Health system outcomes 7/13 






Pharmacist Utilization 11/32 
Clinical Effects 10/27 
Relationship 8/23 
Minimal effect 6/21 
Adverse effect 9/19 
Role recognition 7/18 
Lack of engagement 4/16 
Varied response 7/14 
Health system outcomes 5/13 





CPA/written 15% n=8/52  
Partnership 4% n=2/52 
Collaborative 62% n=32/52 
Limited 23% n=12/52 
None 10% n=5/52 
Negative 10% n=5/52 
CPA/written 10% n=6/63 
Partnership 6% n=4/63 
Collaborative 70% n=44/63 
Limited 36% n=23/63 
None 5% n=3/63 
Negative 10% n=6/63 
CPA/written 16% n=11/68 
Partnership 12% n=8/68 
Collaborative 51% n=35/68 
Limited 29% n=20/68 
None 4% n=3/68 




When separating the data based on the number of pharmacists working per shift, a few 
associations can be made. The most obvious was that as prescription volume increased 
subsequently the number of pharmacists working increased. Pharmacists with three or more 
pharmacists per shift were more likely to have clinical pharmacists working. Additionally they 
had the highest reported engagement in ESoP activities and were more likely to claim that ESoP 
activities increased collaboration with physicians. 
Summary 
The 17-question questionnaire provided some demographic data used to help paint a 
picture of the 183 pharmacists who submitted their responses to the study questionnaire and 
generally what type of pharmacy practice settings they came from. Demographic data obtained in 
the responses included information about the location of each community pharmacy’s practice 
site, staffing, workload, pharmacists’ experience and position, and current collaborative 
relationship with physicians. This demographic data collected helped provide some context to 
pharmacists’ responses to ESoP and collaboration and included some relevant details pertaining 
to some variables to collaboration.  
Part two of the questionnaire obtained data on ESoP activities, compared the influence of 
each, identified effective mediums used for collaboration, and garnered information about the 
perceived influence of ESoP on collaboration with physicians. Lastly, pharmacists had the 
opportunity to share their opinions on what they perceived as the most effective strategies at 
fostering collaboration with physicians. Data which helps answer the study’s research questions 
was analysed and presented in Chapter 4. A summary of the results of the study will be included 
in Chapter Five; these results will be analyzed and compared to the current literature regarding 




Community Pharmacist Collaboration Model (CPCM). The chapter concludes with suggestions 




















CHAPTER FIVE: DISCUSSION 
 In this final chapter, the first section summarizes the research methods, and findings of 
the study. The next section compares the findings to the existing literature regarding physician 
and pharmacist collaboration. This discussion is followed by an exploration of the implications 
of this study’s findings for pharmacy practice, theory development and future research. The 
chapter concludes with a reflection of how the study unfolded.   
Summary of Research 
For this study, 1165 practicing community pharmacists across Saskatchewan were invited 
to participate in an online 17 question questionnaire distributed by the Saskatchewan College of 
Pharmacy Professionals (SCPP). The main objective was to examine how expanded scope of 
practice (ESoP) has influenced interprofessional collaboration between physicians and 
pharmacists. Another goal was to determine what level of engagement community pharmacists 
had in ESoP activities and which were the most impactful for collaboration. Lastly, the 
researcher endeavoured to discover which strategies have improved collaboration with 
physicians. The questionnaire’s response rate was approximately 16%, and those completing the 
questionnaire were invited to enter a gift draw and to indicate if they would like a summary of 
the research findings. Of the 160 pharmacists who entered the gift draw, 70% requested a 
summary of the research findings. The results of the questionnaire provided data pertaining to 
pharmacist and pharmacy demographics, engagement in ESoP activities including the frequency 








 Demographic questions were asked to determine the context of the pharmacists’ 
experience and work environment. Key demographic factors such as the location of the 
pharmacy, the staffing levels and levels of workload, and the years of experience of the 
pharmacists could have an impact on the responses on the questionnaire. This data was used to 
help paint a picture to gauge the current pharmacy landscape in Saskatchewan. Included in the 
distribution of the data are some notable difference observed between groups. However the 
reasons for these differences was not determined. Further research into observations and 
correlations may be valuable to examine specific demographic differences and their relationship 
with ESoP and physician collaboration. 
Community Pharmacy Location 
Community pharmacists participating in the study provided a diverse sample size of 
practice locations. Approximately half of the respondents were from large and medium urban 
centres and half from small centres or rural locations. Only one pharmacist reported being from a 
remote community. The majority of pharmacists practiced in pharmacies that were not in or 
directly beside physician clinics, but rather within a couple blocks or in the same town as the 
physician clinics. The proportion of pharmacists from each location is fairly representative of the 
current distribution of all practicing community pharmacists in Saskatchewan, based on data 
obtained from SCPP. Results between groups were quite similar with no major outliers; however 
there were some notable differences in some areas.  
Pharmacists practicing in small urban and rural centres generally had less prescription 
volume, were comprised of more owners, and had less physical proximity to physician clinics. 




urban and rural pharmacy locations reported having the most favorable opinions about the 
influence on ESoP on physician collaboration when compared to medium and larger urban 
centres. Furthermore, pharmacists practicing in small urban and rural centres classified their 
relationship with physicians as more positive, collaborative, and containing more partnerships 
and written agreements.  
Comparing the data obtained from the questionnaire based on how close the pharmacy 
was in in relation to the physician clinic revealed some interesting details. Although fax was the 
main medium used when collaborating with physicians by all groups, pharmacies that were in 
the same building or directly beside physicians’ groups were 4 to 5 times more likely to utilize 
verbal communication channels such as in-person communication or communication over the 
phone. Further they ranked in-person communication higher as an effective medium for 
collaboration. Pharmacies that were within or directly beside physicians’ clinics were two to 
three times more likely to report collaborative relationships with physicians and less than twice 
as likely to report having a verbal or written partnership. They were also half as likely to report 
collaboration being limited and reduced to technical matters. 
Community Pharmacy Staffing and Prescription Workload 
The sample represented a wide range of prescription volumes at each pharmacy; 
however, on average, half the pharmacies were completing under 200 prescriptions a day and 
half over 200 per day, with the majority filling 100-200 daily prescriptions. Prescription 
workload did not seem to significantly affect pharmacists’ estimated engagement in ESoP with 
one exception. Pharmacies doing under 100 prescriptions a day reported approximately 50% less 
engagement in ESoP activities than larger volume pharmacies. There appeared to be no major 




frequency or quality of the exchanges. Prescription volume did not seem to affect the number of 
written or verbal agreements or how pharmacists viewed their collaborative relationship with 
physicians. 
Pharmacy staff composition also varied among locations; however, most operated with 
one to three pharmacists per shift with the majority having two pharmacists. Most pharmacies 
did not have registered technicians, but those that did generally had one technician. Non-
registered technicians were more common with about half having one non-registered technician 
per shift and the other half having two or three. Pharmacy assistants were the most common non-
pharmacist staff. The approximate composition for half of the pharmacies was having one 
assistant per shift while the other half had two or three assistants per shift.  
The more prescriptions the pharmacy completed, the more registered technicians there 
were. Further, there appeared to be a positive correlation in pharmacists’ engagement in ESoP 
activities and the number of registered technicians. Pharmacies who reported having one 
registered technician on a shift had a 10% increase in their estimated percentage of their 
workload spent on ESoP activities and a 20% increase when two or more registered technicians 
were on a shift. Another observation included the positive correlation between registered 
technicians on staff and the reported number of written and verbal agreements. Pharmacies that 
had more registered technicians reported more written and verbal agreements with physicians. 
When separating the data based on the number of pharmacists working per shift, a few 
associations can be made. The most obvious was that as prescription volume increased 
subsequently the number of pharmacists working increased. Pharmacists with three or more 




had the highest reported engagement in ESoP activities and were more likely to claim that ESoP 
activities increased collaboration with physicians. 
Pharmacist Demographics 
Over half of the pharmacists who responded to the questionnaire had more than ten years 
of experience working in a community pharmacy setting, while approximately a third had 
between three and ten years of experience. Consequently, most participants were practicing 
pharmacists during the last ten years when the majority of the changes to pharmacists’ scope of 
practice were implemented. There were a few notable differences in pharmacists’ responses for 
those who had more than 11 years of experience. Pharmacists in this group were the only group 
who indicated that fax was the more influential medium over verbal communication mediums 
such as the phone. Out of the 25 pharmacists who stated they had a written or collaborative 
practice agreement, 17 or 68% of those had over 11 years of pharmacy practice experience. 10 
out of 11 of the pharmacists who stated that there was no collaboration between pharmacists and 
physicians were also pharmacists who practiced more than 11 years. 
On average, half of the pharmacists classified their position within the pharmacy as a 
staff pharmacist and a third as pharmacy managers or owners. Clinical pharmacists and relief 
pharmacists represented the smallest fraction of the pharmacist positions, at ten percent 
combined. Pharmacists who stated their pharmacy position was that of a clinical pharmacist 
reported a 50% higher engagement in ESoP activities and twice as many written or verbal 






Expanded Scope of Practice Activities 
 The focus of the study concerned the nature of collaboration between pharmacists and 
physicians and the influence that an ESoP for pharmacists may have had on this collaborative 
work. The following section summarizes the data gathered from the questionnaire with regard to 
the nature of these collaborative activities and any changes that have happened, based upon the 
pharmacists’ perceptions.  
Pharmacist Engagement and Frequency of Exchanges 
Pharmacists estimated that within an average workday they spend 30% of their time 
performing ESoP activities compared to traditional pharmacy activities. The ESoP activities they 
were most involved in were extending prescriptions, prescribing for minor ailments, providing 
injections, issuing emergency supplies, and performing medication assessments. When the data 
are grouped together, the average frequency of exchanges with physicians is similar regardless of 
whether they were providing ESoP activities or traditional pharmacy activities. However, when 
compared to pharmacists who spend <20% of their workload on ESoP versus those who spend 
>40% of their workload on ESoP, there was a positive correlation between the frequency of the 
exchanges and ESoP engagement. Data suggested that pharmacists who spent more of their 
workload on ESoP activities had a 50% increase in the frequency of exchanges with physicians. 
Quality of Exchanges 
Along with the evaluation of frequency of pharmacists’ exchanges with physicians, the 
evaluation of the quality of those exchanges was asked of participants. For the purposes of this 
study, quality referred to exchanges that had the potential to improve patient care or health 




physicians were 20% greater with ESoP activities compared to traditional activities. With ESoP 
activities, the amount of low-quality exchanges was lower by 30% than that reported for 
traditional activities.  
Further investigation conveyed a positive correlation between the quality of exchanges 
and engagement in ESoP activities. Pharmacists who spent more of their workload on ESoP 
activities indicated the quality of exchanges almost doubled compared to traditional activities; 
pharmacists who spent less of their workload on ESoP activities did not report this observation. 
There was a marked difference in the amount of low quality exchanges with a strong inverse 
correlation between low quality and amount of time spent on ESoP activities. Compared to 
pharmacists with low ESoP involvement, pharmacists with high ESoP involvement reported a 
six to seven-fold decrease in the amount of low-quality exchanges compared to traditional 
activities. 
Influence on Collaboration 
 Community pharmacists suggested that ESoP influenced physician collaboration in the 
following ways: the amount pharmacists initiated an exchange or contact with physicians; and 
the amount of information pharmacists share about a patient’s health and medication status with 
physicians. ESoP also improved the pharmacists’ knowledge or understanding of the physician’s 
concerns, goals, and objectives. Additionally, ESoP produced more bilateral exchanges with 
physicians and improved relationships with them. 
Many pharmacists expressed that ESoP did not increase the number of times physicians 
initiated an exchange with pharmacists. Additionally, most did not think it increased the 
opportunity to work in partnership or form a Collaborative Practice Agreement (CPA) or other 




ESoP activities, except in relation to partnership opportunities. Pharmacists more heavily 
involved in ESoP were more likely to agree that ESoP played a role in increasing partnership 
opportunities with physicians compared to pharmacists less involved in ESoP activities, however 
results were not significantly greater than pharmacists who disagreed with the statement. This 
notion seems aligned with pharmacists’ perspectives on the influence of ESoP on collaboration 
with physicians as was communicated in the questionnaire’s open-ended responses.  
When pharmacists were asked directly to explain in their own words what influence 
ESoP had on physician collaboration, the following themes emerged. The most frequently 
mentioned themes were ESoP’s positive influence on communication and collaboration through 
more information sharing between pharmacists and physicians. Next, despite the responses on its 
minimal effect on physician-initiated exchanges, many pharmacists felt that ESoP increased 
utilization and awareness of their role, resulting in more referrals to the pharmacist from both 
physicians and clinics. Additionally, pharmacists claimed ESoP had clinical benefits, such as 
enhanced shared decision making and improved patient outcomes. Several also referred to the 
positive influence on pharmacist-physician relationship which enhanced trust, appreciation, and 
greater understanding of each other’s roles. Some pharmacists also expressed that ESoP played a 
role in improving health system outcomes in particular by decreasing physician workloads. 
Three-quarters of the themes identified suggested ESoP had a positive influence on 
collaboration; however, a subset of pharmacists believed there was little or no influence on 
collaboration. Despite the generally positive perception, a few pharmacists were neutral as to its 
influence and some perceived ESoP as negatively affecting collaboration. 
   Some community pharmacists did not perceive ESoP as positively influencing 




reported minimal or no influence on collaboration. Certain pharmacists felt frustrated with the 
lack of physician response and engagement, especially when pharmacists sent information 
pertaining to ESoP. A fraction went as far as saying ESoP had adversely affected collaboration 
with physicians. They reported that some physicians were limiting or challenging the 
pharmacists’ involvement in patient care. Others felt ESoP activities created territorial issues 
between pharmacists and physicians, which was particularly discouraging to pharmacists desire 
to more fully engage in providing ESoP services. Some pharmacist responses portrayed a sense 
of helplessness, hopelessness, or disempowerment in their ability to effectively collaborate with 
physicians. However, many pharmacists commented that the participation in and response to 
pharmacists’ ESoP activities varied widely among physicians; some physicians were open and 
accepting and others were not, thereby making it difficult to generalize. 
When community pharmacists were asked which ESoP activities were most influential at 
fostering collaboration with physicians, the top responses were in order: medication assessments, 
prescribing for minor ailments, extending prescriptions, and making therapeutic substitutions. 
Administering a drug by injection, ordering and interpreting lab values, and smoking cessation 
services were rated as the least influential overall. 
Fostering Collaboration 
The second open-ended question community pharmacists were asked in the questionnaire 
was which strategies they considered most effective at fostering collaboration between 
pharmacists and physicians. A large subset of the pharmacists stated the medium for 
collaboration played a significant role in the process. Many stated that interactions were most 
effective when they had the opportunity to speak directly with physicians, either in person or 




physicians’ unavailability for consultation with pharmacists, or clinics banning or restricting 
pharmacist communication to fax only. Despite these restrictions, some pharmacists reported that 
written communication transmitted via fax was still an effective means of collaboration, 
especially if followed up with a phone call.  
Many pharmacists stated that an additional strategy resulting in improved collaboration 
was building from ESoP activities. They indicated that medication assessments and minor 
ailment prescribing were particularly effective services to initiate or develop physician 
collaboration at an enhanced level. A further strategy was to consistently provide the physician 
with clear and concise communication containing strong patient-centred evidence-based 
medicine recommendations. Some pharmacists surmised that strong relationships could be built 
with physicians by: developing trust, understanding their needs and concerns, increasing 
awareness of each other’s roles, and highlighting how pharmacists were beneficial for promoting 
collaboration. A few pharmacists suggested that close proximity to the physician clinic was 
advantageous to collaboration.  
Current State of Collaboration 
 When pharmacists were asked to classify their current collaborative relationship with 
physicians, the following information was garnered. Approximately half of the pharmacists 
indicated good collaborative relationships with physicians, in which they worked well together 
and cooperated effectively on matters. About a quarter believed the collaborative relationship 
between pharmacists and physicians was often one-sided or limited to technical matters related 
to filling prescriptions. On average, about a fifth of pharmacists reported having verbal or written 




collaboration what-so-ever or a hostile relationship with conflict. Overall, pharmacists suggested 
positive collaborative working relationships with physicians existed. 
Summary 
 The main objectives of the study were to examine how pharmacists’ ESoP influenced 
interprofessional collaboration with physicians. In addition, a goal of the study was to determine 
community pharmacists’ level of engagement in ESoP activities and which were most impactful 
to physician collaboration. Lastly, another objective was to discover which strategies were 
effective at fostering collaboration. The results indicated that pharmacists spent approximately a 
third of their workload performing ESoP activities, with medications assessments, minor 
ailments prescriptions, and extension of prescriptions being the most valuable for collaboration 
with physicians. The overall influence of pharmacists’ ESoP appeared positive and suggested 
increased collaboration, communication, pharmacist utilization, enhanced clinical management, 
and improved relationships. The most effective strategies for fostering collaboration were 
increasing exchanges particularly by maximizing opportunities for direct communication with 
physicians, utilizing EsoP as an avenue to collaborate, and effectively communicating strong 
evidence-based recommendations rooted in patient-centered care. Enhancing relationships with 
physicians, increasing awareness of each other’s roles, and understanding their needs and 
objectives were also considered valuable. 
 Although this study’s objectives were not to determine barriers to pharmacist and 
physician collaboration, the questionnaire rendered some interesting considerations on the 
subject matter. The questionnaire identified some reoccurring themes related to hindrances to 
collaboration. Lack of physician engagement and participation in pharmacists’ efforts to 




and source of frustration for some pharmacists. Another barrier impeding pharmacists’ ability to 
collaborate, was physicians or physician clinic staff restricting direct communication channels by 
refusing phone calls and only accepting faxed communication. Lastly, a few pharmacists 
suggested that providing EsoP activities was viewed as threatening in nature to some physicians 
and created hostility. Despite hinderances, most pharmacists classify their relationships with 
physicians as collaborative in nature.  
Discussion and Interpretation of Findings 
Community pharmacists who responded to the questionnaire were from various sized 
urban and rural settings across Saskatchewan. Pharmacists provided information on engagement 
in ESoP activities, influence on physician collaboration, and strategies for effective 
collaboration. Although traditional pharmacy activities still account for the majority of 
pharmacists’ workload, community pharmacists in Saskatchewan report spending a significant 
amount of their workload engaged in ESoP activities. Subsequently, the study’s findings include 
a reasonable amount of data on ESoP and physician collaboration for analysis and interpretation. 
Community Pharmacist Engagement  
 On average community pharmacists indicate that they spend approximately 30% of their 
workload on ESoP activities. The majority of pharmacists also report having an effective 
collaborative working relationship with physicians in which they work well together 
consistently. Further many of the open-ended responses results reinforce findings by Jove et al. 
(2014) and Kelly et al. (2013) that community pharmacists largely show a willingness to 
participate collaboratively, demonstrate an understanding of the value of collaboration to 
improved patient outcomes, and want more collaboration opportunities. The results challenge 




are unwilling to participate in team-based models of interprofessional practice. Furthermore, 
findings suggest that interprofessional collaboration in community pharmacies may be 
misunderstood and could require an alternate perspective from which to examine it, especially 
when compared to models derived from primary health care teams in institutional-like settings. 
Influence on Collaboration 
This study identified several ways that ESoP influenced collaboration with physicians. 
The most common reoccurring theme in the data was the effect ESoP had at increasing and 
improving communication and collaboration between pharmacists and physicians. Along with 
the positive impact of ESoP, was acknowledgement of the challenges faced by community 
pharmacists to collaborate effectively. Additional influences of ESoP on physician collaboration 
were in the areas of pharmacist utilization, relationships, role recognition and awareness, and on 
health system outcomes. 
 Communication and Collaboration  
The results from the study indicated the largest influence of pharmacists’ ESoP has been 
enhanced communication and collaboration with physicians. Liu and Doucette (2011) believed 
that effective communication between pharmacists and primary care providers plays a vital role 
in successful provision of medication management services. The importance of communication 
is also referred to in theoretical models of collaboration as described in the literature. 
Communication is the third stage in Artimage’s taxonomy of collaboration, which denotes 
encounters, correspondence, and transfer of information, followed by the fourth stage, 
collaboration (Bradley et al., 2012). Hudson’s models of collaboration also suggest that 





When we apply the study’s data to the Community Pharmacists Collaboration Model 
(CPCM), it supports the premise that ESoP facilitates a transition away from a differentiated 
system to one that is more integrative. ESoP assists in moving collaboration forward along the 
spectrum of possible collaborative actions. Data obtained demonstrates a positive correlation 
between the frequency of exchanges with physicians and ESoP activities. Rathbone et al. (2016) 
discussed the importance of the frequency of interactions between physicians and pharmacists 
and surmised that increased frequency is a critical element for successful collaborations between 
physicians and pharmacists. The study results suggest that the more pharmacists actively perform 
ESoP activities, the more frequent the exchanges with physicians become. Furthermore, 
pharmacists report initiating these exchanges more often with physicians because of ESoP 
activities. Subsequently, they are having more bilateral communication with physicians. 
Bidirectional communication enhances collaboration and is an important component in effective 
multidisciplinary teams (Doucette et. al., 2005). Although, most pharmacists thought that ESoP 
enhanced bilateral exchanges when initiated by the pharmacist, many indicated that it did not 
significantly increase physician-initiated exchanges.  
Most pharmacists did not feel that ESoP increased the opportunity for partnerships, 
Collaborative Practice Agreement (CPA), or other written agreement. Although most 
pharmacists stated ESoP did not play a significant role at increasing physician-initiated 
exchanges, partnerships, or formalized written agreements, many indicated it was an avenue they 
could utilize to enhance collaboration with physicians. Further, many pharmacists expressed that 
ESoP contributed to more utilization of pharmacists and increased referrals from clinics. This 
finding suggests that physician-initiated engagement was enhanced with ESoP; however it was 
perhaps more indirect or less overt in nature. According to Oandasan et al.’s (2006) Spectrum of 




Referrals from one healthcare professional to the next is a step toward interdependence and co-
provision of care (Oandasan et al., 2006). The CPCM was altered, as seen in Figure 5.1, to 
separate bilateral exchange and physician-initiated exchange since they have differing results 






       
 Figure 5.1 Adapted Community Pharmacist Collaboration Model (CPCM) 
In the adapted CPCM, collaboration is not one single entity or stage that is reached, but 
rather varies depending on the exchanges and agreements made, some being more differentiated 
in nature and some more integrative. Collaboration begins at contact and progresses through a 
series of pharmacist and physician exchanges toward more formalized partnership and written 
agreements. As exchanges progress toward integration, there becomes an increasing level of 
interdependence required from pharmacists and physicians. 
Barriers 
Although most pharmacists report good collaborative working relationships with most 
physicians, some expressed concerns over lack of physician participation in the process. Some 
pharmacists suggested that collaboration was absent or impeded due to lack of physician 
engagement. Despite pharmacists attempting to collaborate with ESoP activities, some 
    
   


















physicians never reciprocated communication. Often this lack of response was very physician 
dependent or limited to certain physicians. This finding may explain why ESoP activities did not 
produce more physician-initiated exchanges or result in more partnerships and formalized 
agreements. As expressed in the CPCM model, there is an increasing level of interdependence 
required or participation expected from physicians as exchanges become more integrated in 
nature. This concern was reflected in the literature by Van et al. (2011) where they ascertained 
that out of all the known barriers between pharmacists’ and physicians’ collaboration and 
integration of services, lack of interest from physicians was at the forefront. The reasons for lack 
of physician engagement is unclear in this study; however, Edmunds and Calnan (2001) 
surmised that collaboration could be hindered due to the expansion of the pharmacist’s role if 
physicians see it as a threat to their autonomy and control. Transformation to a team-based 
approach in healthcare has been slow, largely due to professionals continuing to protect their turf 
or limiting their scopes of practice to respond to their own needs and interests rather than those 
of the population (Oandasan et al., 2006). If physicians are reluctant to communicate with 
pharmacists or see their expanded scope as a threat, exchanges will likely fail to progress toward 
integration.    
An additional obstacle identified from the data was some physicians or clinic staff 
restricting communication mediums that were considered effective for collaboration and good 
patient care. Most pharmacists reported that communication with physicians was often done via 
fax. However, when asked which the most effective medium for collaboration was, almost half 
said the phone. Further, when pharmacists were asked to suggest effective ways for fostering 
collaboration, a significant proportion claimed that speaking directly with physicians either 
through the phone or in person had the most significant impact. This sentiment and concern over 




querying pharmacists in Newfoundland about their views on collaborative practice. The data 
suggests that ESoP activities create an avenue for enhanced collaboration between pharmacists 
and physicians; therefore physicians should consider providing more opportunities for direct 
communication with community pharmacists. This simple act could potentially enhance the 
collaborative relationship and result in improved patient care and greater efficiencies in 
healthcare.  
A study by Luetsch and Rowett (2016) aimed at developing pharmacists’ 
interprofessional communication skills and thus improving their ability to collaborate, 
acknowledged that there were both external and internal barriers to effective collaboration 
between pharmacists and physicians. However, the internal barriers such as attitudes, beliefs, and 
understanding of respective roles seemed to disappear once pharmacists and physicians actually 
experienced collaborative practice and established a professional relationship (Luetsch & 
Rowett, 2016). In Luetsch and Rowett’s (2016) study, pharmacists were encouraged to develop a 
genuine curiosity about the health professional’s practice, priorities in patient care, motivations 
for practice, and identify gaps in practice to create opportunities for interprofessional learning 
and collaboration. Pharmacists participating in my study seemed to support the notion that ESoP 
played a role in increasing their knowledge or understanding of physicians’ concerns, goals, and 
objectives. This finding suggests that if community pharmacists can continue to pursue such 
professional relations and utilize ESoP as an avenue to do so, barriers can be minimized and 
collaborative practices forged.  
Pharmacist Utilization 
Community pharmacists expressed that collaboration was enhanced with ESoP activities, 




traditional activities. One pharmacist stated that “Expanded scopes have allowed physicians to 
have greater confidence in our knowledge and abilities, allowing them to refer to us for their 
patients, or for their own information”. Bradley et al. (2012) provided a compelling possible 
explanation as to why this may be. They surmised that traditionally pharmacist communications 
were limited to routine matters such as querying prescriptions or alerting the physician to 
potential problems. Since historically pharmacists provide the final check, communication with 
physicians likely involved pharmacists reporting errors and mistakes, thereby being the bearers 
of bad news or only initiating communication when there was a problem. Subsequently, the 
collaborative relationship may have been adversely affected. It is possible that collaboration was 
improved with ESoP activities compared to traditional activities because those interactions were 
more likely to share beneficial information or make recommendations to proactively improve 
patient care, rather than correcting physician error. ESoP activities may shift the focus of the 
contact away from correcting errors and redirect it toward clinical management, sharing 
information, and patient care. Oandasan et al. (2006) stated that collaboration occurs when team 
members share goals and are mutually accountable to provide patient care. This finding may 
explain why pharmacists reported medication assessments and minor ailment prescribing as the 
most beneficial ESoP activities, since they are both highly clinical and patient centered. 
Communication that is clinically oriented and patient-centered may provide a greater opportunity 
to foster characteristics known to enhance collaboration such as improved relationships, trust, 
role recognition, and a better understanding of physicians’ needs. Zillich et al. (2004) stated: 
As physicians become more familiar with pharmacists and achieve confidence in their 
abilities, trust and commitment to the relationship begin to develop. Also, after trust has 
developed, physicians may be more willing to initiate the interaction by seeking the 




CWR model, which posits that the more the providers communicate with one another and 
the more physicians utilize pharmacists’ services, the greater the collaboration between 
them. (p.767) 
This may explain why community pharmacists indicated that ESoP was an effective way to 
foster collaboration with physicians.  
Clinical effects 
Some pharmacists indicated that ESoP enhanced clinical management, including more 
shared decision making and improved patient care. One pharmacist stated that “Expanded scopes 
have allowed physicians to have greater confidence in our knowledge and abilities, allowing 
them to refer to us, for their patients, or for their own information”. Another pharmacist reported 
that physicians were “More likely to take phone calls from us and open to making changes based 
on advice from us”. When pharmacists were queried on strategies for fostering collaboration 
with physicians, many stated that providing strong recommendations rooted in evidence-based 
medicine that were patient centered were effective. Liu and Doucette (2011) stated that to start a 
collaborative relationship, a pharmacist first needs to show the physician their knowledge of 
medications and skills to provide patient care. They also expressed that the pharmacist’s 
knowledge and skills provide the foundation for their responsibilities. An example is in 
Medication Therapy Management services, where pharmacists use their knowledge and skillset 
to review patients’ medications and make proper pharmacotherapy recommendations to 
physicians (Liu & Doucette, 2011). Some community pharmacists who participated in the study 
suggested that the most beneficial ESoP activities for fostering collaboration with physicians 
were medication assessments and minor ailment prescribing. Both activities are highly clinical 




medication and providing pharmacological recommendations. Doucette et al. (2005) explained 
that “in practice settings where pharmacists have been integrated successfully into drug therapy 
management process, patient outcomes have improved” (p. 566). The study data suggests that the 
clinical nature of ESoP activities may provide more opportunities for pharmacists to provide 
strong evidence-based recommendations or showcase their skill set that could improve patient 
care, thereby increasing physician confidence and trust. Some pharmacists in return have 
reported feeling more valued, respected, and appreciated by the physician, thereby further 
enhancing the collaborative relationship.  
Relationships 
A theme some community pharmacists identified when asked about the influence of 
ESoP or strategies for fostering collaboration with physicians was the importance of enhancing 
relationships with physicians and the development of trust. One pharmacist stated that “We 
collaborate a lot more with physicians due to our expanded scope of practice. I believe it is a 
positive increase in collaboration and allows for more opportunity to better our relationships with 
physicians and work together for the benefit of the patient.”. Some community pharmacists 
stated that ESoP increased the trust and confidence between the two parties, or perhaps created 
more opportunity for its development through the interaction. Others suggested that consequently 
there were more referrals and utilization of the pharmacists by physicians.  
Bradley et al. (2012) and McDonough and Doucette’s (2001) work demonstrated that 
trustworthiness is an important factor in collaborative relationships. In the Collaborative 
Working Relationship (CWR) model, trust is considered an exchange characteristic, which plays 
a role in advancing collaboration forward. Further, when the CWR was utilized to measure 




specification were considered “the most significant factors influencing collaborative 
relationships for both professional groups” (Bradley et al., 2012, p.38). Hudson et al. (1997) also 
suggested that trust plays an important role in integration. Additionally, a study by Loffer et al. 
(2017) examining perceptions of interprofessional collaboration between physicians and 
pharmacists indicated that mutual trust and appreciation appear to be significant factors for 
influencing the quality of interprofessional collaboration. They recommended that for successful 
interprofessional collaboration to occur, interventions and initiatives should focus on increasing 
trust. When analyzing this data in relation to the study results, increased interactions from ESoP 
activities may have contributed to improved relationships and enhanced trust between 
pharmacists and physicians, thereby influencing the claims of improved collaboration.   
Role Recognition and Awareness 
 Some pharmacists surmised that ESoP increased role awareness or recognition. 
Furthermore, some suggested that role awareness and recognition were effective strategies at 
fostering collaboration with physicians. This statement is in alignment with Doucette et al.’s 
(2005) belief that “when pharmacists and physicians jointly determine specific roles, the 
relationship is likely to become more collaborative” (p. 572). In the CWR model, role awareness 
is considered the starting point for the CWR, followed by role recognition. Liu and Doucette 
(2011) discussed the importance of role specification in the formation of collaborative practice. 
They identified that “role specification measures the extent of fit and interdependence between 
pharmacists and physicians” (Liu & Doucette, 2011, p. 415). Role specification is particularly 





Ensuring physicians are aware of the community pharmacists’ new role may be of vital 
importance considering the rapid changes to pharmacists’ scope of practice. This awareness is 
especially important considering that many of the new activities are often ones traditionally 
devoted to physicians, such as prescribing, adapting prescriptions, and ordering and interpreting 
lab tests. Kelly et al. (2013) explained that physicians’ perceptions of the pharmacist role were 
more technical and tied to dispensing rather than cognitive pharmacist functions. They also 
claimed that further studies reported a disconnect between physicians’ and pharmacists’ 
perceptions on the perceived role of the pharmacist in patient care. This sentiment was reflected 
in my study by one pharmacist who said pharmacists perceived confusion or unawareness from 
some physicians about pharmacists’ scope of practice. This lack of awareness could increase the 
likelihood of physicians perceiving ESoP exchanges in a negative light.  
Poor awareness of pharmacists’ new role could create territorial issues with physicians, 
particularly if physicians view expansion of the pharmacists’ role as a threat. One pharmacist in 
the study reported that “Once physicians understand our scope of practice they are more open to 
suggestions”. Another pharmacist stated that “Expanded Scope of Practice has allowed an 
avenue of communication and education between both parties as to what each can do and 
allowed us to better understand the roles of pharmacists and physicians as a team”. In my 
experience working as a pharmacist, awareness and support of each other’s roles often begins in 
post-secondary teaching and learning; however further encouragement by governing and 
advocacy bodies for both professions may also be advantageous. Community pharmacists, as 
part of their professional responsibilities, may also need to be cognizant of how ESoP activities 
are being perceived by local physicians and take an active role to inform, coordinate care with, or 
reassure physicians as to their mutual value. Pharmacists can encourage collaborative 




physician their knowledge of medications and skills to provide patient care (Liu & Doucette, 
2011). 
 Health Systems Outcomes 
A common theme identified by pharmacists when questioned about the influence of ESoP 
was its ability to decrease the workload of the physician and improve efficiencies in the 
healthcare system. One pharmacist expressed that “ESoP has given our pharmacists a forum to 
show the physicians exactly what we can add to patient care and to ease their workload”. 
Another pharmacist reported that “Doctors are starting to appreciate us taking off some of the 
pressure. Therefore, we have (been) able to create extended CPAs with several different clinics 
and physicians”. Oandasan et al. (2006) acknowledged that collaboration had the potential to 
improve patient care, enhance patient safety and lower workload among healthcare professionals. 
Bryant et al. (2010) indicated that both community pharmacists’ and physicians’ believed 
improvements in collaboration could result in greater satisfaction and professional development, 
while making the healthcare system easier to use. This shared belief may be an encouraging 
sentiment considering maximizing interprofessional collaboration was suggested as a way to 
address the need for reducing the burden of the Canadian Health Care System and making it 
more sustainable (CPhA, 2016a). ESoP activities themselves have been suggested as a way to 
improve health system outcomes. Some pharmacists in the questionnaire indicated that 
prescribing for minor ailments was particularly valuable for collaboration with physicians. The 
CPhA (2016b) report stated:  
The Ontario Pharmacists’ Association estimates that the implementation of a pharmacist 
minor ailment program would result in an increased capacity of 570 full-time general 




proposal by the British Columbia Pharmacy Association states that $95 million is spent 
yearly on the treatment of minor ailments by physicians and transferring those services to 
a pharmacist would yield savings of $32 million annually (p. 16). 
Expansion of pharmacists’ scope of practice has the potential to increase patient access to health 
services, potentially saving valuable health care dollars, and alleviating physician workloads. 
Implications for Theoretical Models of Collaboration 
The CWR lists five progressive stages in collaboration: professional awareness, 
professional recognition, exploration and trial, professional relationship expansion, and 
commitment (Liu & Doucette, 2011). The model stated that collaboration is a process influenced 
by three sets of characteristics including individual, context, and exchange, each of which have 
their own multiple variables (Liu & Doucette, 2011). Doucette et al. (2005) proposed that the 
three most significant of these variables associated with collaborative care were professional 
interaction, trustworthiness, and role specification. These three variables are consistent with 
factors that community pharmacists suggested as being effective for fostering collaboration with 
physicians. Additionally, some pharmacists who completed the questionnaire suggested that 
ESoP influenced collaboration by providing more and higher quality professional interactions, 
enhanced relationships and trust, and facilitated more role awareness and recognition. The 
alignment of these principles may have contributed to pharmacists’ claims that ESoP positively 
affected or enhanced collaboration with physicians.  
Results from this study also suggested that foundational principles for collaboration, as 
identified by the CWR, such as relationships, trust, role recognition, and role awareness, may not 
necessarily have to be present prior to beginning pharmacist-physician collaborations. Some 




had been implemented. It is possible that attributes deemed beneficial for collaboration could be 
a fortunate biproduct of engagement in ESoP activities, which can, in turn, foster more robust 
collaboration. Figure 5.2 illustrates a theory on collaboration as suggested by this study’s results 
called the Community Pharmacist Collaboration Positive Feedback Loop (CPCFL). The diagram 
depicts that an increase in exchanges that move towards integration results in the production of 
biproducts that are attributes deemed beneficial for enhancing collaboration. This interaction 
implies a positive feedback relationship between the two entities. Furthermore, each step closer 
to integration contributes more valuable attributes for collaboration and therefore has an even 








Figure 5.2 Community Pharmacist Collaboration Positive Feedback Loop (CPCFL) 
Advances in collaboration might not need to be as complicated to implement as the CWR 
model portrays it to be. Community pharmacists likely do not have the time or resources to 
address all the factors identified as requirements for advancing collaboration with physicians. 
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practice toward integration. For pharmacists pursuing opportunities for more contact, more 
pharmacist-initiated exchanges, more bilateral exchanges, more physician-initiated exchanges, 
and ultimately more partnerships and formalized agreements, these factors can provide an 
avenue for enhancing collaboration and organically fosters attributes deemed beneficial for 
collaboration.  
Further, the CPCM and CPCFL models are versatile; regardless of which stage a 
pharmacist is at, movement can start from that location. For example, a pharmacy that has 
limited contact can begin by simply increasing contact points with physicians and having their 
pharmacist initiate more exchanges. Another pharmacy that has more enhanced collaboration 
with physicians in the form of active bilateral exchanges may want to pursue a partnership on a 
mutually beneficial activity. ESoP activities are innately more aligned with physician activities, 
are generally more clinical, and have built in expectations of collaboration; because of these 
characteristics, they serve as a pathway that community pharmacists can utilize or build upon to 
advance collaboration with physicians. Pharmacists in the study confirmed that building from 
ESoP activities such as medication assessments helped foster collaboration; however, the 
pharmacists also offered more suggestions for improved collaboration. Incorporating strategies 
that community pharmacists have deemed effective at fostering collaboration with physicians 
could help advance collaborative efforts, especially when coupled with ESoP activities. 
Strategies for Collaboration 
 When community pharmacists responded to the study’s questionnaire regarding effective 
strategies for fostering collaboration, some common themes emerged. Figure 5.3 lists the seven 









Figure 5.3 Strategies for fostering physician collaboration 
When these strategies are inserted into the CPCFL model and rearranged in a 
chronological fashion, we can see the following working model for collaboration, taking into 
consideration ESoP activities.  
Figure 5.4 provides a visual depiction of the study results. The figure portrays how ESoP 
activities may contribute to advancing collaboration forward. Community pharmacists indicated 
that some strategies for fostering collaboration forward were to utilize ESoP activities as an 
avenue to collaborate with physicians. Using the communication involved in ESoP activities as 
an opportunity to increase the physician’s awareness of the pharmacist’s role, using opportunities 
to communicate directly with physicians, and providing clear and concise evidence-based 
recommendations that are patient centered may contribute to furthering collaboration. 
Communication received from the physician can provide more information about physicians’ 
needs, thereby providing the pharmacists with information to adapt their communication style 
and target services to physicians’ needs. As ESoP enhances the quantity and quality of the 
exchanges between professionals, biproducts or influences of the ESoP interaction such as 
relationship building, trust, respect, appreciation, increased understanding of role, sharing of 









































Figure 5.4 ESoP and the CPCFL model 
 
Data suggest that ESoP may contribute to enhancing collaboration with physicians. 
Community pharmacists who want to expand their services must foster collaborative 
relationships with physicians that go beyond discrete exchanges. One approach is to look at each 
interaction as an opportunity to expand the relationship (McDonough & Doucette, 2001). ESoP 
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Implications for Practice 
 The Canadian Healthcare System is currently overburdened and in need of reform in 
order to ensure its continued sustainability (CPhA, 2016b). Stressors to the healthcare system 
will likely continue as the rates of chronic disease rise, the population ages, and technical and 
pharmaceutical advances drive up costs (CPhA, 2016b). Focus is being placed on making 
fundamental changes at reorganizing, financing, and delivering healthcare in a way that is more 
sustainable and efficient, while still providing good patient outcomes. Healthcare professionals 
have been called upon to increase interprofessional collaboration to improve patient outcomes 
and respond to the changing landscape of healthcare (Dobson et al., 2006). Expanding the scope 
of practice of healthcare professionals is one of the ways proposed to help address the situation 
(CPhA, 2016a).  Pharmacists’ collaboration has proven valuable in a variety of programs; 
however research is limited when it comes to understanding collaboration as a routine part of 
community pharmacy practice (Dobson et. al., 2016). In Saskatchewan, 75% of pharmacists’ 
jobs are in the field of community pharmacy practice (Bareham, 2016; Government of 
Saskatchewan, 2014). Therefore, if we are going to have a major shift in pharmacists improving 
patient outcomes and reorganizing the health system to improve efficiencies, it is essential that 
we understand how to foster and implement collaboration at a community pharmacy level. 
 The results of this study support the notion that many community pharmacists seem 
interested in collaborating and appear engaged in the process. Most pharmacists view their 
relationship with physicians in a positive light in which they work well together in a coordinated 
and collaborative manner. Few pharmacists believe there is no collaboration occurring between 
the two parties or that the relationship is adverse or marked with hostility. Further, it appears that 
most community pharmacists are implementing Expanded Scope of Practice (ESoP) activities 




ESoP activities, the more likely they perceive them as positive or valuable for collaboration. 
They are also more likely to classify their relationship with physicians as a collaborative one 
compared to pharmacists who are less engaged. 
The findings suggest that community pharmacists’ involvement in ESoP may improve 
communication and collaboration with physicians and could possibly support goals of improved 
patient and health systems outcomes. ESoP activities that are more clinical and patient centered 
compared to traditional activities may be better received by physicians than traditional 
exchanges, and thereby help encourage more collaboration. Increasing the frequency and quality 
of exchanges with physicians could play a role at fostering attributes considered important for 
improved collaboration such as relationship development, professional interactions, role 
recognition and awareness, and understanding physicians’ needs. The data suggest that ESoP 
may be an avenue that pharmacists can practically implement to encourage more collaboration, 
achieve more robust collaboration, or use to help develop foundational principles for advancing 
collaboration.  
The data also indicates that pharmacist engagement in ESoP alone may not be enough to 
secure the richest form of collaboration such as partnerships, Collaborative Practice Agreements 
(CPA) or a written commitment for both parties to work in a formalized and interdependent 
manner. It draws attention to the notion that there is a need to engage physicians more in the 
process and have them more actively utilizing pharmacists’ newly expanded roles. If community 
pharmacists are going to continue to positively influence collaboration with physicians and move 
towards integration of services, they need to identify how to enhance physician engagement and 




Expanding community pharmacist collaboration is particularly important considering 
some literature is scrutinizing community pharmacists for not collaborating, not embracing their 
expanded role, or not being active members of healthcare teams (Dobson et al., 2006). It is 
possible that the rigid descriptions of interprofessional collaboration derived from primary 
healthcare teams have been directly applied to community pharmacy, and not adapted to meet 
the unique environment within which community pharmacies operate. The CPCM or CPCFL 
models may be a more practical and representative model for examining collaboration in the 
community pharmacy setting than existing models of collaboration. Community pharmacists, 
given their unique role and practice environment, from among all of the healthcare professionals, 
may have the largest role to play in improving patient outcomes, improving efficiencies and 
reducing the financial costs of delivering high quality care in a coordinated fashion. 
Organizational theory supports the premise that most effective organizations are ones that 
have both high levels of differentiation and integration; therefore, it is incumbent that we 
examine strategies to assess and improve the levels of integration (Lawrence & Lorsch, 1967). 
The pharmacist profession began as highly integrated with physicians and over time has become 
largely differentiated and specialized (Liaw, 2009). The changes to the healthcare system are 
now demanding more integration for its continued and improved functioning. While I do not 
believe that community pharmacists should completely return to a fully integrated system, the 
specialization of pharmacists’ duties is still valuable. It may be beneficial to strive for more equal 
balance between integration and differentiation. Literature suggests the need for more 
incorporation of activities that are integrated in nature. Continued development and expansion of 
the pharmacist’s role, increased pharmacist utilization, and exploration into best practices for 




to the wide spread overarching efforts of improving the sustainability of the Canadian healthcare 
system. 
Limitations of the Study 
 The research conducted had the following limitations: 
• Opinions on the influence of ESoP on pharmacist and physician collaboration were only 
taken from the community pharmacist’s perspective. Therefore, results may have been 
limited or one-sided and not fully representative of the true effect. 
• The study used a quantitative research design and therefore did not fully explore opinions 
expressed in the questionnaire. Open-ended responses were often brief and lacked detail. 
• The questionnaire was distributed during the start of influenza season and therefore may 
have reduced the potential number of participant responses due to the increased workload 
on pharmacists at the time. Furthermore, SCPP did not send out the final email reminder 
to pharmacists. This may have reduced the potential sample size which could have 
influenced the results. 
• Participating pharmacists may have been pharmacists who were more involved in ESoP 
activities or already working collaboratively with physicians. Therefore, the data may not 
be as representative of the group of practicing pharmacists as a whole. 
Recommendations for Further Research 
Although this study produced a lot of interesting data regarding the influence of ESoP, 
the results are indicative of community pharmacy practice and ESoP in Saskatchewan. It would 
be interesting to discover if the results held true if they were compared to other provinces with 
varying degrees of ESoP regulation. Additionally, it would be valuable to explore the opinions 




depth understanding of collaborative practices between community pharmacists and physicians 
and provide more perspectives and insights into underlying themes identified. The following 
questions emerged that require further exploration: 
• Does the increase in registered pharmacy technicians help alleviate pharmacists’ 
technical workload so they can be more involved in ESoP or collaborative efforts?  
• Why do pharmacies in smaller centres report more favorable relationships and 
collaborative agreements than those located in more populous regions?  
• Does high prescription volumes adversely affect a pharmacists’ engagement in ESoP 
activities and collaboration with physicians? 
• Does pharmacy ownership affect engagement in ESoP activities or increase collaborative 
agreements and why? 
An additional way to provide a more well-rounded perspective on the subject matter is to 
query physicians on the influence of ESoP. This approach would also help researchers and 
practitioners better understand the current state of collaboration and help identify some 
alternative strategies for improved collaboration. Given the results of the study, exploring ways 
community pharmacists can more actively engage or better communicate ESoP activities with 
physicians could prove valuable. Interviewing both physicians and community pharmacists who 
have CPAs or strong collaborative relations may also provide direction regarding factors 
necessary for successful partnerships and potentially provide direction to community pharmacists 
on how to foster such partnerships.  
Exploring the CPCM and CPCFL theoretical models through further study could be 
beneficial. CPCM and CMCFL models potentially offer a theoretical basis to better understand 




complicated than the CWR model, making them perhaps more applicable and easier to 
implement. CPCM and CMCFL models could be researched and potentially refined as a practical 
tool to measure and help direct progression of collaboration with physicians in the community 
pharmacy setting.    
Concluding Thoughts 
 Researching pharmacists’ ESoP and collaboration in community pharmacies has been 
rewarding and insightful. Gathering information directly from practicing community 
pharmacists, through a study designed by a community pharmacist working in collaborative 
practice, offers another perspective on which to examine the topic. I could identify with some of 
the findings from this study based on experiences working in community pharmacy. In my 
experience most pharmacists are interested in and eager to take on more responsibilities to 
support the best interest of their patients. Many pharmacists are yearning for better relationships 
with physicians and want to contribute their knowledge and skill set through interprofessional 
collaboration. Pharmacists’ apathy often originates in a place of despondency and futility that 
their efforts will be valued, or result in meaningful changes, and that efforts may be met with 
hostility or resistance. I was surprised that most pharmacists did not feel ESoP increased 
partnerships or written agreements since my experience was the contrary. However after 
reflecting on the data, I can see how lack of physician engagement could possibly limit such 
efforts. The most exciting and challenging portion of the study was adapting a new theoretical 
model on which to examine collaboration in community pharmacy. 
 When reflecting upon the study, the quantitative design chosen was successful at 
obtaining a large volume of data to gain more perspective on the topic, as anticipated. However, 




collaboration in greater detail. Although my quantitative study design intentionally included 
open-ended questions to obtain more in-depth opinions from pharmacists, unfortunately many of 
the responses were brief and lacked detail or explanation. A mixed-method or qualitative study 
design would have provided more opportunity for a deeper and more robust understanding of the 
data, which may have identified new themes or ideas pertinent to collaboration.  
The study provided data on ESoP and collaboration, including the fact that partnerships 
and written agreements are actively occurring between community pharmacists and physicians in 
Saskatchewan. I intend to build upon the study’s findings by further exploring these partnerships, 
along with pharmacists’ and physicians’ perspectives on collaboration with those who have 
successful partnerships or agreements. I am also excited to further test, experiment, and refine 
my theoretical model of collaboration through further study. Additional areas of interest include 
exploring what role pharmacy workload and staffing play in ESoP and interprofessional 
collaboration, including the incorporation of registered technicians, and the role of pharmacy 
managers or business owners. Another keen area of interest includes the teaching and learning of 
collaboration and interprofessional practice, particularly in a post-secondary environment. I hope 
these findings will lead to considerations for practice and for further research, with 
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Appendix A: Community Pharmacist Questionnaire on Expanded Scope of Practice and 
Physician Collaboration 
DIRECTIONS: Below is a list of questions pertaining to community pharmacists’ expanded 
scope of practice and collaboration with physicians. The purpose of the survey is to gain insight 
into your current community pharmacy environment, your experience with expanded scope 
activities, and explore the effect it has had on interprofessional collaboration with physicians. 
Please provide an honest, accurate, and if possible, detailed account of your experience in this 
area. All responses will be anonymous and confidential. Thank-you for your participation! 
Survey Outline – 18 questions 
PART 1: Community Pharmacy and Pharmacist Demographics – 7 Questions 
PART 2: Expanded Scope of Practice and Physician Collaboration – 11 Questions 
 
PART 1: Community Pharmacy Demographics 
1. What type of centre is your community pharmacy located in 
a. Large urban community pharmacy (population >100,000) 
b. Medium urban community pharmacy (population 30,000-99,999) 
c. Small urban community pharmacy (population 5000-29,999) 
d. Rural community pharmacy (population < 5000) 
e. Remote/isolated community pharmacy (a large distance from a larger settlement 
or lacks transportation links 
f. Other - Explain 
 
2. Choose which best describes your community pharmacy practice location 
a. Within the same building as a physician clinic 
b. Directly beside a physician clinic 
c. Within 2 blocks of a physician’s clinic 
d. In the same town/city as a physician clinic 
e. Not in the same town/city as a physician clinic 
 
3. What is the average number of prescriptions your pharmacy does per day? 















4. How many pharmacists are typically working on staff during an 8-hour daytime shift 





e. 5 or more 
 
5. How many support staff work at your pharmacy during a typical 8-hour shift? 
___ Registered technicians 
___ Non-registered pharmacy technicians 
___ Pharmacy assistants  
 
6. How many years have you been practicing as community pharmacist? 
a. Less than 6 months 
b. 6 months to 2 years 
c. 3-5 years 
d. 6-10 years 
e. 11-20 years 
f. Over 20 years 
 
7. What is your current position. Select all that apply 
a. Floater pharmacist 
b. Staff pharmacist 
c. Clinical pharmacist 
d. Pharmacy manager 
e. Pharmacy owner 
PART 2: Expanded Scope of Practice and Physician Collaboration Questions  
For the purposes of this survey, the following terms are defined as such: 
TRADITIONAL role of the pharmacist: activities such as processing, dispensing, compounding, 
prescription counselling, patient education, third party billing etc.  
EXPANDED SCOPE OF PRACTICE: activities such as providing emergency prescription 
refills, renew/extend prescriptions, change drug dosage/formulation, making therapeutic 
substitutions, prescribing for minor ailments/conditions, initiating prescription drug therapy, 
ordering and interpreting lab tests, administering a drug by injection, medication assessments 
(e.g. SMAP), and smoking cessation services (PACT). 
COLLABORATION: the action of working with someone to produce or create something.  
EXCHANGES: any interaction with a physician including phone call, fax communication, email, 




QUALITY: actions such as sharing information, making recommendations, decision making etc. 
that have the potential improve patient care outcomes or health system outcomes 
1. Ranking question: Rank the top FIVE EXPANDED SCOPE OF PRACTICE activities 
you are MOST engaged in (1 – being the most) 
__ Provide emergency prescription refills 
__ Renew/extend prescriptions 
__ Change drug dosage/formulation 
__ Make therapeutic substitutions 
__ Prescribe for minor ailments/conditions 
__ Initiate prescription drug therapy 
__ Order and interpret lab tests 
__ Administer a drug by injection 
__ Medication Assessments (e.g. SMAP) 
__ Smoking cessation services (PACT) 
 
2. Estimate on average what percentage of a typical 8-hour day you are involved in 












d. Email or digital messages 
e. Text 
f. Round-table discussions with other health care professionals 
g. None 
 




k. Email or digital messages 
l. Text 










5. Rank each statement on a scale of 1 to 5. 1 – Strongly disagree 2- Disagree 3 – Neutral 4 
– Agree 5- Strongly agree  
 
COMPARED TO TRADITIONAL pharmacy EXCHANGES or COLLABORATIONS 
with physicians: EXPANDED SCOPE OF PRACTICE activities has: 
___a. Increased the amount of information sharing with physicians about a patient’s 
health and medication status  
___b. Increased the amount I have initiated an exchange with physicians 
___c. Resulted in more bilateral (back-and-forth) exchanges with physicians 
___d. Increased the amount a physician has initiated an exchange with me 
___e. Improved the relationship I have with physicians 
___f. Created opportunity to work in partnership with a physician or group of physicians 
___g. Increased the opportunity for a formalized agreement or practice collaborative     
agreement  
___h. Increased my knowledge or understanding of physician’s concerns, goals, and 
objectives 
 
6. On a scale of 1 to 5 (1- low, 5 –high) estimate the QUANTITY of EXCHANGES or 
COLLABORATIONS with physicians for 
___TRADITIONAL pharmacy activities 
___EXPANDED SCOPE OF PRACTICE pharmacy activities 
 
7. On a scale of 1 to 5 (1- low, 5 –high) estimate the QUALITY of EXCHANGES or 
COLLABORATIONS with physicians for 
___TRADITIONAL pharmacy activities 
___EXPANDED SCOPE OF PRACTICE pharmacy activities 
 
8. Rank in the TOP 5 (1-most) EXPANDED SCOPE OF PRACTICE activities that have 
been most influential at improving or fostering collaboration with physicians 
__ Provide emergency prescription refills 
__ Renew/extend prescriptions 
__ Change drug dosage/formulation 
__ Make therapeutic substitutions 
__ Prescribe for minor ailments/conditions 
__ Initiate prescription drug therapy 
__ Order and interpret lab tests 
__ Administer a drug by injection 
__ Medication Assessments (e.g. SMAP) 
__ Smoking cessation services (PACT) 





9. What influence has EXPANDED SCOPE OF PRACTICE activities had on 
COLLABORATION with physicians? Explain 
 
10. What has been the most effective strategy for COLLABORATION with physicians? 
Explain 
 
11. Choose which BEST describes you or your pharmacies collaborate relationship with a 
physician(s)?  
a. A CPA (Collaborative practice agreement) to perform formalized through SCPP 
to perform activities or services 
b. A written agreement to perform activities or services 
c. A verbal agreement to perform activities or services 
d. No written or verbal agreement however a cooperative relationship in which we 
work well together on individual patients or tasks consistently 
e. Limited collaboration. Communication is one-sided and limited to technical 
matters related to filling prescriptions 
f. No collaboration. As professionals we work independently almost exclusively. 
g. Adversarial. There is often hostility, conflict, or opposition when dealing with 















Appendix B: Community Pharmacists Letter of Invitation 
Hello <Insert Pharmacist Name>, 
My name is Amber Ly. I am a practicing community pharmacist currently working on my Master’s 
degree through the College of Education’s Educational Administration program at the University of 
Saskatchewan. I am conducting a research study exploring if changes to pharmacists’ scope of practice 
have influenced collaboration with physicians.  
As you are aware, our professional role has expanded dramatically over the last ten years. Coupled with 
the implementation of expanded scope of practice activities are expectations of physician collaboration. 
However, there is limited information about how these changes have affected collaboration with 
physicians, particularly from a community pharmacist’s perspective. I am hopeful to gain insight from 
pharmacists working in the community pharmacies throughout Saskatchewan by inviting them to share 
their opinions and experiences via a short online questionnaire.  
Information garnered in this area could identify effective strategies for improved collaboration with 
physicians within the community pharmacy setting. Additionally, it may guide further legislative changes 
and practice guidelines connected to expansion of the pharmacists’ role. The results will give a voice to 
community pharmacists in Saskatchewan and may have the potential to improve the current state of 
pharmacy practice in our province or possibly foster further research in this area.  
In the next week, you will be sent an email distributed by SCPP (Saskatchewan College of Pharmacy 
Professionals) via your email listed in your registration, requesting participation in the questionnaire. To 
participate just click onto the link in the email which will take you to the online questionnaire. The 
questionnaire should take no more than 15-20 minutes. The questionnaire will create anonymous 
identification codes for the participants and this code will be used to link participants’ questionnaires for 
subsequent analyses. This data will be analyzed, however will be free of any personal identifiers. SCPP, 
myself, your employer, physicians or health clinics will have NO knowledge of how specific pharmacists 
responded. Participation in this questionnaire is voluntary, and you can decide not to participate at any 
time by closing your browser. Questionnaire responses will remain anonymous. Since the questionnaire is 
anonymous, once it is submitted it cannot be removed. By completing and submitting this questionnaire, 
your free and informed consent is implied and indicates that you understand the above conditions of 
participation in this study. 
Those who participate in the questionnaire will be sent a summary of the research findings from the study 
if desired AND may win a $100 Tim Hortons OR Starbucks gift card. This information will be stored 
separately and will NOT be linked in any way to the answers you provided in the questionnaire. Thank 
you once again for your consideration for participating in this important and timely topic. 
If you have further questions or would prefer a paper copy of the questionnaire sent to you, please email 








Appendix C: Community Pharmacists First Email Invitation 
 
 
   




My name is Amber Ly. I am a practicing community pharmacist who is currently working on my 
Master’s degree through the College of Education’s Educational Administration program at the 
University of Saskatchewan. I am conducting a research study exploring if changes to pharmacists’ scope 
of practice have influenced collaboration with physicians. Last week, you should have received a letter to 
let you know about this upcoming electronic questionnaire.  
 
Purpose of the Study: The purpose of the study is to determine how changes to Saskatchewan 
pharmacists’ scope of practice have influenced the interprofessional collaborative relationship between 
community pharmacists and physicians. Additionally, the study will gather data on the types of expanded 
scope of practice activities and collaborations community pharmacists are currently involved in, and 
obtain perspectives on strategies to improve collaboration.  
 
For more information about this study please contact: 
Amber Ly: amber.ly@usask.ca or  
Vicki Squires, Assistant Professor, Department of Educational Administration 
 306-966-7622 or vicki.squires@usask.ca 
 
Procedures: 
As a participant in this study, you are asked to fill out an online questionnaire. It should take 
approximately 15 minutes to complete. Your participation in this study is completely voluntary.  
You may choose to discontinue the survey at any point by closing your browser. Once the questionnaire is 
submitted, the data cannot be removed. 
 
Compensation:  
As an incentive to participate your name will be entered into a draw a $100 Tim Horton’s or Starbucks 
gift card. If you choose to enter the draw, you will click on a link at the end of the questionnaire that takes 
you to a separate document that is NOT linked to your responses. You can record your personal 
information within this separate document to be entered in the draw.  
 
Potential Risks:  
There are no known or anticipated risks to you by participating in this research.  
 
Potential Benefits:  
Community pharmacists can offer valuable insight into how expansion of their role has affected 
collaboration with physicians, and offer ideas and strategies for more robust collaboration. Your thoughts 
on the questions will contribute to an overall understanding of Saskatchewan’s community pharmacists’ 
collaborative experiences. A final report, using aggregated data, will be available through Saskatchewan 








The data will be treated confidentially. All findings will be presented in an anonymized fashion. 
This data will be analyzed, free of any personal identifiers. SCPP, the researcher, their employer, 
physicians or health clinics will have no knowledge of how specific pharmacists responded. The raw data 
will be stored on Survey Monkey’s servers (on a Canadian server, by an American firm); as an 
institutionally supported survey tool, Survey Monkey is accessed through the U of S secure portal. Once 
the questionnaire is complete, the file of raw data may be downloaded onto the University of 
Saskatchewan cabinet (university server) into a password protected file for the student researcher and her 
supervisor.   
 
 
The link to the questionnaire is found below. By completing and submitting the questionnaire, YOUR 
FREE AND INFORMED CONSENT IS IMPLIED and indicates that you understand the above 
conditions of participation in this study. 
 
 
Questionnaire Link: https://www.surveymonkey.ca/r/5PQPDCK 
 
 ****Please Note that your web browser is going to ask your permission to proceed to this website. 
Survey Monkey is a valid and confidential data collection tool employed by the University of 
Saskatchewan. If you have any concerns please contact me. 
 
You may choose to discontinue the survey at any point by closing your browser.  
  
This research project has been approved on ethical grounds by the University of Saskatchewan 
Behavioural Research Ethics Board (BEH # 1212).  Any questions regarding your rights as a participant 
may be addressed to that committee through the Research Ethics Office ethics.office@usask.ca (306) 
966-2975. Out of town participants may call toll free (888) 966-2975. 
 
















Appendix D: Community Pharmacists Second Email Invitation 
 
 
   




My name is Amber Ly. Approximately 10 days ago, SCPP sent an email inviting you to complete a 
questionnaire. I would really appreciate your feedback. If you have already completed this questionnaire, 
I thank you so much for your support. If you have not had time to complete it yet, I would be grateful for 
your participation. 
 
I am a practicing community pharmacist who is currently working on my Master’s degree through the 
College of Education’s Educational Administration program at the University of Saskatchewan. I am 
conducting a research study exploring if changes to pharmacists’ scope of practice have influenced 
collaboration with physicians.  
 
Purpose of the Study: The purpose of the study is to determine how changes to Saskatchewan 
pharmacists’ scope of practice have influenced the interprofessional collaborative relationship between 
community pharmacists and physicians. Additionally, the study will gather data on the types of expanded 
scope of practice activities and collaborations community pharmacists are currently involved in, and 
obtain perspectives on strategies to improve collaboration.  
 
For more information about this study please contact: 
Amber Ly: amber.ly@usask.ca or  
Vicki Squires, Assistant Professor, Department of Educational Administration 
 306-966-7622 or vicki.squires@usask.ca 
 
Procedures: 
As a participant in this study, you are asked to fill out an online questionnaire. It should take 
approximately 15 minutes to complete. Your participation in this study is completely voluntary.  
You may choose to discontinue the questionnaire at any point by closing your browser. Once the 
questionnaire is submitted, the data cannot be removed. 
 
Compensation:  
As an incentive to participate your name will be entered into a draw a $100 Tim Horton’s or Starbucks 
gift card. If you choose to enter the draw, you will click on a link at the end of the questionnaire that takes 
you to a separate document that is NOT linked to your responses. You can record your personal 
information within this separate document to be entered in the draw.  
 
Potential Risks:  
There are no known or anticipated risks to you by participating in this research.  
 
Potential Benefits:  
Community pharmacists can offer valuable insight into how expansion of their role has affected 
collaboration with physicians, and offer ideas and strategies for more robust collaboration. Your thoughts 




collaborative experiences. A final report, using aggregated data, will be available through Saskatchewan 
College of Pharmacy Physicians (SCPP)’s website when the study is completed.  
 
Confidentiality:  
The data will be treated confidentially. All findings will be presented in an anonymized fashion. 
This data will be analyzed, free of any personal identifiers. SCPP, the researcher, their employer, 
physicians or health clinics will have no knowledge of how specific pharmacists responded. The raw data 
will be stored on Survey Monkey’s servers (on a Canadian server, by an American firm); as an 
institutionally supported survey tool, Survey Monkey is accessed through the U of S secure portal. Once 
the questionnaire is complete, the file of raw data may be downloaded onto the University of 
Saskatchewan cabinet (university server) into a password protected file for the student researcher and her 
supervisor.   
 
 
The link to the questionnaire is found below. By completing and submitting the questionnaire, YOUR 
FREE AND INFORMED CONSENT IS IMPLIED and indicates that you understand the above 
conditions of participation in this study. 
 
Questionnaire Link: https://www.surveymonkey.ca/r/5PQPDCK  
 
 ****Please Note that your web browser is going to ask your permission to proceed to this website. 
Survey Monkey is a valid and confidential data collection tool employed by the University of 
Saskatchewan. If you have any concerns please contact me. 
 
You may choose to discontinue the questionnaire at any point by closing your browser.  
  
This research project has been approved on ethical grounds by the University of Saskatchewan 
Behavioural Research Ethics Board (BEH # 1212).  Any questions regarding your rights as a participant 
may be addressed to that committee through the Research Ethics Office ethics.office@usask.ca (306) 
966-2975. Out of town participants may call toll free (888) 966-2975. 
 












Appendix E: Community Pharmacists Third and Final Email Invitation 
 
 
   




My name is Amber Ly. Within the last month, SCPP has sent two emails inviting you to complete a 
questionnaire. I would really appreciate your feedback. If you have already completed this survey, I 
thank you so much for your support. If you have not had time to complete it yet, I would be so grateful 
for your participation. This email will be the final reminder to complete the questionnaire.  
 
I am a practicing community pharmacist who is currently working on my Master’s degree through the 
College of Education’s Educational Administration program at the University of Saskatchewan. I am 
conducting a research study exploring if changes to pharmacists’ scope of practice have influenced 
collaboration with physicians.  
 
Purpose of the Study: The purpose of the study is to determine how changes to Saskatchewan 
pharmacists’ scope of practice have influenced the interprofessional collaborative relationship between 
community pharmacists and physicians. Additionally, the study will gather data on the types of expanded 
scope of practice activities and collaborations community pharmacists are currently involved in, and 
obtain perspectives on strategies to improve collaboration.  
 
For more information about this study please contact: 
Amber Ly: amber.ly@usask.ca or  
Vicki Squires, Assistant Professor, Department of Educational Administration 
 306-966-7622 or vicki.squires@usask.ca 
 
Procedures: 
As a participant in this study, you are asked to fill out an online questionnaire. It should take 
approximately 15 – 20 minutes to complete. Your participation in this study is completely 
voluntary.  
You may choose to discontinue the questionnaire at any point by closing your browser. Once the 




As an incentive to participate your name will be entered into a draw a $100 Tim Horton’s or Starbucks 
gift card. If you choose to enter the draw, you will click on a link at the end of the questionnaire that takes 
you to a separate document that is NOT linked to your responses. You can record your personal 
information within this separate document to be entered in the draw.  
 
Potential Risks:  







Potential Benefits:  
Community pharmacists can offer valuable insight into how expansion of their role has affected 
collaboration with physicians, and offer ideas and strategies for more robust collaboration. Your thoughts 
on the questions will contribute to an overall understanding of Saskatchewan’s community pharmacists’ 
collaborative experiences. A final report, using aggregated data, will be available through Saskatchewan 
College of Pharmacy Physicians (SCPP)’s website when the study is completed.  
 
Confidentiality:  
The data will be treated confidentially. All findings will be presented in an anonymized fashion. 
This data will be analyzed, free of any personal identifiers. SCPP, the researcher, their employer, 
physicians or health clinics will have no knowledge of how specific pharmacists responded. The raw data 
will be stored on Survey Monkey’s servers (on a Canadian server, by an American firm); as an 
institutionally supported survey tool, Survey Monkey is accessed through the U of S secure portal. Once 
the questionnaire is complete, the file of raw data may be downloaded onto the University of 
Saskatchewan cabinet (university server) into a password protected file for the student researcher and her 
supervisor.   
 
 
The link to the questionnaire is found below. By completing and submitting the questionnaire, YOUR 
FREE AND INFORMED CONSENT IS IMPLIED and indicates that you understand the above 
conditions of participation in this study. 
 
 
Questionnaire Link: https://www.surveymonkey.ca/r/5PQPDCK  
 
 ****Please Note that your web browser is going to ask your permission to proceed to this website. 
Survey Monkey is a valid and confidential data collection tool employed by the University of 
Saskatchewan. If you have any concerns please contact me. 
 
You may choose to discontinue the questionnaire at any point by closing your browser.  
  
This research project has been approved on ethical grounds by the University of Saskatchewan 
Behavioural Research Ethics Board (BEH #1212).  Any questions regarding your rights as a participant 
may be addressed to that committee through the Research Ethics Office ethics.office@usask.ca (306) 
966-2975. Out of town participants may call toll free (888) 966-2975. 
 














THE INFLUENCE OF PHARMACISTS’ EXPANDED SCOPE OF PRACTICE ON 
PHYSICIAN COLLABORATION IN COMMUNITY PHARMACY                                                   
…………………………….SUMMARY OF RESEARCH FINDINGS AND RECOMMENDATIONS        AMBER LY BSC BSP MED 
 
ABSTRACT 
The Canadian Healthcare System is overburdened and requires fundamental changes for its continued 
sustainability. One possible solution is healthcare professionals working more collaboratively and to their 
maximum scope of practice. Saskatchewan pharmacists have had significant expansion in their scope of practice in 
the last decade and correspondingly, expectations of collaboration. This study’s primary objective was to explore 
the influence of pharmacists’ expanded scope of practice (ESoP) on physician collaboration in the community 
pharmacy setting. This thesis proposes a new model, the Community Pharmacists Collaboration Model (CPCM), for 
analysis of community pharmacists’ collaboration derived from the Collaborative Working Relationship, Hudson’s, 
Artimage’s, and Spectrum of Collaboration models. It uses this model to examine collaboration in the context of a 
community pharmacy setting, taking into consideration pharmacy partnerships and Collaborative Practice 
Agreements.  
An online questionnaire was emailed to all 1165 practicing community pharmacists in Saskatchewan. The 
questionnaire acquired data on: participant demographics, ESoP engagement, most beneficial activities, influence 
on physician collaboration, and strategies for fostering collaboration. The questionnaire response rate was 15.7%. 
Pharmacists suggested ESoP positively influenced communication and collaboration, pharmacist utilization, clinical 
management, and pharmacist-physician relationships. ESoP may play a role at increasing the frequency and quality 
of exchanges between pharmacists and physicians, however, did not appear to improve the opportunity for verbal 
or written agreements. The most effective strategy identified for fostering collaboration was maximizing 
exchanges with physicians, especially verbal exchanges. Lack of physician engagement and restrictions to direct 
communication channels with physicians were hindrances. 
Pharmacists’ utilization of ESoP activities and its subsequent correspondence may be an avenue in which to 
improve collaboration with physicians. The CPCM model could prove to be a useful tool to aide in the 
understanding of collaborative practice in the community pharmacy setting. Further exploration into community 
pharmacy collaboration, particularly regarding physician engagement will prove advantageous.  
 
Thank you for your participation in this study and for taking the time to share your experiences and opinions on 
the influence of pharmacists’ Expanded Scope of Practice (ESoP) on collaboration with physicians.   
Included in this document is the study’s abstract, relevant study details, major research findings, summary, and 
practice recommendations for your consideration.  
















































•The Canadian healthcare system is 
under pressure for its continued 
sustainability. Expansion of 
healthcare professionals roles and 
improved interprofessional 
collaboration are possible solutions. 
Recent expansion of pharmacists’ 
scope of practice may provide an 
opportunity for enhanced 
collaboration with physicians. 
BACKGROUND
•To determine what influence 
expansion of pharmacists’ scope of 
practice has had on collaboration 
with physicians in the community 
pharmacy setting throughout 




SUMMARY OF MAJOR FINDINGS 
What percentage of time in a typical 8 hour shift does 
the average pharmacists spend providing Expanded 
Scope of Practice services? 
 
Which Expanded Scope of Practice activities were the 
most beneficial for fostering collaboration with 
physicians? 
 
What was the primary medium and most effective 
medium pharmacists used for collaboration with 
physicians? 
         Primary Medium              Most Effective Medium 
 
How do community pharmacists classify their 







































Pharmacists Practicing in Large Urban
Centres (>100,000)
Pharmacists Practicing in Medium
Urban Centres (30,000-99,999)
Pharmacists Practicing in Small Urban
Centres (5000-29,999)
Pharmacists Practicing in Rural
Centres(<5000)
Pharmacist Experience: 57%  >11 years of pharmacy experience
Average Pharmacy Prescription Volume:  200 - 500+ Rx/day 
Pharmacist Position: 53% staff pharmacists  25% managers       
11% owners  6% floaters  5% clinical pharmacists
Pharmacy Proximity to Clinic: 



























 How many pharmacists agreed versus disagreed with the following statements regarding the influence of Expanded 
Scope of Practice on physician collaboration? 
 
What were the top five most common responses on the influence of Expanded Scope of Practice to collaboration 
with physicians? 
 
What do the study results look like when applied to the Community Pharmacists Collaboration Model (CPCM)?     
 
What strategies did pharmacists indicate were most effective for fostering collaboration with physicians?  
                                     











































































































Lack of physician engagement and participation in 
pharmacists collaboration efforts
Physician clinics limiting pharmacists collaboration 
efforts by restricitng direct verbal communication with 














Expanded scope of practice activities 
appear to increase contact, 
pharmacist initiated exchanges and 
bilateral exchanges with physicians. 
In the exchange process, bi-products 
of attributes considered valuable for 
collaboration are produced, which 
in-turn promote collaboration.         
A positive feedback loop is formed 
inducing collaboration closer 
towards integration and further 


































The results of this study support the notion that many community pharmacists seem interested in collaborating and 
appear engaged in the process. Most pharmacists view their relationship with physicians in a positive light in which 
they work well together in a coordinated and collaborative manner. Few pharmacists believe there is no 
collaboration occurring between the two parties or that the relationship is adverse or marked with hostility. 
Further, it appears that most community pharmacists are implementing Expanded Scope of Practice (ESoP) 
activities into their daily workload. Data indicates that as pharmacists become more involved in providing ESoP 
activities, the more likely they perceive them as positive or valuable for collaboration. They are also more likely to 
classify their relationship with physicians as a collaborative compared to pharmacists who are less engaged. 
The findings suggest that community pharmacists’ involvement in ESoP may improve communication and 
collaboration with physicians and could possibly support goals of improved patient and health systems outcomes. 
ESoP activities that are more clinical and patient centered compared to traditional activities may be better received 
by physicians than traditional exchanges, and thereby help encourage more collaboration. Increasing the frequency 
and quality of exchanges with physicians could play a role at fostering attributes considered important for improved 
collaboration such as relationship development, professional interactions, role recognition and awareness, and 
understanding physicians’ needs. The data suggest that ESoP may be an avenue that pharmacists can practically 
implement to encourage more collaboration, achieve more robust collaboration, or use to help develop 
foundational principles for advancing collaboration.  
The study also indicates that pharmacist engagement in ESoP alone may not be enough to secure the richest form 
of collaboration such as partnerships, Collaborative Practice Agreement (CPA) or other written commitments for 
both parties to work in a formalized and interdependent manner. It draws attention to the notion that there is a 
need to engage physicians more in the process and have them more actively utilizing pharmacists’ newly expanded 
roles. If community pharmacists are going to continue to positively influence collaboration with physicians and 
move towards integration of services, they need to identify how to enhance physician engagement and formalize 
the commitment to work together in the form of verbal, written agreements, or CPAs. 
 
SUMMARY & PRACTICE RECOMMENDATIONS 
 
 
Expanded scope of practice activities may be an avenue to 
enhance collaboration with physicians. Maximizing 
communication of these activities with physicians with 
effective verbal or written communication may prove 
advantageous.
Increasing the frequency and quality of exchanges toward 
integration, especially when done through verbal medium 
channels (such as the phone or in-person) may assist in 
fostering attributes deemed valuable for collaboration.
Attributes identified as valuable for collaboration were 
effective communication, relationship building, role 
recognition and awareness, utilizing professional and 
clinical skill set, understanding physician needs.
Expanded scope of practice activities alone may not be 
enough to secure partnerships, written agreements and 
CPAs. Improving physician engagement and accessing direct 
communication channels may be beneficial.
PRACTICE RECOMMENDATIONS
